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ABSTRACT 
Transforming Growth Factor-β (TGFβ) can induce an epithelial to mesenchymal transition 
(EMT) in lens that results in fibrotic cataract. It has previously shown that the reactive 
oxygen species (ROS) producing enzyme, NADPH oxidase 4 (Nox4), is upregulated in 
response to TGFβ-signalling. To better elucidate the role(s) of Nox4 in lens EMT, the present 
study characterised TGFβ-induced EMT and cataract formation using both in vitro and in 
vivo models, including Nox4 deletion strategies.
We demonstrated that TGF-β can induce the upregulation of Nox4 in lens epithelial cells 
with a concomitant increase in reactive oxygen species (ROS) at early stages of in vitro 
culture. Pharmacological inhibition of Nox4 revealed that the presence of ROS at these early 
timepoints was due to Nox4 expression. When cultured over 5 days, pharmacological 
inhibition of Nox4 in lens cells delayed the progression of EMT by attenuating the formation 
of both TGF-β-induced capsular wrinkling and myofibroblasts, evidenced by the absence of 
alpha-smooth muscle actin (αSMA). 
One of the most notable findings of the present study was when mice overexpressing TGF-β 
specifically in the lens (that have anterior subcapsular cataracts) were crossed to Nox-4 
deficient mice, and the lenses of their resultant progeny remaining transparent up to postnatal 
day 30. Despite this transparency, histology and immunolabelling of these same lenses 
revealed the presence of anterior subcapsular plaques; however, devoid of the typical EMT 
markers. Labelling of Nox4-deficient lens epithelial explants, and also the transgenic mouse 
lens sections revealed elevated pSmad2/3- and pERK1/2-signalling. Further qPCR analysis of 
these tissues revealed compensatory upregulation of Nox2 in mice deficient for Nox4. 
Moreover, TGFβ-treatment induced elevated but delayed ROS-labelling in Nox4-deficient 
lens epithelial explants.
These results indicate that in mice at least, Nox4 plays a role in the development of TGFß-
induced lens EMT leading to cataract, potentially by modulating pSmad2/3- and pERK1/2-
signalling. In the absence of Nox4, there are other compensatory producers/sources of ROS, 
such as Nox2 and mitochondrial ROS. Taken together, these findings provide a better 
understanding of TGFß-induced lens EMT, as well as a platform allowing us to delineate 
putative Nox4 interactions with Smad2/3 and/or ERK1/2, as well as other signalling 
intermediates.
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1. Introduction
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1.1 The Lens 
Situated in the anterior aspect of the eye, the lens is posteriorly and anteriorly bathed by the 
vitreous and aqueous humours, respectively. As light enters the eye through the pupil the lens 
refractively converges light rays that are focused on the retina. The retina is comprised of 
photoreceptors that enable phototransduction and higher sensory processing. Reflecting the 
notion that the focal length of an object affects where it is focussed in the eye, the lens must 
therefore be able to morphologically change which in turn changes the angle of refraction. This 
phenomenon is known as accommodation and is controlled by the ciliary body and lens 
zonules. Essentially, when a distant object is being observed, the ciliary body relaxes allowing 
the zonules to pull on the lens and reduce its curvature (shown in Figure 1.1.1). Conversely, 
the focussing of a nearby object requires a greater angle of refraction and this is facilitated by 
the relaxation of the zonules and the resultant increase in the curvature of the lens (7, 8). 
To maintain visual acuity, the lens must remain transparent +owever, it must also exhibit 
a greater density than that of the preceding aqueous humour to have a greater refractive 
index and, thus, IXOILOO its ocular purpose. These seemingly contradictory traits are 
simultaneously enabled by its simple architecture, comprised of an anterior monolayer of 
simple cuboidal epithelium, a predominant mass of fibre cells and a surrounding lens capsule 
that serves as a basement membrane for the epithelia and fibres (9). Transparency is 
afforded by the progressive accumulation of crystallin proteins during embryogenesis. 
Consistent with the Rayleigh ratio, crystallin accumulation at concentrations of up to 450 mg 
ml-1 (10) would be expected to induce significant scattering of light throughout the lens.
However, it has been shown that the relatively high crystallin concentration facilitates short-
range spatial order (11) between the proteins that yields uniform light scatter throughout
the lens and, therefore, uniform refraction of light.
CKDSWHU  *HQHUDO ,QWURGXFWLRQ
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1.1.1 Lens Development 
Perhaps best summarised by Coulombre, the lens can be thought of as a target of outside 
influence (12). Morphogenesis of the lens is marked by deepening of the embryonic head 
ectoderm to form the lens pit, and its subsequent dissociation from both the overlying 
embryonic ectoderm to form the lens vesicle. Cells in the posterior half of the vesicle elongate 
and differentiate to form the primary fibres, whereas cells in the anterior part of the vesicle 
differentiate to form the epithelial monolayer; thereby, giving rise to the distinctive polarity 
associated with the developed lens. Throughout life, this architecture is maintained through 
proliferation of the epithelium and gradual differentiation of the resultant progeny into fibres 
(13). 
Figure 1.1.1 Diagrammatic representation of the location and function of the lens in the eye. Focusing of a distant object, 
as shown in (A) requires that the lens maintain a reduced curvature. Denoted by the direction of the orange arrow, this is 
achieved via zonular ligaments pulling on the lens. However, as the object spatially approaches the lens (B), light rays from 
the object are focused beyond the retina. Finally, as shown in (C), the nearby object is focused on the retina through an increase 
in the curvature of the lens. In this case, the zonular ligaments relax, denoted by the direction of the orange arrow, such that 
the lens may return to its natural spheroidal shape. 
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1.1.2 Cataract 
Given the relatively simple architecture and function of the lens, there are few pathologies of 
which the lens can succumb. Termed generally as cataract, opacification of the lens represents 
the most prevalent cause of blindness in Australia (14). An increased prevalence in advanced 
age demographics has indicated that age is a key contributor to disease onset. This is 
compounded by a large body of research suggesting that the onset of cataract is influenced by 
many risk factors such as lifestyle, genetics, trauma and comorbidities (15).  Clinical 
presentation of age-related cataracts encompasses three broad classifications; nuclear 
sclerotic, cortical and subcapsular.  :KLOH both nuclear sclerotic and cortical cataract 
are most commonly associated with the degenerative effects of ageing, subcapsular cataracts 
commonly arise from trauma and inflammation or irritation of the eye. 
Reflective of the natural ageing process, pathogenesis of age-related cataract is marked by 
degenerative changes to the fibres and/or loss of transparency. Lens nuclear sclerosis is the 
most common variant and is characterised by condensing of the central portion of the lens, 
accompanied by progressive yellow pigment deposition to yield scattering of light As this 
uniformly occurs throughout the central portion of the lens and does not interfere with short-
range spatial order, patients initially become myopic and are treatable with glasses (15). 
Whereas, in cases of mature cortical cataract, onset of opacity is principally the result of 
disruption to fibre cell membranes and the subsequent formation of globules in the cytoplasm. 
It is believed that the opacification passes along adjacent fibres to yield spoke-like opacities, 
growing centripetally from the lens periphery (16). Visual acuity is not greatly affected until 
these opacities impede the visual axis. 
Anterior subcapsular cataract (ASC) is the least prevalent form of cataract and is characterised 
by dense light scattering regions under the anterior lens capsule. The implication of trauma and 
irritation to the eye delineates subcapsular cataract from those associated with ageing. This is 
due to the formation of fibrotic cellular masses that arise as part of a wound-healing response 
to the injurious stimuli. Discussed later, fibroblasts are believed to originate from transitioning 
epithelia through the biological process of epithelial-mesenchymal transition (EMT) (17, 18). 
Due to its progressive nature and absence of effective treatment strategies, surgery remains the 
only interventional option for patients whose cataracts greatly hamper visual acuity. Termed 
phacoemulsification, surgical removal of cataract is initiated by accessing the lens and 
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performing capsulorhexis, such that the anterior central aspect of the lens capsule is removed. 
The exposed cataract is then ultrasonically emulsified, ZKLOH simultaneously aspirated until 
the lens capsule is devoid of most cells, and a prosthetic intraocular lens (IOL) is implantable 
(19). 
Phacoemulsification leaves residual lens epithelial cells attached to the lens capsule.  As part 
of a wound healing response, these cells can undergo hyperplasia to progressively occupy the 
denuded areas of the lens capsule and undergo epithelial to mesenchymal transition (EMT). 
The aggregation of mesenchymal growths are initially localised to the remaining anterior 
capsule +owever, cell hyperplasia across the posterior aspect of the capsule and 
subsequent changes associated with the mesenchymal phenotype (discussed in 1.2) 
yields posterior supcapsular cataract, more commonly known as posterior capsular 
opacification (PCO), that extends across the visual axis. :KLOH the hyperplastic generation 
of a thin layer of cells is insufficient to significantly affect visual acuity, the acquisition of a 
mesenchymal phenotype and extracellular matrix (ECM) deposition and changes 
associated with EMT potentiates significant scattering of light (18). 
Figure 1.1.2 Schematic of the lens capsule before and after cataract removal surgery. A) As part of phacoemulsification, 
an intraocular lens (IOL) is implanted through an opening created by removing the anterior lens capsule. The IOL is held 
within the remaining lens capsule through two projections from the IOL, termed haptics. B) Residual lens epithelial cells 
undergo hyperplasia sometime after surgery, to occupy the previously denuded posterior capsule. Prolonged exposure to 
inflammatory signals induces a wound-healing response marked by disruption to the ECM, across the visual axis. This gives 
rise to significant scattering of light and the onset of PCO.
A
B
Lens capsule 
Haptic 
Lens 
epithelia 
Capsular 
wrinkling 
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Incidence of PCO following phacoemulsification was recently documented to be 38.5 % within 
3-years (14). :KLOH ongoing improvements in surgical technique and biomaterials have been 
associated with decreases in overall incidence, it still remains a common complication of 
phacoemulsification. The clinical relevance of PCO lies in that it is progressive, and cell 
mediated changes across the visual axis can often lead to secondary loss of vision and the 
requirement of further surgery. Given the immediate contraindications of performing surgery 
on advanced-age demographics and a potentially unnecessary financial burden, questions have 
been raised as to non-surgical alternatives to PCO treatment. Pharmacological options have
sought to prevent the onset of PCO by blocking hyperplasia of the lens epithelial cells post-
surgery +owever, a lack of specificity to the lens has often resulted in cytotoxicity in
experimental models (17). As a result of this, focus on the prevention of PCO has shifted to
understanding the signalling pathways associated with EMT, in the hope that molecules can be
identified that play a role in the transitioning of lens epithelial cells.
1. ESithelial-MesenchyPal Transition
As implied by the name, EMT encompasses a series of biochemical events whereby epithelial 
cells undergo multiple changes that enable a mesenchymal phenotype. The underlying 
biochemical changes that facilitate this transition are triggered in response to a wide array of 
cytochemical moieties. EMT events have been proposed as occurring in three contexts; i. 
embryonically, ii. as part of neoplastic metastasis, and iii. the result of tissue repair. Signalling 
pathways eventually converge at the point of transcription; where transcriptional activation and 
repression of key genes marks the shedding of the epithelial phenotype. 
1.2.1 Morphological transition 
The morphological changes that define EMT reflect the concept that exertion of tissue-specific 
function is ultimately determined by phenotypic characteristics. Essentially, the epithelial 
phenotype is marked by a simple cuboidal cell morphology and intramembranous proteins such 
as gap junctions, tight junctions, adherens junctions and desmosomes. These features serve to 
facilitate the formation of organised layers, through tight cell-cell adhesion. Furthermore, 
attachment and communication with an underlying basement membrane, through integrin 
proteins, gives rise to a distinctive apico-basal polarity to cells; ensuring that cells exhibit 
limited to no migratory capacity into the ECM. By contrast, a loss of cell-cell adhesion means 
that the mesenchymal phenotype is not subject to organised layer formation; mesenchymal 
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cells may, therefore, only interact with other mesenchymal cells through points of focal 
adhesion. Importantly, EMT-mediated degradation of the basement membrane, and increases 
in production of ECM components allows for enhanced migratory capacity and loss of apico-
basal polarity (20-22). :KLOH the development of a mesenchymal phenotype is conserved, 
notable differences are observable as to the purpose and ultimate result of each type of EMT. 
Figure 1.2.1 Schematic of EMT. Functional differences between epithelial and mesenchymal cells are attributable to 
progressive morphological and biochemical changes that occur throughout EMT.  Under persistent cytochemical signals, 
epithelial cells lose cell-adhesion and cell-basement membrane adhesion such that a general loss in apico-basal polarity is 
observable. Shown beneath each picture, cytochemical signals allow for simultaneous upregulation of mesenchymal markers 
and downregulationtion of epithelial markers. Adapted from (23)
1.2.2 Types of EMT 
The early underpinnings of what is now termed EMT were initially described through studies 
that sought to understand the gastrulation stage of embryogenesis. Trelstad and collegues used 
electric coupling to identify variable degrees of cell-cell contact between the three germ layers, 
of which most cells derive (24). This pioneering work used the chick primitive streak to identify 
that increases in the propensity for cellular migration in the endoderm and mesoderm, distinct 
from the ectoderm, appeared to be directed by the degree of cell-cell contact. It was postulated 
that development of the embryonic germ layers was underpinned by variable cell-cell adhesion. 
However, it was not until the 1980s that evidence emerged citing an underlying biological 
process that facilitated this. 
Summarised recently, these studies found that culturing of embryonic and adult lens epithelial 
cells on collagen gels led to elongation and migration of individual cells (25). This process was 
termed as EMT and gave rise to the identification of a variety of tissue remodelling events that 
occur throughout embryogenesis. Importantly, the observation that adult cells were also 
Vimentin 
Fibronectin 
FSP1 
α-Smooth Muscle Actin 
E-Cadherin
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capable of undergoing transition highlighted the reversible nature of EMT events and that 
certain cells exist in a quasi-terminally differentiated state. It is currently believed that a degree 
of cellular plasticity exists which is facilitated by both EMT and the reverse process, 
mesenchymal-epithelial transition (MET). Aside from dispersing progenies of epithelial cells, 
the primary mesenchyme can ultimately give rise to connective tissues that are essential for 
supporting epithelial cells, such as astrocytes, adipocytes, chondrocytes and muscle cells (23).  
Therefore, the significance of such events lies in that cells can undergo cycles of EMT and 
MET, to ultimately lay the foundation for which complex structures such as organs are built. 
Perhaps best encapsulating its disseminating property, EMT associated with epithelial tumour 
progression arises from the initial imbalance of hyperplasia and apoptosis. It is believed that 
once a primary tumour site has formed, the acquisition of an invasive phenotype is enabled via 
EMT. As aforementioned, EMT mediated loss of cell-cell adhesion and increased cellular 
motility increases the migratory capacity of cells within the primary tumour site. Additionally, 
changes to the ECM facilitates intravasation of the mesenchymal cells into the circulatory 
system; thereby enabling the development of secondary tumour sites. Interestingly, it has been 
documented that the secondary tumour sites histopathologically resemble the epithelial 
phenotype of the primary tumour; implying an inherent importance in the local biochemical 
environment on modulating the progression of EMT (23). 
EMT associated with tissue repair remains distinct from both the embryonic and neoplastic 
variants, as increased cellular migration is not the principal function of the mesenchymal 
phenotype; rather, it is used as a means to generate a wound-healing response (23). In this case, 
an injury to the epithelia disrupts cell-cell adhesion such that there is an increase in 
inflammatory stresses. Among other changes to the cellular milieu, the induction of fibroblasts 
represents a key occurrence in order to reconstruct the tissue, as fibroblasts lay down 
connective tissues. Aberrant activation of these fibroblasts leads to excessive connective tissue 
deposition and this is known as fibrosis. It has been argued that fibroblasts are generated from 
marrow stromal cells that populate the peripheral organs, capable of developing a fibroblastic 
phenotype; however, an alternate argument proposes that fibroblasts are generated locally as 
part of an EMT in response to cytochemical signals (26). It is important to note that recent 
literature has suggested that a distinction is made between these fibroblasts and the 
aforementioned mesenchymal cells associated with other forms of EMT. It is cited that, 
although the fibroblast and mesenchymal cell are morphologically conserved, fibroblasts are 
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not capable of undergoing MET and express specific proteins not observable on a 
mesenchymal cell (27).  
Evidence supporting the concept that fibroblasts can transition from epithelia comes from in 
vitro studies that identified the fibroblast marker, fibroblast-specific protein (FSP1), in cultured 
epithelial cells undergoing transition. Iwano and colleagues used an experimental mouse model 
of renal fibrosis to demonstrate that transitioning epithelial cells not only began to take the 
shape of fibroblasts, but were also FSP1-positive (26). Acquisition of this transitional state has 
been termed partial EMT, reflecting the notion that the cells concomitantly 
express characteristics of both fibroblasts and epithelia (see figure 1.2.1. Under persistent 
signals, the epithelial cell shedding its previous epithelial characteristics and invasion of the 
ECM marks the development of a fully-fibroblastic phenotype. Once settled in the ECM, it 
is the role of the fibroblast to secrete large quantities of ECM components such as collagen 
and fibronectin that provide structural integrity to the wound. Additionally, a subset of both 
fibroblasts and epithelia has the potential to undergo further transition to form 
myofibroblasts (20, 28, 29). Myofibroblasts amplify the wound healing response through 
ATP-modulated actin stress fibre contraction that ultimately allows for wound closure 
through matrix contraction and re-epithelisation. 
1.2.3 EMT Induction 
The process of EMT is manifested through the convergence of numerous molecular signalling 
pathways. Briefly, the interplay of soluble growth factors, cytokines, and ECM components, 
allows for shedding of the epithelial phenotype. Growth factors, such as Transforming Growth 
Factor-beta (TGF-β), Hepatocyte Growth Factor (HGF), Platelet-derived Growth Factor 
(PDGF) and Wnt, are ligands to some of the more established signalling pathways (20, 21). 
The precise role of these growth factors is governed by the physiological context that 
necessitates EMT, although TGF-β is believed to be the prototypical factor responsible for 
driving EMT induction. For example, ZKLOH HGF is capable of inducing EMT during 
somitogenesis, it also prevents EMT in the fibrogenic kidney. Additionally, synergistic roles 
among certain growth factors have been reported (23).  Discussed later, mechanisms for 
controlling the effects of growth factors are predominantly observable at the level of the 
receptor; where, binding of a specific domain induces phosphorylation and subsequent 
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recruitment of downstream effector proteins. It has been postulated that such a degree of 
heterogeneity in the induction of EMT exists as a means to avoid aberrant activation (20). 
Interestingly, however, nearly all of the mentioned growth factors and their respective effector 
proteins lead to recruitment of the same group of transcription factors. This is reflective of the 
concept that the development of the mesenchymal phenotype is predicated on engagement of 
a conserved EMT programme. Transcription factors, such as, SNAI1, SNAI2, twist, nuclear β-
catenin, and Smads bind regions of the EMT transcriptome such that epithelial genes such as 
E-cadherin are downregulated, while upregulating mesenchymal genes such as LEF1, 
vimentin and fibronectin (20); thereby, modulating cytoskeletal arrangement, cell-cell contact 
and cell-basement membrane attachment (13).
1.2.4 TGF-β and Fibrotic Cataract 
Due to its association with fibrosis and wound-healing, the signalling pathways that result 
from TGF-β activation have been an area of intense research.  :KLOH the surgical breaching of 
the blood-ocular barrier explains an initial influx of inflammatory cytokines such as TGF-β 
within a few months, the progressive nature of PCO implies persistent involvement well 
beyond the initial stimuli (30). PCO can, therefore, be thought of as an aberrant amplification 
of TGF-β signalling. Evidence supporting this was initially described by Liu and colleagues, 
who found that upon addition of exogenous TGF-β to rat lens epithelial explants, cells began 
to elongate, undergo ECM accumulation and capsular wrinkling (31). Subsequent studies 
found upregulation of mesenchymal markers, such as fibronectin, collagens I and III, and α-
smooth muscle actin, with addition of exogenous TGF-β to lens cells (32). α-smooth muscle 
actin is a specific myofibroblast marker, implying that the observed associated capsular 
wrinkling is, at least in part, mediated by myofibroblast activity. 
In vivo models have used transgenic mice overexpressing TGF-β to further the link between 
TGF-β and cataract. Using the αA-crystallin promoter, Srinivasan and colleagues 
overexpressed TGF-β specifically to the lens (4). By postnatal day 21 the mice developed a 
fibrotic plaque in the subepithelial region, consistent with ASC. Periodic acid-Schiff staining 
revealed diffuse staining of ECM components in this plaque, distinct from the non-transgenic 
group that stained positive only in the lens capsule. Additionally, the plaque stained positive 
for α-smooth muscle actin (4). 
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Indeed, assessment of post-phacoemulsification lens capsules confirms this, by also 
implicating elevated TGF-β levels in these biopsies (33). Using donor eyes that contained 
prosthetic IOLs, capsular bags were isolated, such that immunocytochemistry could be 
performed. In particular, attention is drawn to an ex vivo capsular bag one month after 
phacoemulsification. It is documented that significant wrinkling of the posterior capsule was 
observed, and hyperplasia had occurred across the posterior capsule with α-smooth muscle 
actin present. This correlated to the other capsular bags used within this study, that had 
undergone sham-cataract surgery. A distinct spike in active TGF-β levels were observed in the 
lens capsules by day 28 of serum-free culture (33). Taken together, the mentioned findings 
from in vitro, in vivo and ex vivo studies provide strong experimental evidence for the 
implication of TGF-β in fibrotic cataractogenesis. It is therefore of paramount importance to 
understand the signalling pathways through which TGF-β induces fibrotic cataract. 
1.3 Transforming Growth Factor-β 
The TGF-β superfamily consists of 30 ligands, including TGF-β, inhibin, nodal, bone 
morphogenetic protein, growth differentiation factors and mullerian inhibiting substance. 
These ligands are responsible for regulating aspects of hyperplasia, cellular recognition, 
differentiation and apoptosis. TGF-β ligands arise from a conserved larger precursor protein 
(ssentially, the ligands exhibit 6 conserved cysteine residues that are collectively referred to 
as the cystine knot (34). The seventh cysteine residue is reserved for the joining of two 
monomeric ligands to form a dimer upon receptor activation. The binding of two monomeric 
ligands at this residue is facilitated by hydrophobic interactions, strengthened via disulfide 
linkages. The TGF-β ligands bind serine-threonine kinase receptors, comprised of 12 
members; 7 type I (TβR1) and 5 type II (TβR2) (35). Activation of signalling pathways 
requires the dimeriVation of a type I and II receptor. 
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1.3.1 TGF-β Ligand regulation 
The eponymous TGF-β sub-class of ligands exist as 3 isoforms in humans and their secretion 
and activation remains the most understood within the family. :KLOH each isoform is capable 
of driving an EMT response, TGF-β2 & 3 have been shown to be more potent than TGF-β1 
at inducing EMT in the lens. Within the lens, however, TGF-β2 remains the most widely 
used to induce EMT, as it is the most abundant isoform in the eye (36). The vast majority 
of TGF-β2 is stored in the aqueous and vitreous humours and ligand-binding traps 
tightly regulate its release. Associated with the TGF-β transcriptome, the Latency 
Associated Peptide (LAP) is concomitantly secreted with the TGF-β homodimer and 
competitively binds the bioactive epitopes of the ligand to render it into a latent 
inactive state. Additionally, the Latent TGF-β Binding Protein (LTBP), which is 
anchored to the ECM, associates with this complex by binding the LAP through 
disulfide bridges (34) to create stores of latent TGF-β. The mechanisms that 
underlie activation are largely unknown. However, proteases, including plasmin and 
matrix metalloproteinases (MMPs), and elements of tissue stress, such as integrin αvβ8 have 
all been implicated in the dissociation of binding proteins (37). 
Within the lens, antagonists existing in the aqueous and vitreous humours can also 
determine/control TGF-β regulation. Schulz and colleagues found that the effects of exogenous 
TGF-β were diminished by both of the humours. Additionally, isolation of α2-macroglobulin 
from both of the humours could independently achieve the same result.  From this finding it 
was postulated that the presence of molecules, such as α2-macroglobulin, afforded the eye an 
Figure 1.3.1 Schematic of TGF-β’s inactive state. The bioavailability of TGF-β is primarily mediated through association 
with Latency Associated Peptide (LAP) and Latent TGF-β Binding Protein (LTBP). Newly synthesised TGF-β binds LAP 
within the cell. Further binding with LTBP allows the complex to move out of the cell and bind ECM components. Together, 
these proteins bind active TGF-β such that the bioactive epitopes are shielded from the TGF-β receptor. Plasmin and matrix 
metalloproteinases (MMPs) and disruption to integrin αvβ8 are examples of molecules believed to be capable of disrupting the 
inactivating complex.
21
additional protective barrier from the effects of active TGF-β. Essentially, it was cited that 
α2-macroglobulin, in addition to inhibiting TGF-β activity, could bind proteases that release 
the active dimer (38). 
1.3.2 TGF-β receptor mechanism 
The precise effect a particular TGF-β family member has on a signalling cascade is, as 
aforementioned, governed at the receptor level. It is currently understood that activated TGF-
β binds TβR2, which then recruits TβR1. TβR2 is a constitutively active kinase that does not 
require ligand binding for activation and is able to freely bind ligand in the tissue or that 
presented by β-glycan. However, TβR1 is unable to directly contact freely circulating ligands. 
TβR1 contains a GS domain of 30 amino acid residues, which undergoes phosphorylation 
following complexing with the ligand through TβR2 (39). Within the lens, requirement of both 
types of receptors was confirmed upon the observation that competency to TGF-β-signalling 
was displayed only in postnatal rats which express both T βR1 and TβR2, distinct from 
younger developing rats that only express TβR1 (36). In spite of the inherent structural 
similarities among the ligands, the combinatorial variances that are enabled by the tetrameric 
ligand-receptor complex allows for a wide array of binding motifs. 
1.3.3 Signalling pathways resulting from TGF-β activation 
TGF-β signals through both a canonical, and several non-canonical pathways. Non-canonical 
pathways are currently being elucidated, as their contributions to the overall phenotype created 
through TGF-β signalling are not well understood. The pleiotropic effects of TGF-β appear to 
stem from the TGF-β receptors having multiple binding domains for many substrates which 
activate different non-canonical pathways (40). The mitogen-activated protein kinases 
(MAPK) are the best described pathways. These signal through extracellular signal-regulated 
kinases (ERK1/2), p38 and JNK kinases. TGF-β has been shown to directly activate ERK1/2 
through Ras, whereas p38 and JNK may be activated through more indirect mechanisms. All 
of these pathways have been implicated in the onset of EMT with studies highlighting a role in 
regulation of genes associated with cell-matrix interaction and cytoskeletal modulation. 
Additionally, studies from our lab have indicated that ERK1/2 signalling is required in the lens 
for EMT to occur (41). TGF-β is also believed to activate both PI3k/Akt and Rho/GTPases 
(42); however, little definitive knowledge exists as to the individual contributions of these 
pathways to EMT. 
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A large body of research details the canonical signalling pathway, which utilises the 
intracellular effector proteins, Smads. Known as receptor-Smads (r-Smads), both Bone 
Morphogentic Protein (BMP) and TGF-β use these proteins as signalling cascades. BMP 
signalling pathways use Smad1, Smad5 and Smad8, whereas TGF-β uses Smad2 and Smad3. 
Activation of the TGF-β receptors initiates endocytosis of the receptor-ligand complex. Smad 
Anchor for Receptor Activation (SARA) enables r-Smads to bridge the gap to the TβR1. In 
spite of structural similarities existing between receptors and between r-Smads, it has been 
shown that subtle variations in the residues of the receptor kinase and MH2 domains, 
respectively, enable preferential r-smad binding depending on the physiological context (43). 
R-Smads then interact with Smad4, which translocates to the nucleus and binds various
promoter regions that engage the EMT transcriptome. Activation or repression of a particular
gene is thought to be afforded by concomitant DNA-binding cofactors.
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Figure 1.3.2 Canonical TGF-β signalling through Smad2/3 recruitment. 1). Active TGF-β binds TβR2 which recruits 
TβR1 and induces its phosphorylation at the GS domain. 2). In an inactive system, Smads2/3 are retained in the cytoplasm 
bound to SARA. Upon ligand binding, SARA facilitates the binding of Smads to the TβR1. TβR1 phosphorylates Smads which 
undergo a conformational change at the MH2 domain such that SARA dissociates and the higher affinity Smad4 binds in its 
place. 3). The Smad complex binds specific promoter DNA regions with the aid of a binding adaptor. Given the physiological 
context, this complex is capable of recruiting either transcriptional coactivators or corepressors that regulate posttranslational 
histone modification; thus, mediating chromatin accessibility to the transcriptional machinery. 4). The transcriptional complex 
undergoes ubiquitination and subsequent degradation within the nucleus, to terminate TGF-β signalling. Smads 2/3 may return 
to the cytoplasm, bound to SARA.
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In the context of the lens, Smad signalling has been shown to play a key role in the development 
of fibrotic cataract. Saika and colleagues administered an injurious stimulus to the lenses of 
Smad3-null and wildtype mice. 8 weeks after the stimuli, the wild type mice presented 
elongate fibroblast-like cells around the wound area; whereas, in the double-knockout, cells 
morphologically resembled the uninjured epithelial cells. This was confirmed upon positive 
staining for α-smooth muscle actin 3 days post-injury, comparable to negative α-smooth 
muscle actin staining in the double-knockout (44). However, a more recent study found that 
crossing the αA-crystallin promoter induced TGF-β2 overexpressing mice with Smad3-null 
mice yielded only a diminished ASC (45). The authors cite that differences in results between 
the studies are likely due to the different TGF-β2 modes of delivery; the injury-induced model 
requires subtle activation of latent TGF-β2, whereas the αA-crystallin promoter induces a 
strong phenotypic response from early embryogenesis. Additionally, the authors speculated 
that there are differences in the degree of upregulation of non-canonical signalling pathways 
as a compensatory mechanism to the loss of Smad3.  
1.3.4 Synergism between signalling pathways 
:KLOH the roles of Smads2, 3 and 4 have been classically considered in the context of the 
EMT programme, it is postulated that cross talk exists between Smads and MAPKs. This is in 
contrast to the traditionally held belief that pathways largely follow a linear chain of activation. 
Notionally, the crosstalk of parallel signalling pathways serves to elicit a greater range of 
cellular responses, without increasing the number of signalling components (46). Smad-MAPK 
crosstalk has been previously reported, and has been indirectly evidenced through TGF-β 
responsiveness in Smad4-deficient cells (47). Somewhat paradoxically, ERK1/2 is required for 
canonical TGF-β-derived Smad2 activation, through serine phosphorylation of the Smad linker 
region (48). Indeed, phosphorylated ERK1/2 has also been observed before phosphorylated 
Smads in various TGF-β-stimulated cells types. However, whether an effector is enhancing or 
inhibitory on a pathway appears to be tissue specific and, as such, no paradigmatic conclusions 
can be drawn.  
Irrespective of the individual pathway, the mechanisms that govern crosstalk modulate aspects 
of signal amplitude and duration. This is perhaps best represented through the regulation of 
Smad activity. Discussed by Massague 2000, ligand-based regulation of Smad activity is 
controlled through Smad6 and Smad7. It is purported that the levels of these molecules are 
25
largely controlled by diverse, possibly unrelated, signals to provide cross-talk links; thereby, 
facilitating the formation of large complex signalling networks that are subtly altered to change 
the functioning of the cell. The study of pathway regulators has, unsurprisingly, garnered much 
interest in an attempt to discover novel interventional targets in the onset of many TGF-β-
driven pathologies. Smad7 is a class of endogenous competitive inhibitor that interacts with 
Smad4 to interfere with Smad2/3 nuclear translocation. The inhibitory action of Smad7 is 
augmented by Smurf2, which was shown to mediate ubiquitin-based degradation of Smad2 
and Smad3, leaving Smad4 intact (49). 
In contrast to the aforementioned complex-mediated regulation of Smads, members of the 
MAPK family are negatively regulated through protein phosphatase recruitment. Phosphatases 
are a large group of enzymes with the conserved function of hydrolysing the phosphate group 
on certain amino acid residues. Removal of protein phosphates greatly reduces MAPK activity 
to prevent or augment signalling. In the context of intracellular signalling, phosphatases are 
classed into three major categories: tyrosine, serine/threonine and dual specificity (capable of 
acting on both tyrosine and serine/threonine substrates). Within these broad categories, 
phosphatases are further divided, reflective of their functionality and location (50). 
Akin to Smad regulation, phosphatases are transiently activated which makes their effects 
reversible. The presence/absence of specific phosphates on a protein can greatly change its 
behaviour within the cell. Through modulation of allosteric conformation, protein-protein 
interactions may be induced or repressed (51). In particular, ERK1/2 activity is primarily 
regulated by the serine/threonine Protein Phosphatase 2A (PP2A), which dephosphorylates 
both ERK1/2 and its upstream kinase MEK1. Okadaic acid is a potent inhibitor of PP2A and 
has been used to show a pro-tumour role for PP2A and a role in contraction of smooth muscle 
cells (52, 53). Interestingly, PP2A is capable of also directly dephosphorylating TβR1 to block 
TGF-β signalling. Yu and colleagues found that TGF-β was capable of auto-induction in 
prostate cancer cells, but not benign cells. This was attributed to activation by ERK1/2, as 
treatment with TGF-β induced PP2A localisation to TβR1 in the benign cells but not in the 
malignant cells (54).  The findings from this and other similar studies provides evidence that 
changes to the regulatory components of signalling pathways are able to induce maladaptive 
feed-forward loops. The simultaneous activation and repression of both Smads and MAPKs, 
thereby, gives rise to the possibility of many coordinated intracellular actions, including EMT. 
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More broadly, this provides a general mechanism, addressing the progressive nature of diseases 
such as cataracts. 
1.3.5 ROS as regulators of cell function 
Current research has shifted to identifying factors capable of regulating the interplay of 
pathways to elicit a particular response. At the forefront of this movement is the concept of 
redox signalling, where subtle alterations in the intracellular redox environment can confer 
functional changes to the cell. The intracellular redox environment is largely determined by a 
balance between reactive oxygen species (ROS)-producing elements and antioxidants which 
act to remove ROS. Distinct from classical definitions of oxidative stress which describes an 
irreversible loss of cell function, formation of these redox derivatives occurs at sub-toxic and 
controllable levels (55). When the balance shifts to a more oxidised state, key proteins in 
signalling pathways may be activated or repressed. Through mechanisms that will be later 
discussed, the amplitude and duration of a signalling pathway can thus be further controlled in 
a unique and finite manner in relation to a given stimulus. Meyer and colleagues showed that, 
through treatment with ROS, transcription factors such as NFkB and AP-1 were activated and 
inactivated, respectively (56). Additionally, inhibition of PP2A activity has widely been 
reported upon exposure to ROS (57). Given that all MAPK pathways are negatively regulated 
by phosphatases, sources of ROS serve as attractive targets for interventional strategies and 
raises a question of whether ROS are key regulator(s) of MAPK-signalling.  
1.4 Reactive Oxygen Species and redox homeostasis 
Reactive oxygen species (ROS) is a term used to describe reactive compounds that 
have resulted from incomplete reduction of molecular (ground-state) oxygen. Shown in 
Figure 1.4.1, ROS and its derivatives are formed from ground-state oxygen preferentially 
only accepting one electron during redox reactions. Ground-state oxygen uniquely exhibits 
two electrons spinning in the same direction in the outer orbital. As the spin of most 
compounds’ electron pairs is in opposite directions, molecular oxygen is largely unreactive. 
In an excited state, where the spin of an electron is changed, singlet oxygen may be formed, 
which exhibits paired electrons with opposite spins; thus, increasing the reactivity relative to 
molecular oxygen. However, ground-state oxygen may also react with other molecules with 
unpaired electrons, such as transition metals, to give rise to the superoxide anion (O2—). A 
further one-electron reduction of O2— 
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gives rise to the more stable peroxide molecule. Determined largely by redox potentials, which 
drive reactions to a thermodynamically-favourable outcome, the formation of a chain of 
derivatives from a single O2— is thus possible (58). 
Figure 1.4.1 Schematic representation of the formation of ROS and RNS. The reactivity of ROS species are largely 
determined by the electron spin configuration in the outer shell of the molecule (red arrows) (A). The electronic configuration 
of a compound drives the reduction reaction to give rise to numerous oxygen derivatives, which are all possible from a single 
superoxide anion O2•—(B). In red are the redox reduction potentials of a given reaction, i.e., the more positive the numerical 
potential, the more likely the new species will be reduced. Adapted from (59).
The unstable and non-specific nature of ROS has long been touted as only being deleterious 
and toxic to intracellular homeostasis (60, 61). However, the wide range of ROS/reactive 
nitrogen species and their relative redox potentials has raised thoughts relating a compound’s 
reactivity against its life in solution/cytosol. Essentially, while the hydroxyl anion HO• is 
highly reactive in solution, it also degrades quickly in solution; thus, making its reactivity very 
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nonspecific but also short-lived. This is in contrast to hydrogen peroxide H2O2 that has less 
reactivity due to its complete outer shell, but exhibits a longer life in solution (62). Discussed 
in 1.3.4, this ties in with the notion of intracellular signalling pathways largely relying on signal 
amplitude and duration as a means to regulate a pathway. Taken together, with the previously 
discussed evidence of ROS playing a role in activation/repression of proteins (see 1.3.5), this 
provides further evidence of an important role for ROS intermediates in regulating signalling 
pathways.  
The biochemical manner in which ROS regulate pathways has been an area of intense research 
in recent years. While it is known that ROS can activate/repress proteins, a key mechanism has 
been highlighted through posttranslational allosteric modification of the protein (61). It is 
timely to reiterate that ROS have the potential to irreversibly target/damage macromolecules 
such as proteins, DNA, and lipids. However, in the case of reversible oxidative modifications, 
these changes are transient and serve to uphold homeostasis. Reversible cysteine thiol 
oxidation is a well-documented and accepted example of this process. Essentially, it is 
understood that certain cysteine residues are capable of having their thiol group oxidised (61). 
The propensity of a thiol group to be oxidised is driven by thiol nucleophilicity, the surrounding 
proteins/residues and (most importantly) the proximity of the thiol to the ROS source (63).  
Thiol oxidation initially yields the sulfenic ion which represents a posttranslational 
modification, thus, capable of changing the protein’s overall function. In the oxidised form, the 
sulfenic ion likely interacts transiently with antioxidant molecules such as glutathione (GSH) 
(64). This complex may act as a substrate for reducing enzymes such as thioredoxin or 
glutaredoxin (discussed in 1.4.1); thus allowing the changes in enzymatic activity to be 
reversible. In highly oxidised milieus, the sulfenic ion may undergo further oxidation to yield 
the sulfinic ion and, subsequently the sulfonic ion (64). Formation of the sulfonic ion is an 
irreversible change to the protein’s cysteine residues (shown in Figure 1.4.2 $).  
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The net effect of multiple cysteine residues undergoing controlled oxidation is such that 
conformational changes occur in proteins that consequently affect their intracellular roles (61). 
In certain cases, this may affect protein complex formation, which may affect cellular processes 
such as nuclear translocation. More importantly, this conformational change may affect 
enzyme activity (shown in Figure 1.4.2 %). Interestingly protein phosphatases are known to 
contain reactive cysteine residues in the catalytic site of the holoenzyme which are capable of 
serving as an on/off switch for the enzyme (65, 66). It has been shown that ROS such as 
hydrogen peroxide significantly inhibit phosphatase activity which consequently led to 
induction of ERK1/2 phosphorylation (pERK1/2) (67, 68). Importantly, both of these studies 
Figure 1.4.2 Reversible protein oxidation by GSH. The R-side chain of a cysteine residue contains a thiol group 
(–SH). In the presence of ROS, such as H2O2, this thiol group may become oxidised. Now more reactive, this 
oxidsed thiol may undergo further oxidation events for may complex with other proteins to form PSSPs (A). In the 
case of phosphatases, the effect of many cysteine residues undergoing oxidation is transient inactivation of the 
enzyme, through the formation of the sulfenic ion, which may be reversed through the action of glutathione (B). 
Adapted from A: (3) and B: (6) 
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showed that the pERK1/2 induction occurred exclusive of changes in PP2A expression and 
that reactivation of phosphatase activity could be achieved through antioxidant treatment.  
1.4.1 Intracellular redox buffering 
ROS is produced from numerous sources, including by-products of mitochondrial respiration, 
the endoplasmic reticulum and ROS producing enzymes such as xanthine oxidase. As these 
are secondary sources of ROS, cytosolic ROS accumulation is relatively uncontrollable at the 
enzymatic level; therefore, the cell requires defences to avoid excessive collection (69). ROS 
may also be produced deliberately through enzymes such as NADPH oxidases (70). 
Irrespective of the source, ROS levels are largely regulated through the following antioxidant 
mechanisms: i) enzymes, such as catalase that cleave ROS into less-reactive compounds; ii) 
small molecules, such as glutathione (GSH) that bind ROS and facilitate the formation of a 
temporary ROS reservoir; iii) metal ion sequestration molecules (not discussed further); iv) 
and thiol-based redoxin systems (71) that ultimately restore the redox status of the cell.  
The balance of oxidants and antioxidants is known as redox homeostasis (70). Due to the 
potentially deleterious effects of ROS derivatives, the maintenance of adequate redox 
homeostasis is critical to ensure a cell remains metabolically/homeostatically viable. The 
intracellular redox state is in a constant flux, as ROS are produced and simultaneously utilised 
(72). Regulation of the redox environment is most directly achieved through the use of enzymes 
that are able to cleave and degrade ROS and its derivatives, such as superoxide dismutase and 
hydrogen peroxide (73). Essentially, the principal source of mammalian ROS is electron 
leakage from the electron transport chain, which then interact with oxygen to form O2—. As a 
first line of antioxidant defence, O2— may be rapidly converted to H2O2 by superoxide 
dismutase (SOD) (72). H2O2 may be degraded by catalase to form water or it may be used in 
other intracellular events, such as those previously described (72). 
Free ROS can also be thought of as large store of potential energy, and as such, constant 
enzymatic degradation of ROS serves as an inefficient metabolic means to manage it. As 
previously mentioned, the thiol R-group of cysteine residues is a major target of oxidative 
modifications. Thioredoxins (Trxs) are the major regulators of the intracellular thiol status and, 
ultimately, the metabolism of free ROS. There are three classes of Trxs: thioredoxin, 
glutaredoxin (Grx) and peroxiredoxin (Prx) RUiJiQDOO\ WHUPHG R[iGRUHGXFWDsHs DQG QRZ 
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proteins is the ability to make/break disulfide bridges, upon oxidative modifications; thus 
conferring structural changes to the protein in the same manner described briefly in 1.3.5. In 
the case of Trx, an oxidised protein containing disulfides may be reduced again by crosslinking 
the thiol from Trx, to essentially transfer the disulfide to Trx, which also oxidises it. The protein 
is restored back to its original reduced form, while Trx is reduced by thioredoxin-reductase 
(TrxR) (2). Prxs are more recently documented and have been delineated from other 
thioredoxin members on the basis of their ability to reduce the sulfinic ion back to the sulfenic 
ion via sulfiredoxin (Srx), such that regular Trxs are able to return the protein to its natural 
state (74).  
Glutathione (GSH) is a small reactive thiol-based molecule that is widely recognised as the 
most abundant cellular antioxidising agent. Its roles within in the cell are varied and broadly 
fall into the classification of GSH acting as a cofactor in ROS reduction reactions and/or 
directly interacting with ROS (75); thus, classifying its potential forms as being either reduced, 
oxidised or conjugated. Upon direct interaction with particular ROS species, GSH molecules 
become oxidised which leads to the formation of two GSH residues, linked by a disulfide 
bridge (GSSG) which is an important cellular redox couple, akin to NADP+/NADPH (76). 
Importantly, GSH acts as a FRIDFWRU for glutathione peroxidase-based H2O2 degradation. It has 
been shown that H2O2 is preferentially degraded by glutathione peroxidase over catalase (77, 
78) and this is likely due to GSSG being an important FRIDFWRU in numerous cellular metabolic
processes; therefore, serving as a more energy conserving means of dealing with free ROS.
GSSG has been shown to cross link proteins, using the disulfide bridges to direct intracellular
trafficking of certain proteins or xenobiotics (79), which is known as thiolation. More
specifically, GSSG is also a sXEsWUDWH for glutathione reductase (GR) which catalyses the
GSSG to 2GSH, using NADPH as the cofactor, and the final key member of the
TrxIROG family, glutaredoxin (Grx), as the crosslinked protein. Thus, GSH ultimately
returns back to its reduced form and NADP+ may be used as an electron carrier for
important metabolic functions, such as the hexose monophosphate glycolytic shunt (75).
This simplistic overview of redox homeostasis provides a framework to understand how ROS 
are regulated so as to not reach cytotoxic levels and be used in a beneficial means. The 
reversible nature of oxidative posttranslational modifications to proteins can thus be explained 
through the interplay of Grx, Trx and Prx systems. Essentially, ROS oxidise the thiol residues 
of a protein to form the sulfenic ion. This is a relatively unstable structure and may form a 
32
disulfide bridge between adjacent sulfenic ions or a single sulfenic ion may crosslink to a GSH 
residue. Whatever the outcome, Trx or Grx (respectively) systems are employed to return the 
protein’s thiol status to its reduced form; thus conferring only a transient change to the protein’s 
structure/function (see Fig. 1.4.3). 
1.5 ROS in the lens 
Given the relatively large abundance of proteins in the lens (80), it comes with little surprise 
that the potential roles of ROS have been a pertinent research area. The vast majority of these 
studies have sought to implicate ROS in the onset of age-related (senile) cataracts, with decades 
of research pointing to a distinct shift towards a pro-oxidant environment with increasing 
cellular senescence (81). This is compounded by recent research suggesting an important role 
of ROS in EMT-derived fibrotic cataract. However, the underpinnings of present-day lens 
redox biology are arguably grounded in a series of independently conducted studies, 
accounting for the interplay between GSH and H2O2. It is through these studies that the central 
dogmas surrounding ROS and redox homeostasis in the lens were established. 
Figure 1.4.3 Thiol-based detoxification. Starting on the right side of the figure, reduction of an oxidised cysteine thiol is may 
be achieved through the employment of the Grx and Trx antioxidant mechanisms. This flow of electrons culminates at the 
hexose monophosphate shunt (pentose phosphate cycle). Adapted from (2)  
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1.5.1 GSH in the lens 
GSH was first isolated from lens by Hopkins in 1922 (82). It was subsequently found to exist 
at a relatively high concentration in the lens and, as imaginable, prompted questions as to why 
this was the case and what roles GSH could be playing in the lens. By radioactively tracing the 
uptake and utilisation of GSH subunit peptides, it was conclusively shown that the lens is 
entirely capable of de-novo GSH synthesis (83). Additionally, in a subsequent study, the lens 
was found to be so adept at GSH synthesis that complete breakdown and resynthesis of its 
essential components was possible and occurred in a relatively short timeframe. GSH levels 
were also found to be highest in the lens periphery over its anterior and posterior segments 
(84). More recently, the lens was found to exhibit distinct metabolic regions in response to 
aging, with cysteine-glutathione disulfide notably being depleted from the inner-cortex in 
response to hyperbaric-oxygen treatment (85). Taken together, these findings are suggestive of 
a deliberate and specific role for GSH in the lens and, potentially, the surrounding ocular media 
(86).  
Knowing that GSH contained a reactive thiol also prompted a flurry of work using the lens as 
a model to implicate GSH in mitochondrial electron transport. Stemming from their work in 
the cornea, Kinoshita and colleagues were the first to suggest GSH was not capable of direct 
H+ uptake and that GSH could likely be playing a role in carbohydrate metabolism in the lens. 
They were also arguably one of the first to propose the idea of the GSH feeding into the hexose-
mono phosphate shunt (HMS) (87). The authors also found that GSH did not easily efflux from 
the lens and speculated that the major fraction of lens GSH is bound to proteins. This finding 
came in conjunction with concurrent literature from other tissues that found GSH could not 
function as a direct H+ carrier, as GSH oxidation proceeded too slowly; thus, suggesting a 
directed role of GSH in lens redox biology and as a direct antioxidant (88). 
The role of thiols in the lens has been an area of intense research with a focus on understanding 
what specific roles GSH plays in upholding redox homeostasis and detoxification. Indeed, it 
was confirmed that addition of exogenous H2O2 to culture medium containing rabbit lenses led 
to an increase in NADPH production as a result of H2O2 metabolism feeding into the hexose 
monophosphate shunt (89). The authors further highlighted the important antioxidant role of 
GSH in the lens by finding that cultured GSH-depleted LECs were particularly susceptible to 
morphological changes induced by H2O2, in a follow-up paper (90). Work by Spector and 
colleagues reiterated the important interplay of GSH and H2O2, by showing that H2O2 induced 
34
formation of GSSG which shortly returned to basal levels; thus suggesting that GSH levels 
initially decrease upon oxidative insult, but are restored to normal levels when the oxidative 
insult is removed (91). Taken together, these findings are suggestive of an important role for 
GSH in the maintenance of lens redox homeostasis. 
Delineating its role in general redox homeostasis, an important association between changes to 
GSH redox status and the onset of cataract has been noted; implying that maintenance of 
adequate GSH is critical to lens transparency. It is now widely accepted that this is due to 
overwhelming the antioxidant capacity of the lens and the formation of mixed disulfides. Many 
of these mixed disulfides are derived from GSH and, as such, the onset of age-related nuclear 
cataract is often preceded by a decline in free GSH. Perhaps best summarised in this review by 
Lou, GSSG may undergo protein S-thiolation whereby a protein thiol is conjugated to a non-
protein thiol through a disulfide bridge (92). The most common thiolation events that have 
Figure 1.5.2. The role of GSH in lens detoxification. GSH is synthesized in the outer cortical regions of the lens. From there 
it is able to freely move around (1). Upon oxidation, one glutathione molecule is bonded to another by disulfides to form GSSG 
(2). GSSG may enzymatically be reduced back to GSH enzymatically (not shown), or be conjugated to nearby protein thiols 
(PSH) to form protein-S-S-glutathione (PSSG) (3). PSSGs are then able to react with other nearby PSHs to form protein-S-S-
protein conjugates. If senile cataract is preceded by a decline in free GSH, it is easy to see how PSSPs are able to form large 
aggregates with other PSSPs. It is the progressive accumulation of these PSSP conjugates that are believed that increase the 
water-insoluble protein content of the lens leading to opacities. 
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been reported in the lens are protein-S-S-GSH (PSSG), protein-S-S-Cysteine (PSSC), protein-
S-S-cysteamine (PSSCy) and gamma-glutamylcysteine (PSSGC) formation (92 ). Akin to
the changes in GSH levels post H2O2 treatment there were previously discussed, Lou showed
that the production of PSSG was proportional to H2O2 concentration. It was subsequently
proposed that, due to the lens cortex containing the highest concentration of GSH, the oxidant
may react with this pool of GSH, thus enabling the GSSG to react with lens proteins to
form PSSGs, which reacts with adjacent proteins to form PSSPs (85) (see Fig. 1.5.2).
A major consequence of the lens’ progressive inability to uphold redox homeostasis with age 
is an increase in the water-insoluble protein content. Water-insoluble aggregates precede the 
formation of nuclear cataracts and are believed to be a major contributor to clinical symptoms 
of cataracts, such as brunescence and opacification. Many theories have been proposed as to 
how oxidative insult to the proteins manifests to form these aggregates. It has been shown that 
chronic exposure of lenses to H2O2 not only depleted overall GSH levels, but also led to a 
significant increase in GSH bound to sulfonic acid (GSO3H) as the water-soluble content of 
the lens formed progressive disulfide crosslinks to yield an increase in protein insolubility. 
Additionally, the crosslinked aggregates were mostly made of β- and γ-crystallin (93). These 
findings are suggestive of the lens being well protected against the deleterious effects of excess 
H2O2, however, particularly susceptible to H2O2 (and ROS, in general) during sustained periods 
of insult (such as in progressive age-related cataract).  
The susceptibility of the lens to oxidative insult with increasing age is a key research direction, 
suggesting a progressive breakdown/dysregulation of redox homeostasis within the lens. The 
“lens barrier” model has been suggested as a potential mechanism for this dysregulation, 
whereby the theorised barrier impedes the normal microcirculation of the lens (please refer 
here for a detailed review of lens microcirculation (94)). As this microcirculation is essential 
for molecules and nutrients to reach the lens nucleus, a dysregulation of it may explain why 
cataractous protein oxidation is most evident in the centre of the lens (95). Indeed, it has been 
shown that the lens barrier prevents synthesised GSH from moving to the centre of the lens 
(96). Given that minimal GSH synthesis occurs in the lens nucleus (94), the importance of the 
microcirculation is apparent. This is also particularly important given that the lens appears to 
facilitate GSH efflux, potentially serving to upholding redox homeostasis in surrounding ocular 
tissues (97, 98). This also provides a probable explanation as to why mixed disulfides are more 
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prominent approaching the nucleus of the lens, and why the nucleus is more prone to oxidation 
(99).  
The lens barrier model serves as an important reminder that mature fibre cells are devoid of 
organelles and that maintenance of their integrity, throughout a lifetime, is likely extrinsically 
controlled (94, 100). :KLOH the model accounts for the decline in bioavailable GSH and 
degradation of mature fibre cells in age-related cataract, it does not necessarily account for any 
increases in ROS preceding the onset of cataract. Indeed, as the epithelia and transitioning cells 
have a full complement of cellular components, it is likely that the pre-cataract shift to a pro-
oxidant milieu initially originates from changes to the epithelial cells and not direct targeting 
of mature central fibres. In a seminal paper, LECs from senile cataract patients were found to 
exhibit notable DNA damage compared to that of non-cataractous controls, with the authors 
proposing that LEC DNA damage is a key precursor to nuclear cataract (101).  
Although senile cataract is considered a multifactorial disease, with risk factors including 
alcohol consumption, cigarette smoking, and diabetes (102), particular attention has been given 
to progressive exposure of LECs to ultraviolet radiation (UV) and its inherent implication in 
DNA damage. This association has been drawn from a large body of research linking increased 
prevalence of senile cataracts to increased exposure to ultraviolet (UV) radiation from sunlight. 
However, it has been noted that a distinct lack of direct correlation to UV causing senile 
cataract may be due to sunlight-alone being insufficient to induce cataract; with the authors 
suggesting that endogenous tryptophan-based UV filters become trapped in the nucleus which 
form crosslinks to GSH in the nucleus(103, 104). Indeed, in vitro experiments attempting to 
implicate dysfunction of the epithelium to onset of cataract have been inconclusive and unable 
to determine whether DNA damage is indeed necessary for senile cataract or just a by-product 
of UV exposure. Further devaluation of the sunlight hypothesis has been cited that all senile 
cataracts should be clinically preceded by keratitis, as UV passes through the cornea before 
the lens (104, 208). 
It would also be remiss to overlook the potential of mitochondrial dysfunction in the onset of 
senile cataracts. Indeed, it has been shown that deletion of the mitochondrial repair enzyme, 
methionine sulfoxide reductase A (MsrA) led to impairment of mitochondrial membrane 
potential, increased levels of ROS as well as HBO-induced cataract formation (105, 106).  
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$GGLWLRQDOO\, GHOHWLRQ RI WKH PLWRFKRQGULDO HQ]\PH *U[ KDV EHHQ VKRZQ WR LQGXFH HDUO\
RQVHW FDWDUDFW 20 7KH contribution of mitochondrial dysfunction and ROS to the onset of 
senile cataract is still yet to be determined.  
The pleotropic roles of ROS in the lens have been further characterised more recently in the 
lens epithelium, with a view towards both fibrotic cataracts but also general redox homeostasis. 
The work reviewed herein also sheds light on the importance of growth factor signalling 
pathways on the balance of both pro-oxidant and anti-oxidant effectors to modulate LEC 
function (see Fig. 1.5.3). Given that LECs are bathed by the aqueous humour, which contains 
a wide assortment of growth factors (107), research into the redox signalling effects of these  
Figure 1.5.3. Potential sources of dysregulation to redox homeostasis in LECs. Perhaps one of the most important 
regulators of redox homeostasis in the lens is through growth factor-driven mechanisms, and through activation of aberrant 
signaling pathways (1). Activation of these signaling pathways are capable of shifting the cell to a pro-oxidant milieu. This 
may be achieved through the simultaneous downregulation of antioxidant enzymes such as catalase and superoxide dismutase 
and also upregulation of ROS producing enzymes such as NOX4 (2). UVB irradiation is also thought to be an important 
generator of H2O2, although the mechanisms behind this are not well understood. Despite there being sparse information as to 
the individual contribution of mitochondrial dysfunction to onset of senile cataract, it is with little doubt that any of the 
aforementioned mechanisms are capable of disrupting mitochondria and leading to the release of significant amounts of ROS. 
Most importantly, however, ROS that are produced by LECs are capable of crossing biological membranes in either adjacent 
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growth factors has been an area of particular interest. Of the many growth factors that are 
present in the aqueous humour, particular attention has been given to Transforming Growth 
Factor-beta (TGFβ) and Platelet Derived Growth Factor (PDGF), for their roles in fibrotic 
cataract and mitogenic pathways, respectively.  
1.5.2 TGF-β, ROS and LECs 
:KLOH the aforementioned describes how ROS are managed by the lens, it is widely 
recognised that ROS are normally produced to facilitate particular functions, such as signal 
pathway regulation (60). As such, the cell must be capable of shifting the redox balance to a 
more oxidised state. Given its important role in pro-inflammatory responses, it comes with 
little surprise that TGF-β is capable of shifting this balance towards the oxidant end. There is 
a large body of research describing TGF-  β’s ability to simultaneously upregulate ROS 
production mechanisms and downregulate antioxidant mechanisms. ROS production 
mechanisms appear to be directed to either mitochondria (108, 109) or professional ROS 
producing enzymes such as the NADPH oxidases (discussed in detail in 1.6). ROS degrading 
enzymes such as catalase and SOD are downregulated by TGF-β (108, 110, 111). TGF-  β has 
also been shown to interfere with de novo GSH assembly, thereby decreasing freely 
available intracellular GSH (112). Taken together, the above provides a useful platform 
to appreciate that the control of intracellular ROS is, at all times, a balancing act and 
that not all ROS are bad.  
Chamberlain and colleagues were the first to look at a role for ROS in epithelial to 
mesenchymal transition (EMT) leading to fibrotic cataract. Using both whole lenses and lens 
epithelial explants from young rats, concomitant treatment of TGFβ with either GSH or 
catalase abrogated the fibrogenic effects of TGFβ (113); thus, suggestive of an important role 
of ROS in the progression of EMT in LECs. Indeed, it has been shown that treatment of 
LECs directly with H2O2 or Fe2+ (to induce Fenton chemistry) led to induction of the 
fibrogenic  factor, CTGF, independent of other signalling events or the incorporation of other 
proteins (114). TGFβ also has been shown to directly induce H2O2 levels in a time-dependent 
manner in LECs (115). This is in congruence to findings from mouse LECs that were 
depleted of GSH synthesis pathways which showed increased in pro-EMT markers (116). 
These findings provide important evidence that alludes to a distinct function of TGFβ in the 
production of ROS in LECs. 
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The specific effects of TGFβ on the downregulation of antioxidant mechanisms has been well 
characterised in LECs, through peroxiredoxins (Prdxs). Pak and colleagues found that addition 
of low levels of both TGF-β1 and H2O2 to a human lens epithelial cell line yielded upregulation 
of 1-cysPrdx expression however, progressively larger dosages of both TGF-β1 and H2O2 
downregulated 1-cysPrdx expression. (117). The antioxidant and protective effects of 
peroxiredoxins has also been highlighted in Prdx6-deficient mice exhibiting elevations in 
TGFβ and fibrotic markers expression in LECs, with a particular emphasis towards actin-
cytoskeletal remodelling (118, 119).  
Experimental EMT models in heart, kidney and liver have all reported shifts to a pro-oxidant 
intracellular milieu preceding and during EMT. Importantly, TGF-β has been shown to be a 
common mediator of this outcome; prompting the question what was causing such a shift in 
the redox status of the cell (108, 110, 111). :KLOH it has already been described that TGF-β is 
capable of downregulating antioxidant mechanisms, the question is whether TGF-β is also 
capable of upregulating ROS production?  
A potential link between ROS production and EMT has been found in several experimental 
models, through the identification of NADPH oxidases (Noxs). This family of enzymes is 
unique in that its only biological function is the catalytic transfer of electrons across membranes 
from NADPH to oxygen, to yield the superoxide anion (1). A particular member of the Nox 
family, Nox4, has been found to be upregulated in the presence of TGF-β in numerous fibrotic 
models of disease (120). Importantly, Nox4 is believed to be up regulated through Smad2/3 
signalling (121); thus, implicating Nox4 as a targeted and directed means to produce 
intracellular ROS. In the current study, it is thus proposed that Nox4 is upregulated in the 
presence of TGF-β in the lens and contributes to the development of EMT. 
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1.6 Nox4 
1.6.1 The NADPH oxidase family 
Nox4 is a member of the Nox family of enzymes consisting of 7 homologues (Nox1-5, DUOX1 
and DUOX2), with the exclusive function of producing ROS. As a result of this, there are 
numerous structurally conserved features. At the C-terminus there are binding areas for both 
NADPH and FAD, 4 heme-binding histidine residues and 6 transmembrane α-helix domains. 
Each Nox member has additional components and cytoplasmic subunits that are required to 
associate with this basic structure (1). The vast majority of Nox research has looked at roles 
for Nox2 and Nox4, with Nox2 being the first identified of the family due to its association 
with immune-cell phagocytosis (122) (see Fig. 1.4.1). 
Separating Nox4 from other Nox members is that Nox4 has been shown to remain catalytically 
active in cells that do not express the subunits essential to other Noxs; only requiring 
association with the 22 kDa phagocytic oxidase (p22phox) (1). The observation that Nox4 
expression was not affected by blocking of p22phox indicates a likely role that p22phox is 
required for catalysis, rather than stabilising Nox4 (123). Recent literature suggests, however, 
that p22phox associates with polymerase DNA-directed delta-interacting protein2 (PolDip2), 
such that the enzymatic activity of Nox4 is increased 3-fold (124). The enhancing role of 
Figure 1.4.1 A diagrammatic representation of the intramembranous NADPH homology. Within the cytosol, electrons are 
received from NADPH. Noxs facilitate the coupling of these electrons to molecular oxygen to yield the superoxide anion.  An 
array of cofactors and catalytic subunits are required to associate with each homolog. Adapted from (1)
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Poldip2 is in congruence to the concept that Nox4 activity is transcriptionally regulated and 
targeting of its effects must be well-directed. 
1.6.2 NADPH oxidases in the lens 
With such an esteemed history of redox homeostasis research in the lens, it comes with some 
surprise to learn that there are few papers describing the role of Nox in the lens. In fact, of all 
the literature to date, a role of Nox2 in the lens has been reported, with the limited papers 
indicating an important role of Noxs in redox signalling. In a seminal paper by Rao and 
colleagues, the “non-phagocytic NADPH oxidase” was first characterised in the lens (125). A 
lucigenin chemiluminescence model was used to show that increased lucigenin-activity was 
superoxide-dependent and that most of the photoemissions were localisable to the epithelium, 
over cortical and nuclear regions. Furthermore, it was shown that EGF, FGF, TGF-β and 
lysophosphatidic acid (LPA) were all capable of enhancing ROS generation in these lenses 
(125). Although the effect of these growth factors were not directly correlated to Nox activity, 
these data suggested that growth factors played an important role in the regulation of Nox in 
the lens.  
Building on previous observations that PDGF was a potent mitogen of LECs via a ROS 
mechanism (126), Lou and colleagues were the first to investigate the potential role of Nox in 
this mechanism. An initial finding of this study was the importance of p22phox expression for 
Nox activity, downstream signalling pathways and cell proliferation, with ROS and 
proliferation levels remaining low after PDGF treatment in p22phox-knockdown cells. The 
authors also found that low molecular weight protein-tyrosine-phosphatase (LMW-PTP) 
inactivation was mediated through PDGF in a Nox2-dependent manner, which regulated the 
activation of the PDGF receptor. It was thus proposed that the ROS produced by Nox2 
conferred transient PDGF receptor activation, hence the mitogenic signal (127). Indeed, a 
similar hypothesis was proposed by Xing and colleagues upon the observation that LMW-PTP 
activity was particularly susceptible to H2O2 exposure (128). In this experimental model, it was 
found that activity of LMW-PTP could be restored by thiol-transferase (TTase) and GSH; thus 
proposing a mechanism whereby the antioxidant abilities of TTase-GSH were important in 
regulating LMW-PTP (128). The ROS-mediated transience of PDGF signalling, thus, adds 
evidence to the notion that ROS serve homeostatic function in LECs. 
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1.6.3 Regulation of Nox4 
Currently, most of the literature has focussed on Nox4 expression in the context of TGF-β 
stimulation from fibroblasts and myofibroblasts; where it is emerging that Nox4 is 
constitutively active, upon expression. This conclusion is based on the observation that no 
specific Nox4 activation mechanisms have been identified. It has thus been proposed that Nox4 
is principally regulated at the level of transcription (123). Serrander and colleagues sought to 
characterise the relationship between Nox4 expression, Nox4 mRNA and resultant ROS 
production using a tetracycline inducible cell-line (129). It was found that upon tetracycline 
treatment, Nox4 mRNA gradually increased over a period of 24 hours, which was followed by 
increases in Nox4 activity (129). Importantly, upon removal of tetracycline, both Nox4 mRNA 
and Nox4 activity decreased significantly within 24 hours. Taken together, this adds to the 
concept that Nox4 is regulated at the transcription level, rather than at the level of enzymatic 
activity. 
:KLOH it is generally accepted that Nox4 is not necessarily controlled by posttranslational 
modifications, Nox4 is increasingly being implicated in numerous growth-factor signalling 
pathways; adding a layer of complexity to its regulation. As aforementioned, the principal 
motivation of the present study is to examine the role of Nox4 in the onset of TGF-β-driven 
EMT. A comprehensive paper by Boudreau and colleagues documented the importance of 
Smad3 on Nox4 upregulation, where inhibition of Smad3 significantly decreased Nox4 
promoter activity (121). The results of this paper would imply that canonical TGF-β signalling 
is sufficient to upregulate Nox4; however, TGF-β has also been shown to regulate Nox4 
through Rho-signalling. Using a RhoA inhibitor Manickam and colleagues found a significant 
decrease in TGF-β-induced Nox4 expression and activity. It was thus proposed that RhoA was 
upstream of Nox4 and that, possibly, the Nox4 enhancer PolDip2 played a central role in 
organising Nox4 upregulation (130). It must be noted that the authors of this paper pointed out 
that there are discrepancies between tissue types as to whether Nox4 is upstream or downstream 
of Rho-signalling. Validity exists in both the experimental models of Boudreau (121) and 
Manickam (130) and it could be possible that Smad3 may upregulate Nox4 and RhoA could 
independently upregulate Poldip2 under TGF-β stimulation; the implications of such a 
relationship would require further investigation. Although this adds an air of uncertainty as to 
the upstream origins of Nox4, it is for certain that TGF-β is potent inducer of the enzyme.  
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Epidermal growth factor (EGF) signalling has recently been implicated in the upregulation of 
Nox4. The underpinnings of this body of research are grounded in the observation that 
inhibition of the EGF pathway induces cytotoxicity in neural cell types. In a series of studies 
using the EGF receptor (EGFR) inhibitor, erlotinib, Simons and colleagues found that in 
squamous carcinoma cells, enhanced Nox4 expression and activity were contributing to the 
erlotinib-induced cytotoxic phenotype (131). Interestingly, Chen and colleagues found that 
inhibition of Nox4 disrupted the signalling of EGFR that led to downstream modulation of 
ERK1/2-driven proliferation; thus, potentially implying a feedback loop between Nox4 and 
EGF(R) signalling. Interestingly, the authors of this study proposed that this relationship may 
be facilitated by oxidative inhibtion protein tyrosine phosphatase 1B (132), akin to what was 
discussed in 1.6.2. These data serve as a mechanistic corollary to the findings of Simons and 
point to a heterogeneous pathway in regulation of Nox4.  
1.6.4 Nox4-derived ROS targets 
The known homeostatic functions of Nox4 remain diffuse, implicated in aspects of pro-
inflammatory responses, cell migration, differentiation, proliferation and apoptosis (1). Like 
its other homologues, Nox4 exerts its biological activity through the production of O2—. It is 
believed that O2— undergoes rapid dismutation to yield H2O2. Dismutation may be 
spontaneous or through catalysis by superoxide dismutase (SOD) (133). Evidence has 
emerged; however, that Nox4 may be able to also directly produce H2O2 upon observation that 
increased expression of p22phox leads to increased H2O2 and constant O2—, with the authors 
suggesting that Nox4 uniquely contains a domain capable of direct O2— dismutation (134). In 
the context of signal modulation, H2O2 remains the more relevant product of Nox activity, as 
it easily passes through biological membranes (71) and is readily diffusible into 
the surrounding cytosol; key characteristics that are particularly important in the context of 
the lens.  
The subcellular localisation of Nox is a critical factor in redox-mediated signalling. Expression 
of Nox at particular subcellular locations is tissue and context specific; Nox4 has been reported 
to be expressed at focal adhesions, both intra-nuclear and perinuclear locations, and the 
endoplasmic reticulum  (121, 132, 135). Intra-nuclear Nox4 localisation therefore challenges 
the generally held notion that all Noxs’ are intramembranous enzymes, and alludes to potential 
downstream roles in transcription. The intracellular localisation of Nox4 comes with a degree 
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of controversy, and it has been noted that this may be due to discrepancies in the splice variants 
detected through the use of particular Nox4-antibodies (132). More importantly, the finding 
that Nox4 localises to specific areas of the cell provides credence to the concept described in 
1.4, whereby the propensity of a SURWHLQ
V reactive cysteine to undergo oxidation was largely 
dictated by the proximity of the ROS source. This also raises the exciting possibility of 
Nox4-derived ROS being capable of regulating numerous signalling pathways 
simultaneously, in both a temporal and spatial manner.  
Indeed, the roles of Nox4-derived ROS on signalling pathway modulation are presently being 
elucidated. As imaginable, a concerted effort has been placed on linking Nox4-derived redox 
signalling to phosphatases. Chen found that both Nox4 and PTP1B were co-localised to the ER 
and that Nox4 was capable of spatially inactivating PTP1B activity via ROS (132). The 
significance of this finding lies in that when activated, EGFR is internalised to the ER, PTP1B 
dephosphorylates the receptor complex to remove the EGF signal. Therefore, if Nox4 is 
recruited to the ER, EGF-signalling will by propagated; thus, conferring both a spatial and 
temporal means of regulating EGF-signalling, similar to the previously mentioned concept in 
redox signalling.  
:KLOH the above alludes to the importance of Nox4 in intracellular signalling events, Nox4 
has also been reported to modulate cytoskeletal changes. Fernandez and colleagues have 
alluded to an important role of Nox4 in the assembly of focal adhesions, through the H2O2-
inducible protein (clone), Hic-5. Hic-5, an essential member of the Paxillin family, is an 
essential adapter protein involved in migration. In this study it was found that Nox4 deletion 
impacted on Hic-5 and HSP27, which in turn led to a decrease in focal adhesion maturity 
and cell adherence (136). Indeed, a similar finding has been reported by Datla and 
colleagues, through the implication of Poldip2 (137). These data may have 
important implications on our understanding of EMT, as it is well documented that focal 
adhesions play a significant role in the formation and function of myofibroblasts and the 
contractile apparatus (138). :hatever the respective target of Nox4, growth factor 
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1.6.5 Nox4, ROS and EMT 
It has been proposed that, upon undergoing EMT, fibroblasts upregulate Nox4/ROS production 
which then feeds into the non-canonical TGF-β signalling pathways; thereby providing a 
potential link between Smads and non-canonical pathways. MAPKs, in particular, have been 
cited as a known inducer of myofibroblasts, which are believed to have autocrine TGF-β 
signalling capabilities; thereby creating a feed-forward loop (120) of localised autocrine 
signalling. ECM contraction, resulting from myofibroblast actin cytoskeletal modulation, may 
activate latent TGF-β. Essentially, local ECM remodelling from initial fibroblast-driven TGF-
β signalling leads to stiffening of the matrix. Stress fibres and small focal adhesions form that 
associate with elements of the contractile apparatus pertaining to myofibroblasts; generating 
immense contractile force on the ECM, as the focal adhesions and stress fibres grow in size. 
As the TGF-β LTBP associates with the ECM, it is thus proposed that myofibroblast mediated 
ECM traction is mechanically capable of activating latent TGF-β (139). Together, this self-
perpetuating cycle, implicating both molecular and mechanical feedback, may therefore 
explain why fibrotic disorders, such as PCO and ASC, are progressive in nature.  
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1.7 Objectives of project 
TGF-β is believed to be the prototypical cytokine involved in the induction of numerous 
pathological models of EMT, including fibrotic cataract. However, induction of a conserved 
EMT programme represents the convergence of numerous molecular signalling pathways. 
Evidence has emerged that alludes to potential cross talk between pathways, as a means to 
achieve this. The mechanisms through which this occurs are presently being elucidated, with 
ROS-mediated signalling postulated as being a central player. Based on its implication in other 
models of TGF-β-induced pathological EMT, it is proposed that the ROS-generating Nox4 is 
upregulated in the presence of TGF-β2 in lens epithelial cells. This is in congruence to recent 
research highlighting that antioxidant treatment in TGF-β2 stimulated cells led to a diminished 
cataractous phenotype (113). The precise targets of ROS-mediated signalling are largely 
unknown within the context of EMT. However, evidence from other pathological EMT models 
has indicated that ROS may feed into non-canonical TGF-β signalling. This raises an exciting 
implication of the present study, in that Nox4-dervied ROS may have the capability to regulate 
multiple pathways simultaneously. It is thus hypothesised that Nox4-derived ROS plays a role 
in TGF-β-induced cataract. To test this, the following aims will be explored: 
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2. Materials and
Methods 
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2.1 Animals 
Ocular tissue was collected from postnatal-day-21 albino Wistar rats (Rattus norvegicus) or 
transgenic mice that were sacrificed by asphyxiation and subsequent cervical dislocation. 
Animals were bred at the %osch Animal House (D05) or RMC Gunn Facility, the 8niversity 
of Sydney, Australia. All animal handling procedures were in accordance with the National 
Health and Medical Research Council (Australia), the AR9O statement for the 8se of 
Animals in Ophthalmic and 9ision Research, and were approved by the Animal Ethical 
Review Committee of the 8niversity of Sydney, Australia. 
2.2 Tissue Culture 
2.2.1 Preparation of media 
Immediately prior to tissue collection, Medium 199 with Earle’s salts (Life Technologies, 
USA) was supplemented with 50µg/mL L-glutamine, 50IU/mL penicillin/50µg/mL 
streptomycin (Thermo Scientific, USA), 2.5µg/mL Amphostat B (Thermo Scientific, USA) 
and 0.1% bovine serum albumin (BSA) (Sigma, USA). M199 was distributed into 35mm 
culture dishes (Nunclon, Nunc, Denmark) and equilibrated in an incubator at 37°C, 5% CO2.  
2.2.2 Preparation of lens epithelial explants 
As previously described (140), the eyeballs of sacrificed rats were removed with curved 
forceps and placed into equilibrated media in culture dishes. Isolation of lenses and 
subsequent explanting was carried out under sterile conditions, within a laminar flow cabinet 
and with the aid of a dissecting microscope (Leica Mz95, Germany). Essentially, using 
watchmaker’s forceps, eyeballs were torn to expose the vitreous humour and allow for 
removal of the lens. The remaining ocular tissues were discarded and the isolated lenses 
were placed into a fresh equilibrated culture dish (2 lenses per dish).  
Upon placement into a new dish, lenses were orientated such that the posterior pole of 
the lens faced upwards. This was achieved through the identification of a characteristic 
Y-shaped suture. Using forceps, a sequence of small tears in the posterior lens capsule
extending to the lens equator were made to expose the lens fibre mass. An edge of the lens
capsule was then held in place, while
CKDSWHU  *HQHUDO 0HWKRGV
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the fibre mass was rolled away from the anterior pole of the capsule; thereby, isolating the 
anterior capsule and, importantly, its adherent lens epithelial cells. The anterior lens capsule 
was pinned to the culture dish, using a series of indentations along the peripheral edge of the 
explant. Explants were left to equilibrate overnight at 37°C, 5% CO2.
2.2.3 Preparation of growth factor and inhibitor stock 
solutions 
Human recombinant TGF-β2 was reconstituted in 
4PM HCL and stored in 20ng/100mL aliquots at 
-80°C. Immediately prior to treatment of explants,
900µL M199 was added to the required number of
aliquots to yield a diluted concentration of 20ng/mL.
50µL of the M199 TGF-β2 solution was added to
950µL of M199 into each dish to yield 1ng/mL
TGF-β2 in each dish. The justification to use a
concentration of 200pg/mL TGF-β2 is as a result of
previous studies highlighting that TGF-β2 induces a
dose-dependent response. Concentrations ranging
from 200pg/mL-20ng/mL (13, 31, 32) have
previously been used to induce EMT in rat lens
explants. Early experiments in the present study
yielded no marked cellular responses using a lower
concentration of TGF-β2, and a more rapid rate of
apoptosis/ cell-loss when higher concentrations
within this range were used. 8sing the start of cell-
loss at day 3 of culture as a positive marker for a
cellular response, a range of TGF-β2 concentrations
were tested.
The selective Nox inhibitor, Vas2870, has previously been shown to be effective at 
inhibiting Nox4 in experimental lung, renal and vascular models (141-143); however, to 
date, its effects have not been studied in the context of the lens or, specifically, the lens 
epithelial explant system. Briefly, 5mg HPLC-grade Vas2870 (Sigma, USA) was 
resuspended in dimethyl sulfoxide (DMSO), giving a stock solution of 13.87mM. To 
ascertain the effects of the inhibitor on lens explants and determine an effective 
Figure 2.1 Diagrammatic representation of the 
lens explantation procedure. Once the lens has 
been orientated such that the posterior pole faces 
upwards, the fibre mass is peeled away from the 
anterior lens capsule. The lens capsule is then pinned 
to the base of dish, such that the lens epithelial cells 
face upwards and are exposed to the growth medium.
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concentration to inhibit Nox4, a dose-response analysis was conducted using 
immunofluorescence to observe increased Nox4 labelling. An effective concentration was 
found within the range of 5-15µM. Dosages exceeding this were cytotoxic within a few 
hours of treatment. 5µM of Vas2870 in each treatment dish was found to block Nox4 
labelling in the presence of TGF-β2 and was consequently used throughout the present study. 
2.2.4 Treatment of lens epithelial explants 
Following overnight equilibration, dishes containing explants were randomly designated into 
control and treatment groups. In the present study, control groups were defined by the 
absence of TGF-β2 and 9as20, and were refreshed with 1mL of M1. For dishes to be 
concomitantly treated with TGF-β2 and 9as20, 2ȝL of 3.4mM 9as20 was added to 
4ȝL of M1 of each dish to yield an effective concentration of 5ȝM 9as20. Consistent 
with current literature in other experimental models, explants were left to pre-incubate with 
9as20 for 30 minutes at 3C, 5 CO2. At the conclusion of pre-incubation, a working 
TGF-β2 concentration of 1ng/mL in relevant treatment groups was achieved by adding 50ȝL 
of M1-diluted-TGF-β2 to each dish (see 2.2.3). In dishes only treated with TGF-β2, 50ȝL 
of M1-diluted-TGF-β2 was added to 50ȝL of M1 in each dish. 8pon the addition of 
9as20 and/or TGF-β2, dishes were gently swirled by hand to ensure homogeneity of 
media. All dishes were cultured at 3C, 5 CO2 for the duration of their relevant time-
points. The timepoints for each experiment are stated in the figure legend for each figure.
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2.2.5 Phase-contrast microscopy 
At relevant time-points, the progression of EMT in live cells was observed using a phase-
contrast microscope (Olympus CK2, Japan) and camera (Leica DFC-280, Germany). A series 
of markings around each dish corresponding to the explant were created such that the dish 
could be similarly orientated for each microscopy session, and the same region of the explant 
could be captured. EMT progression was assessed upon the development of cell elongation, 
cell membrane blebbing, cell loss and lens capsular wrinkling. Dishes were removed from 
culture conditions pending imaging and were either fixed for immunocytochemistry (see 
2.3.1), collected for western blotting (see 2.5.1) or returned to culture conditions for further 
live-cell imaging. 
2.3 Immunofluorescent labelling 
2.3.1 Fixation of lens epithelial explants 
Following the conclusion of the culture period, dishes were removed from the incubator. 
Growth medium was drained and 100% methanol was applied to each dish for 45 seconds for 
fixation. This was followed by 3 consecutive 15 second rinses in phosphate buffered 
saline (PBS) (see appendix 1). Dishes were stored in PBS at 4°C in a humidified chamber 
for no longer than 2 days prior to immunolabelling. 
2.3.2 Immunofluorescent labelling of explants 
Dishes were allowed to return to room temperature for approximately 40 minutes and subMect 
to 3 x 5 minute washes in P%S supplemented with 0.1 bovine serum albumin (%SA) 
(Sigma). Dishes were drained of P%S/%SA, and blocked in 10 normal goat serum (NGS) 
diluted in P%S/%SA for 1 hour to curtail non-specific labelling. Following blocking, excess 
NGS was removed from each explant and an appropriate concentration of primary antibody 
was applied, diluted in 0.15 NGS and P%S/%SA. Dishes were left to incubate overnight at 
4C in a humidified chamber. Source of individual primary antibodLes are detailed in methods 
sections of each respective results chapter.1HJDWLYH SULPDU\ DQWLERG\ VDPSOHV ZHUH LQFOXGHG 
WKURXJKRXW WKH SUHVHQW VWXG\ WR DFFRXQW IRU IDOVHSRVLWLYH ODEHOV DQG DXWRIOXRUHVFHQFH 
The following day, dishes were allowed to return to room temperature for approximately 40 
minutes and subject to 3 x 5 minute washes in PBS/BSA. An appropriate secondary antibody 
was diluted in PBS/BSA and applied to the surface of each explant for 2 hours under dark 
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conditions. Following 2 hours incubation, excess antibody was removed with 3 x 5 minute 
washes in PBS/BSA. Dishes were drained and a 1:2000 solution of bisbenzimide (Hoechst dye) 
was applied for 3 minutes for the visualisation of cell nuclei. Dishes were then rinsed in 3 x 5 
minute washes in PBS/BSA. Pending microscopy, explants were mounted in 40µl o f
10% glycerol/PBS.  
2.3.3 Imaging of immunofluorescence 
Immunofluorescent labelling was viewed with an confocal microscope (Car Zeiss LSM 800). 
The exposure used to identify the protein of interest was mediated by controlling the exposure 
time and intensity of light passing through the explant; however, in order to reliably measure 
changes in protein expression, these variables were kept constant between independent 
experiments when analysing the same protein/feature. Post-capture modification of images 
included uniform adjustment of brightness and contrast levels when merging colour channels 
in Adobe Photoshop, Creative Suite 6 (Adobe Systems, USA).  
2.3.4 Quantitation of immunofluorescent labelling 
Where appropriate, the threshold feature of ImageJ (NIH, 8SA) was used to estimate 
fluorescence intensity as a proportionate measurement of protein expression. Essentially, an 
arbitrary value was chosen as a threshold coefficient which was applied to all images. For 
measurement of early Nox4 labelling, a low coefficient value was set to measure the 
total fluorescence intensity. This methodology was chosen, as the labelling of Nox4 made it 
difficult to determine specific regions of interest at these timepoints.  
2.4 ROS Staining 
2.4.1 Staining of ROS using dihydroethidium (DHE) 
Following the conclusion of the allocated treatment period, 1µL of 30mM DHE (Life 
Technologies, USA) (reconstituted in DMSO, according to manufacturer’s instructions) was 
added to each dish containing 1mL of growth medium to yield a working concentration of 
30µM. Dishes were returned to the incubator for 30 minutes. Explants were then rinsed in cold 
PBS (3x 15 seconds), before being mounted in 40µl 10% glycerol/PBS. In its reduced form, 
DHE typically fluoresces blue; however, it undergoes oxidation in the presence of the 
superoxide anion, enabling it to intercalate with the cell’s DNA and emit red fluorescence; thus 
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staining cell nuclei. Similar to the protocol outlined in 2.3.3, DHE staining was viewed 
with an epifluorescence microscope (Leica-DMLB, Germany) and digital camera (Q-Imaging 
MicroPublisher 3.3 RTV, Canada).  
2.5 Western Blotting 
2.5.1 Lens explant protein extraction 
Following the allocated culture period, M199 was replaced with cold PBS in each dish for a 
total of 2 x 5 minute rinses. Explants of the same treatment groups were removed from the 
culture dishes with watchmaker’s forceps and placed into a 1.5mL eppendorf tube. In cases 
where samples over multiple days were to be collected over multiple days, tubes containing 
explants were stored at -80°C until required. When all samples had been collected, each 
tube was rotated on a spinning wheel at 4°C for 2 hours with 40µL of cold lysis buffer 
(see Appendix 1 for lysis buffer constituents). At the cessation of this, the protein lysates were 
centrifuged for 15 minutes (15,500g, 4°C). The supernatant was transferred to a new 
1.5mL eppendorf tube using a micropipette, careful to leave the pellet behind to be later 
discarded. Purified lysates were stored at -20°C until required. 
2.5.2 Measuring of total protein content 
Eppendorf tubes containing lysates were removed from -20°C conditions and kept on ice. The 
Direct DetectTM spectrophotometer system (Merck Millipore, Australia) was used to create a 
standard curve, according to both the manufacturer’s instructions and included software, using 
a range of known BSA concentrations. Using this, a protein concentration of each lysate was 
determined.  
2.5.3 SDS-PAGE and western blotting 
A sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) assay was used 
to separate the proteins within each lysate according to molecular weight. The polyacrylamide 
gel was cast by making a 10% acrylamide resolving gel, which was allowed to polymerise, 
and layering a stacking gel on top of it (see Table 2.1 for constituents of each gel). Protein 
lysates were diluted in milli-Q (Millipore, Australia) water to a concentration of 5µg/µL in 
20µL. An equal volume of Laemmli sample buffer, containing 5% w/v β-mercaptoethanol, 
was added to each lysate. Lysates were boiled for 7 minutes and immediately placed on ice. 
Each gel was 
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loaded with 5µL of precision plus dual-colour protein standards (Bio-Rad, USA) and 10µL 
samples of lysate were loaded into each well. The remaining 10µL were loaded into a duplicate 
gel to facilitate visualisation of equal protein loading. The gels were electrophoresed? at 200V 
for 1 hour at room temperature in running buffer (see Table 2.1).  
After 1 hour, poly-vinylidine-fluoride porous membranes (PVDF) were activated by 
submerging in 100% methanol. The running apparatuses were dismantled and the gels were 
equilibrated in cold transfer buffer (see Table 2.1), along with the activated PVDF membranes, 
transfer cassettes, filter paper and pads. The transfer cassettes were assembled and placed into 
the transfer chamber along with running buffer. The transfer chamber was placed into a 
container filled with compacted ice and a current of 100V was applied for 1 hour. 
The PVDF membrane was removed from the transfer cassette and immediately incubated in 
blocking buffer (see Table 2.1) for 1 hour at room temperature with gentle rocking. Following 
1 hour, the membrane was incubated overnight at 4°C with gentle rocking with appropriated 
diluted primary antibody in blocking buffer. 
Following overnight incubation, each membrane was drained of primary antibody and rinsed 
in TBST (see Table 2.1) for a total of 3 x 5 minutes. Diluted at 1:5000 in TBST, anti-rabbit 
horseradish peroxidase was applied to each membrane and incubated at room temperature for 
2 hours with gentle rocking. Membranes were rinsed (3 x 5 minutes) and an equal volume 
solution of peroxidase and luminol reagent was applied immediately prior to imaging using the 
ChemiDoc MP imaging system (Bio-Rad, USA).  
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Solution	 Composition	
10x	PBS	 80g	NaCl	
2g	KCl	
11.5g	di-sodium	hydrogen	orthophosphate	
2g	KPO4	
1L	milli-Q	water	
Lysis	buffer	 1.25mL	concentrated	salt	solution	(2.5mM	EDTA,	25mM	Tris,	0.375M	NaCl)	
30μL	250mM	NaVO3	
25μL	10%	Na-deoxycholate	
50μL	Triton-X	
2430μL	milli-Q	water	
500μL	10x	phosphatase	inhibitor	solution	(Roche,	Germany)	(Dissolve	1	table	in	1mL	of	
milli-Q	water)	
715μL	7x	protease	inhibitor	solution	(Roche,	Germany)	(Dissolve	1	tablet	in	1.5mL	milli-Q	
water)	
SDS-PAGE	
resolving	gel	
13%	(v/v)	glycerol	
375mM	Tris	(pH	8.8)	
10%	(w/v)	acrylamide	
0.05%	(w/v)	ammonium	persulphate	(APS)	
0.1%	(w/v)	sodium	dodecyl	sulphate	(SDS)	
0.1%	(w/v)	Tetramethylethylenediamine	(TEMED)	
SDS-PAGE	
stacking	gel	
125mM	Tris	(pH	6.8)	
10%	(w/v)	acrylamide	
0.05%	(w/v)	APS	
0.1%	(w/v)	SDS	
0.1%	(w/v)	TEMED	
SDS-PAGE	running	
buffer	
25mM	Tris	(pH	8.3)	
190mM	glycine	
0.1%	(w/v)	SDS	
Transfer	buffer	 25mM	Tris	base	
0.2M	glycine	
20%	methanol	
10x	TBS	 0.2M	Tris	base	
1.37	M	NaCl	
TBST	 0.1%	Tween-20	
1xTBS	
Blocking	buffer	 2.5%	(w/v)	BSA	
1x	TBST	
Table 2.1 Summary of all reagent used for immunoblotting 
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2.5.4 Semi-quantitative analysis 
Densitometry was performed using ImageLab (Bio-Rad, USA) analysis software (NIH). 
Essentially, labelling of each lane enabled a plot to be generated that highlighted peaks that 
corresponded to areas of greater signal intensity. 2 line segments were drawn onto the peaks 
such that they were bissected and a base could be established (Figure 2.2). The base line 
segment was drawn to merge with the tails of each peak. The area under the curve was then 
measured using ImageJ using one half of the peak. For all analyses, the right side of the 
peak was measured to negate the effects of background noise and consequent skewing.  
FiJure  5eSresentative Slots oI two adMacent lanes 8sing fluorescence intensity as a function of 
each lane, the peaks of each plot appear at the same location and correspond to bands that label 
GAPDH. %efore each peak, significant background noise affects the determination of a left tail; 
therefore, the area under the curve, generated from isolating the right side of the peak, is measured. On 
the right of the below lower plot, a ghost band could be is seen.
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3. Results
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Chapter 3 Peer-Reviewed Paper: TGF-β induces Nox4 Expression 
in vitro 
3.1 Introduction 
The following chapter contains a peer-reviewed that was published during the PhD candidature 
of the candidate. It identifies Nox4 for the first time in the lens and centrally implicates it in 
the process of TGF-β-induced cataracts. 
There are three authors on this paper. Their individual contributions are outlined below. 
Shannon Das 
• Designed and carried out the experiments described
• Wrote and assisted in the editing of the manuscript
Frank Lovicu 
• Provided input as to the design of experiments
• Assisted in the editing of the manuscript
Emma Collinson 
• Provided input as to the design of experiments
• Assisted in the editing of the manuscript
SUMMARY: Nox4 Plays a Role in     7*)ȕDependent Lens Epithelial to Mesenchymal 
Transition 
Cataract is the leading cause of partial blindness in Australia (14). It is a term used to 
describe an opacity of the ocular lens, which impedes uniform light refraction onto the retina 
to enable vision. There are many aetiologies of cataract, however, all yield progressive vision 
loss. As there are no current treatments to slow this progression, the impacts on cataract 
sufferers’ lives are be both severe and debilitating. Currently, surgical intervention is the 
only means to remove a cataract. While highly successful, this procedure inherently 
predisposes patients to the formation of a secondary cataract, at an incidence of 30-40% 
within 5 years of surgery (14) and even higher in paediatric patients. As part of a wound-
healing response to the surgery, lens epithelial cells undergo an epithelial to mesenchymal 
transition (EMT). The generation of disorganised mesenchymal cells and 
deposition of aberrant extracellular matrix once again impedes the refraction of light 
through the lens (18). Surgical intervention is often required again and is now complicated 
by advanced 
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age and potential financial burden (17). Thus, it is paramount to discover novel EMT 
effectors in the hope to treat or ideally prevent secondary cataracts. The work described in the 
present manuscript identifies and characterises a role for Nox4, for the first time in TGFβ-
induced lens EMT. 
As implied by the name, EMT encompasses a series of biochemical events whereby epithelial 
cells undergo multiple changes that enable a mesenchymal phenotype. The underlying 
biochemical changes that facilitate this transition are triggered in response to a wide 
array of cytochemical motifs. Transforming Growth Factor beta (TGFβ) is the 
prototypical growth factor responsible for inducing EMT (20-22). Signalling through a 
multitude of pathways, TGFβ recruits an array of effector proteins that impact the EMT 
program to varying (and largely unknown) extents (34, 43). TGFβ has recently been shown 
to upregulate the reactive oxygen species (ROS) producing enzyme, Nox4, in models of 
fibrosis and cancer (121, 144). In these models, Nox4 inhibition was shown to block the 
pathology or play a significant part in its pathogenesis. These findings have prompted the 
present study; to look for Nox4 in lens EMT. 
Nox4 is part of NADPH family of enzymes, which are designated by their sole function of 
ROS production. Nox4 is transcriptionally regulated and is constitutively active, delineating 
it from the other Nox family members (123). This makes it inherently an early effector of 
TGFβ signaling and potentially an ideal interventional target to block early-stage EMT. In the 
present study, we are able to isolate and explant the lens epithelium and culture these cells 
with TGFβ to observe an EMT that is analogous to the lens cellullar changes seen clinically. 
Using this method, it was found that TGFβ induced Nox4 expression as early as 6 hours. 
At the same timepoints, increased Nox4 expression also led to a concomitant increase in ROS 
levels. This finding has built on previous work that has found endogenous redox activity in 
TGFβ-stimulated lens epithelial cells (113, 115), by identifying Nox4 as the potential source 
of ROS. Importantly, Nox4-derived ROS appeared to play a role in the progression of the 
EMT, by slowing the progression of apoptosis and also abrogating the development of 
myofibroblasts.  
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PURPOSE. Transforming growth factor-b induces an epithelial to mesenchymal transition (EMT)
in the lens, presented as an aberrant growth and differentiation of lens epithelial cells. Studies
in other models of EMT have shown that TGF-b–driven EMT is dependent on the expression
of the reactive oxygen species (ROS)–producing enzyme nicotinamide adenine dinucleotide
phosphate (NADPH)–oxidase-4 (Nox4). We investigate the role of this enzyme in TGF-b–
induced lens EMT and determine whether it is required for this pathologic process.
METHODS. Rat lens epithelial explants were used to investigate the role of Nox4 in TGF-b–
driven lens EMT. Nox1–4 expression and localization was determined by immunolabeling
and/or RT-PCR. NADPH–oxidase–produced ROS were visualized microscopically using the
fluorescent probe, dihydroethidium (DHE). VAS2870, a pan-NADPH oxidase inhibitor, was
used to determine the specificity of Nox4 expression and its role in ROS production, and
subsequently TGF-b–driven EMT.
RESULTS. We demonstrate, for the first time to our knowledge, in rat lens epithelial explants
that TGF-b treatment induces Nox4 (but not Nox1–3) expression and activity. Increased Nox4
expression was first detected at 6 to 8 hours following TGF-b treatment and was maintained
in explants up to 48 hours. At 8 hours after TGF-b treatment, Nox4 was observed in cell
nuclei, while at later stages in the EMT process (at 48 hours), Nox4 was predominately
colocalized with a-smooth muscle actin. The inhibition of Nox4 expression and activity using
VAS2870 inhibited EMT progression.
CONCLUSIONS. Transforming growth factor-b drives the expression of the ROS-producing
enzyme Nox4 in rat lens epithelial cells and Nox4 inhibition can impede the EMT process.
Keywords: lens opacity, lens epithelium, transforming growth factor-beta
Age-related cataract (i.e., a loss of lens transparency) is themost common cause of blindness in the world. A causal
link has been established between the development of cataract
and reactive oxygen species (ROS), with the deletion of major
cellular antioxidants leading to the development of cataract.1–3
Indeed, the macromolecules of the lens (i.e., proteins, lipids,
and DNA) are oxidatively damaged by these ROS in cataract.4–7
This damage is thought to occur, at least in part, as a result of
the levels of the cellular antioxidant defenses declining with
age.8–10 Routine surgery resolves cataract; however, in many
cases 2 to 4 years later, a secondary cataract develops, known
as posterior capsular opacification (PCO), where residual lens
epithelial cells (LECs) migrate and undergo an epithelial-
mesenchymal transition (EMT), as they encroach on the
posterior capsule,11 requiring further treatment. Developing a
successful strategy to prevent the development of cataract and
a treatment that offers permanent resolution of the cataract
would substantially reduce health cost outlays and social
benefit costs, and restore the quality of life for the aging
population.
Work in our laboratory and others has focused on
understanding the molecular basis of cataract development in
the lens, in particular the EMT process. Specifically, it has been
shown that TGF-b induces an EMT in the lens that arises from
aberrant growth and differentiation of the lens epithelial
cells.12,13 Transforming growth factor-b drives this lens EMT
through Smad and ERK signaling in animal models of
cataract14,15 and in humans.16 Recently, a link has been
established between TGF-b–driven cataract and oxidative
stress,17 where addition of the antioxidant glutathione (GSH)
has been shown to suppress TGF-b–induced opacification and
subcapsular plaque formation.17 Interestingly, studies by Dawes
et al.14 examined the transcriptional response of human lens
epithelial cells to TGF-b and uncovered a potential source of
the TGF-b–driven ROS production and subsequent oxidative
stress. In this model, only one professional ROS producer (i.e., a
direct ROS producer, not producing ROS as a side-effect of its
enzymatic activity) was upregulated in response to TGF-b,
namely, NADPH oxidase 4 (Nox4). This discovery adds to the
growing evidence that growth factor–dependent NADPH
oxidase activity has a role in TGF-b driven EMT of the lens
and more generally in the EMT process.
Growth factors have been shown to induce NADPH oxidase
activity in the lens, with PDGF stimulating Nox2 activity and
ROS production in human lens epithelial cells.18 However, to
our knowledge this is the first time the role of Nox4 in TGF-b–
driven EMT has been investigated in the lens and we expect it
to be significant given that Nox4 has been shown to have an
important role in other models of TGF-b–driven EMT.19
Specifically, in breast cancer cells, TGF-b has been shown to
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signal through the Smad signaling cascade to induce Nox4
expression leading to an EMT.19 Interestingly, in this model,
blockade of the Smad signaling pathway inhibited Nox4
expression and abolished the development of the EMT.19
Moreover, blocking Nox4 alone (either pharmacologically or
by siRNA), also prevented the EMT in breast cancer cells.19
Here, in experiments described, we have identified a potential
source of TGF-b–driven ROS in the lens. Specifically, we have
identified that TGF-b induces expression of Nox4 in the lens.
Nox4 is an inducible enzyme, responsible for the production of
the superoxide anion radical and hydrogen peroxide.20 We
have shown that TGF-b–driven Nox4 protein expression leads
to concomitant ROS production in the lens and now plan to
identify how this contributes to the development of TGF-b–
mediated cataract. Based on these findings, we hypothesize
that TGF-b–driven Nox4-dependent oxidant production has a
role in the development of an EMT in the lens and resultant
cataract.
METHODS
Animals
Tissue was collected from postnatal-day-21 albino Wistar rats
(Rattus norvegivus) that were euthanized by asphyxiation and
subsequent cervical dislocation. All procedures were approved
by the Animal Ethical Review Committee of the University of
Sydney, Australia and were carried out in accordance with the
National Health Medical Research Council (Australia) guide-
lines and the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals in Ophthal-
mic and Vision Research (United States).
Rat Explant Preparation
Lens epithelial explants were prepared as described previous-
ly21 and cultured in Medium 199 with Earle’s salts (Life
Technologies, Waltham, MA, USA), supplemented with 50 lg/
mL L-glutamine, 50 IU/mL penicillin/50 lg/mL streptomycin
(Thermo Fisher Scientific, Waltham, MA, USA), 2.5 lg/mL
Amphostat B (Thermo Fisher Scientific), and 0.1% BSA (Sigma-
Aldrich Corp., St. Louis, MO, USA). M199 was equilibrated at
378C, 5% CO2. To induce EMT, recombinant TGF-b2 was added
to media in each culture dish at a working concentration
ranging from 200 pg/mL up to 1ng/mL (R&D Systems,
Minneapolis, MN, USA). Before the addition of TGF-b2, some
explants were pretreated with the pan-NADPH oxidase
inhibitor VAS2870 at a working concentration of 5 lM. The
progression of EMT in live cells was observed and captured
using phase-contrast microscopy (Olympus CK2, Tokyo, Japan)
and a digital camera (Leica DFC-280; Leica Camera, Wetzlar,
Germany). Percentage cell loss quantification was performed
using the thresholding function of ImageJ (National Institutes
of Health [NIH], Bethesda, MD, USA), such that cells could be
distinguished from bare lens capsule.
Immunofluorescence Analysis
At the end of the culture period, explants were fixed in 100%
methanol for 45 seconds, followed by 3 consecutive 15-second
rinses in PBS. Explants were blocked in 10% normal goat serum
(NGS) for 1 hour at room temperature. Excess normal goat
serum was removed and primary antibody was applied, diluted
in 0.15% NGS/PBS supplemented with 1% BSA. Dishes were
left to incubate overnight at 48C in a humidified chamber. a-
Smooth muscle actin (aSMA) was labeled with a specific
monoclonal mouse antibody (Sigma-Aldrich Corp.), diluted
1:100. Nox4 was labeled with a specific polyclonal rabbit
antibody (Santa Cruz Biotechnology, Dallas, TX, USA), diluted
1:50. E-cadherin was labeled with a specific polyclonal mouse
antibody (BD Biosciences, North Ryde, NSW, Australia), diluted
at 1:100.
The following day, dishes were equilibrated to room
temperature and subject to 33 5 minute washes in PBS/BSA.
An appropriate secondary antibody was diluted in PBS/BSA and
applied to each explant for 2 hours in dark conditions. a-
Smooth muscle actin and E-cadherin were detected using goat
anti-mouse Alexa-Fluor 488 (Cell Signaling, Danvers, MA, USA).
Nox4 was detected using an anti-rabbit whole IgG conjugated
to Cy3 (Sigma-Aldrich Corp.). A dilution of 1:1000 was used for
all secondary antibodies. Dishes subsequently were rinsed in
PBS/BSA and a 1:2000 solution of bisbenzimide (Hoechst dye)
diluted in PBS/BSA was applied for 3 minutes to visualize cell
nuclei. Pending microscopy, explants were mounted in 10%
glycerol/PBS. Immunofluorescent labeling was viewed and
captured using epifluorescence microscopy (Leica-DMLB;
Leica Camera), and a digital camera (MicroPublisher 3.3 RTV;
Q-Imaging, Surrey, BC Canada). Where appropriate, fluores-
cence also was visualized and images were collected using a
Zeiss LSM-5Pa confocal microscope (Carl Zeiss AG, Jena,
Germany).
RT-PCR mRNA Analysis
After appropriate treatment, lens epithelial explants were
placed into a 1.5 mL centrifuge tube. Total RNA extraction
was performed using a Quick-RNA MiniPrep Kit (Zymo
Research, Irvine, CA, USA) according to manufacturer’s
instructions. First-strand cDNA synthesis was done using
150 ng of RNA with a reverse transcription system (Bioline,
Eveleig, NSW, Australia) according to the manufacturer’s
instructions. Control reactions omitting reverse transcriptase
were set up and later tested, confirming that genomic DNA
was absent from the purified RNA template (data not shown).
For PCR amplification, the MyTaq Red DNA Polymerase
(Bioline) kit was used, according to manufacturer’s instruc-
tions. Primers used for the detection of Nox1–4 and GAPDH
mRNA were based on those previously published.22 For
detection of Nox1–4 mRNA, sequence-specific primers were
used: Nox1: Fw: 5 0-CTTCCTCACTGGCTGGGATA-3 0, Rev: 5 0-
TGACAGCATTTGCGCAGGC-3 0; Nox2: 5 0-CCAGTGAA
GATGTGTTCAGCT-3 0, 5 0-GCACAGCCAGTAGAAGTAGAT-3 0;
Nox3: 5 0-GTGTCCTTCGTGGTTGCTCT-3 0, 5 0-TCTACAGCA
CACGCTCGTTC-30; Nox4: 5 0-AGTCAAACAGATGGGA-3 0, 5 0-
TGTCCCATATGAGTTGTT-3 0; GAPDH: 5 0-TGAACGGGAAGCT
CACTGG-3 0, 5 0-TCCACCACCCTGTTGCTGTA-3 0. cDNA was
amplified for 35 cycles: Nox1 and Nox2: 958C for 45 seconds,
518C for 45 seconds, and 728C for 45 seconds; Nox1, Nox3,
and GAPDH: 958C for 30 seconds, 628C for 30 seconds, and
728C for 30 seconds. Amplified DNAwas visualized with SYBR
Safe DNA Gel Stain (diluted at 1:10,000; Invitrogen, Carlsbad,
CA, USA) in a 2% agarose TAE gel, run at 100 V for 20 minutes.
Positive control tissues for each Nox homologue also were
examined (Nox1, rat colon; Nox2 and Nox4, rat kidney). We
could not validate Nox3 expression given it is predominantly
expressed in inner ear.
Staining of ROS Using Dihydroethidium (DHE)
Dihydroethidium (Life Technologies) was added to explants in
each dish containing 1 mL of medium to yield a working
concentration of 30 lM. Dishes were returned to the incubator
for 30 minutes. Explants then were rinsed in cold PBS (33 15
seconds) before being mounted in 10% glycerol/PBS. In its
reduced form, DHE fluoresces blue, but when exposed to ROS,
including the superoxide anion radical and hydrogen peroxide,
it readily reacts to form the oxidized red fluorescent DHE
form23,24 that can be viewed readily using epifluorescence
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microscopy. Fluorescence microscopy gives an indication of
the level of total ROS produced by TGF-b2–dependent Nox4;
however, absolute quantification of specific types of ROS
cannot be determined using this method.
SDS-PAGE and Western Blotting
After appropriate treatment, lens epithelial explants were
placed into a 1.5 mL tube with cold lysis buffer containing 2.5
mM EDTA, 25 mM Tris, 0.375M NaCl, 250 mM sodium
orthovandate, 10 mM sodium deoxycholate, and a protease
inhibitor cocktail (complete, Mini; Roche, Basel, Switzerland).
Tubes were rotated for 2 hours and protein lysates were
extracted by centrifuging for 15 minutes (15,500g, 48C). The
Direct Detect spectrophotometer system (Merck Millipore,
Bayswater, VIC, Australia) was used to determine the protein
concentration for each lysate, according to manufacturer’s
instructions.
Equal amounts of protein per sample were loaded onto 10%
SDS-PAGE gels for electrophoresis at 200 V for 1.5 hours and
transferred onto a polyvinylidene fluoride membrane (Merck
Millipore) at 100 V for 1 hour. Membranes then were incubated
with a blocking solution containing 5% skim milk diluted in
0.1% Tween-20 in tris-buffered saline (TBS-T) for 1 hour at
room temperature and probed overnight at 48C with specific
antibodies, appropriately diluted in blocking buffer. Rabbit
monoclonal anti-Nox4 antibody (Santa-Cruz Biotechnology)
was diluted at 1:200, mouse monoclonal anti-a-SMA (Sigma-
Aldrich Corp.) was diluted at 1:2000 and mouse monoclonal
anti-GAPDH (Sigma-Aldrich Corp.) was diluted at 1:5000.
Membranes were then rinsed (3 3 5 minutes) in TBS-T and
anti-rabbit or anti-mouse secondary antibodies conjugated to
horseradish peroxidase (diluted at 1:5000 in TBS-T) were
applied to each membrane and incubated at room temperature
for 2 hours with gentle rocking. Membranes were rinsed (335
minutes) with TBS-T and an equal volume of peroxidase and
luminol reagent was applied immediately before imaging using
the ChemiDoc MP imaging system (Bio-Rad Laboratory,
Hercules, CA, USA).
RESULTS
TGF-b Induces Nox4 Expression
Nox4 expression in TGF-b–driven lens EMT was assayed using
immunolabeling of lens epithelial explant lysates. Specifically,
we determined Nox4 expression using Western blotting at
different time points (0, 2, 4, 6, and 8 hours). Nox4 expression
was initially induced at 6 hours following treatment with TGF-
b2 (Fig. 1), and this level was significantly different to that of
the untreated control at the same time period (Fig. 1A, C6 vs.
T6, P ¼ 0.0392). Expression of Nox4 also was significantly
more pronounced at 8 hours to that observed at 6 hours (Fig.
1A, T6 vs. T8, P¼ 0.0069). At 8 hours after TGF-b2 treatment,
the level of Nox4 protein expression was approximately 2.5-
fold higher to that of the matching control without TGF-b2
(Fig. 1A, C8 vs. T8, P¼ 0.0003). This increase in Nox4 protein
expression also was accompanied by an upregulation in Nox4
mRNA transcription in TGF-b2–treated explants compared to
untreated explants at 8 hours (Fig. 1B). This was not the case
for other Nox homologues, Nox1–3 (Fig. 1B).
Nox4 Exhibits Variable Subcellular Localization
Patterns Over Time
Given that the expression level of Nox4 was more
pronounced at 8 hours after TGF-b2 treatment, this time-
point was used to examine the spatial localization of Nox4
in rat lens epithelial cells using immunofluorescence and
confocal microscopy (Fig. 2). In untreated cells, some
punctate labeling was observable, and appeared to localize
throughout the cytosol (Fig. 2A). This was in contrast to
the two distinct expression patterns of Nox4 seen at 8
hours following TGF-b2 treatment (Fig. 2B). Specifically,
increased Nox4 expression was seen throughout all TGF-
b2–treated epithelial cells at 8 hours, with more pro-
nounced punctate labeling in the cell nuclei and perinu-
clear areas. Interestingly, Nox4 localization in lens
epithelial cells treated for longer periods with TGF-b2, at
48 hours, was predominantly cytosolic (Fig. 2D), with an
overall increase in punctate labeling within these areas.
These cells also labeled for the myofibroblast marker, a-SMA
(Fig. 2E), which was first detectable by 24 hours after TGF-
b2 treatment (data not shown). At 48 hours treatment,
Nox4 appeared to colocalize with particular areas of the a-
SMA reactive stress fibers (see FIg. 2, inset 1), colabeled
yellow. This colocalization of Nox4 and a-SMA has been
observed in other models of TGF-b–driven EMT.25 Interest-
ingly, not all cells with a strong Nox4 label colabeled with
a-SMA (see Fig. 2, inset 2). Similar to untreated cells at 8
hours, untreated cells at 48 hours yielded negligible Nox4
expression and a-SMA–positive stress fiber formation.
FIGURE 1. Transforming growth factor-b2 induces an increase in Nox4
expression in lens epithelial explants: Western blot. (A) Representative
Western blot depicting the time-course (4, 6, and 8 hours) of Nox4
expression following TGF-b2 treatment (T4, T6, and T8), compared to
control explants (C4, C6, and C8). Image is representative of 3
independent experiments. Above: Densitometry was performed to
normalize the expression of Nox4 protein to GAPDH expression. Upon
TGF-b2 treatment, Nox4 expression was significantly upregulated at 6
hours (T6), and these levels significantly increased by 8 hours (T8).
Data are presented as mean6 SEM. One-way ANOVA, Tukey’s post hoc
test (2-tailed t-test) *P < 0.05 and **P < 0.01. (B) A representative RT-
PCR of Nox1–4 mRNA transcripts after 8 hours, in the absence (C8)
and presence (T8) of TGF-b2. Positive controls are included for Nox1,
2, and 4. For each lane, the PCR products shown correspond to the
expected base pair length (Nox1, 201 base pairs [bp]; Nox2, 149 bp;
Nox3, 234 bp; Nox4, 191 bp, and GAPDH, 287 bp).
Nox4 Role in TGF-b–Dependent Lens Transition IOVS j July 2016 j Vol. 57 j No. 8 j 3667
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935424/ on 01/16/2019
63
TGF-b2 Induces Nox4-Derived ROS Production
To validate the specificity of the Nox4 label seen in response to
TGF-b2 treatment, we repeated our immunolabeling experi-
ments with the pan-NADPH oxidase inhibitor VAS2870 (Fig.
3).26 Inhibition of NADPH oxidase blocked Nox4 protein
expression in lens epithelial cells in response to TGF-b2
treatment (Fig. 3I, inset) when compared to TGF-b2–treated
cells without the inhibitor (see Fig. 2B). We next determined
whether this TGF-b2–dependent expression of Nox4 was
accompanied with NADPH oxidase activity, using DHE
fluorescence microscopy to assay for ROS production in lens
FIGURE 2. Transforming growth factor-b2 induces variable Nox4 localization patterns in lens epithelial cells with the progression of TGF-b induced
EMT. Nox4 (red) was merged with the cell nuclear Hoechst dye (blue). Untreated explants at 8 (A) and 48 (C) hours exhibited little Nox4
expression. Explants treated with TGF-b2 (þTGF-b2) exhibited a stronger distinct punctate label by 8 hours (B) that primarily localized to the
perinuclear regions of the cells. At 48 hours (D), this label became more pronounced throughout the cytosol. By 48 hours compared to control
explants (E), epithelial cells treated with TGF-b2 also labeled for a-SMA (green; [F], with a-SMA labeled-stress fibres colocalizing with Nox4 (shown
at higher magnification, Inset 1). Punctate cytosolic distribution of Nox4, independent of stress fibers, also was apparent in some cells ([F], shown
at higher magnification, Inset 2). Images are representative of 3 independent experiments, consisting of 3 replicates per group. Scale bar: 40 and 20
lm for the inserts.
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epithelial cells. As Nox4 was first detected between 6 and 8
hours after TGF-b2 treatment, DHE reactivity was assayed
before and at these time points. Reassuringly, Nox4 expression
was accompanied by a significant increase in NADPH oxidase
specific activity (DHE oxidation) in TGF-b2–treated lens
explants (Figs. 3G, 3H) compared to the control explants not
treated with TGF-b2 (Figs. 3C, 3D) at 6 and 8 hours (Fig. 3J, C6
vs. T6, P ¼ 0.0003; Fig. 3J, T6 vs. T8, P ¼ 0.0005).
Further earlier time points that did not exhibit Nox4
expression (2 and 4 hours) did not produce a DHE label, either
in the presence or absence of TGF-b2 (Fig. 3). In addition,
when TGFb-driven Nox4 expression was inhibited with
VAS2870 (see also Fig. 6B), ROS accumulation was abrogated
(Fig. 3I).
Nox4 Inhibition Abrogates TGF-b2–Induced Lens
EMT
Given that we have shown Nox4 expression and activity is
induced in lens epithelial cells and that we could inhibit Nox4
expression and concomitant activity with VAS2870, we next
investigated the role Nox4 had in the development of TGF-b–
dependent lens EMT. The development of TGF-b2–induced
lens EMT can be followed morphologically in lens explants
using phase-contrast microscopy. In our experimental model,
we observe EMT progression over 5 days. Specifically, cells
begin to considerably elongate by day 2 of culture (Fig. 4B),
and from day 3 exhibit progressive cell loss indicated by
acellular patches (Fig. 4C, asterisk), cellular blebbing (Fig. 4D,
arrowheads), and lens capsular wrinkling (Fig. 4D, arrows),
with most cells lost by 5 days (Fig. 4D). Interestingly, in
explants treated with TGF-b2 in the presence of VAS2870,
cellular loss was significantly delayed by day 3 and most
pronounced at 5 days after TGF-b2 treatment (Fig. 4I; Day 3,
þTGFb vs. þTGFb/VAS, P ¼ 0.0001 and Day 5 þTGFb vs.
þTGFb/VAS, P ¼ 0.005). Moreover, cells in these explants did
not appear to undergo TGF-b2–dependent cellular elongation,
with cells remaining on day 5 of culture, exhibiting a typical
uniformly packed lens epithelial phenotype (Fig. 4H). This was
confirmed by labeling for E-cadherin in these cells (Fig. 5B).
VAS2870-alone treatment had no effect on E-cadherin labeling
(5A). Moreover, consistent with the absence of cell elongation
earlier in the culture period, indicating the absence of
myofibroblastic cells that are thought to promote lens capsular
wrinkling, under these conditions there was no apparent
capsular wrinkling (Fig. 4H).
Nox4 Modulates TGF-b–Mediated a-SMA
Expression
As Nox4 was previously shown (Fig. 2D) to localize with some
a-SMA–reactive stress fibers, it was proposed that Nox4 may
have a role in a-SMA accumulation. Cells treated with both
VAS2870 and TGF-b2 yielded undetectable Nox4 expression
(Figs. 6B, 6G), compared to explants treated with TGF-b2 alone
(Figs. 6E, 6G), and in the process halted the progression of
EMT, with little to no detectable labeling for a-SMA expression
in cells (Fig. 6G) that retained their epithelial-like appearance
(see Hoechst staining, Figs. 6A, 6D).
DISCUSSION
In the present study, for the first time, we describe the novel
temporal and spatial expression of Nox4 and characterize its
activity in the rat lens explant system following TGF-b
treatment. We demonstrated that Nox4 is the only Nox
homologue expressed in rat lens epithelial explants, and is
responsive to TGFb, consistent with other studies.14 Nox4
inhibition using a pan-NADPH oxidase inhibitor slowed the
progression of EMT through the promotion of cell survival.
Furthermore, we also impeded the expression of the known
myofibroblastic EMT marker, a-SMA, and subsequent develop-
ment of capsular wrinkling. The remaining/surviving cells on
FIGURE 3. The ROS probe, DHE, was used to assess increases in ROS
following TGF-b2 treatment. In untreated explants, basal levels of ROS
were observable (A–D). Importantly, TGF-b2 treated explants yielded
noticeable increases in ROS by 6 hours, that increased up to 8 hours
(H). Treatment with VAS2870 blocked TGF-b2–induced ROS (I) as
shown by diminished fluorescence intensity, with less ROS produced.
This was in conjunction to VAS2870 also blocking Nox4 protein
expression (see [I] inset). Representative images from 3 independent
experiments, consisting of at least 2 replicates for each treatment
group. Scale bar: 100 lm (A–I) and 20lm for (inset [I]). Total
fluorescence intensity also was calculated using ImageJ (J), with
significant increases after 6 and 8 hours, effectively blocked by
VAS2870. Data are presented as mean 6 SEM. One-way ANOVA,
Tukey’s post hoc test (2-tailed t-test) ***P < 0.001 and ****P < 0.0001.
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FIGURE 4. Suppression of TGF-b2-induced EMTusing VAS2870. Phase contrast images of explants at days 2 (B, F), 3 (C, G), and 5 (A, E, D,H). Explants
treated with TGF-b2 alone (B–D) underwent morphologic changes associated with EMT compared to untreated cells (A). Explants treated with VAS2870
and TGF-b2 (F–H) showed a delayed EMT response, with less cell elongation apparent by Day 2 (F), reduced cell loss by Day 3 (G) and the retention of
epithelial-like cells by Day 5 (H). Note that, VAS2870 alone (E) had little effect on cells treated up to 5 days of culture. Images are representative of 3
independent experiments, consisting of 3 replicates per group. Scale bar: 100 lm. (I) Percentage cell loss was calculated using the threshold feature of
ImageJ in relation to areas of bare lens capsule, with significant cell loss in TGF-b2–treated explants from day 3, which was abrogated by application of
VAS2870. Data are presented as mean 6 SEM. Two-way ANOVA, Tukey’s post hoc test (2-tailed t-test) **P < 0.01 and ****P < 0.0001.
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the lens capsule following the Nox4 blockade retain an
epithelial-like phenotype and do not progress down the EMT
pathway, highlighting an important role for Nox4 in TGF-b–
dependent EMT in the lens.
Reactive oxygen species are known to have a key role in the
development of cataract. Deletion of known antioxidants leads
to the development of cataract. These antioxidants include the
glutathione synthesis machinery,3 the detoxification enzyme
peroxiredoxin,1 and glutaredoxins,2 that are responsible for
FIGURE 5. Maintenance of E-cadherin expression in cells cotreated
with TGF-b2 and VAS2870. Explants were treated with VAS2870 (A), or
cotreated with TGF-b2 and VAS2870 (B) and fixed at 5 days of culture.
Immunolabeling for the membrane marker E-cadherin (green) was
performed and nuclei were counterstained with Hoechst (blue). In
cells treated only with VAS2870 (A), E-cadherin localized to the cell
membrane and there was no apparent cell loss. Cotreatment with TGF-
b2 and VAS2870 promoted increased cell survival and the maintenance
of a membranous E-cadherin label (B).
FIGURE 6. VAS2870 blocks TGF-b2–induced Nox4 and a-SMA expres-
sion. Explants cultured for 24 hours in the presence of TGF-b2 (A–C),
or TGF-b2 and VAS2870 (D–F) were immunolabeled for Nox4 ([B, E],
red), a-SMA (green; [C, F]) and counterstained with Hoechst dye (A,
D). Compared to explants treated with TGFb alone (A–C), VAS2870
was shown to block TGF-b2-induced Nox4 (E) and a-SMA (F)
expression. Images are representative of 3 independent experiments,
consisting of 3 replicates per group. Scale bar: represents 50 lm. (G)
Protein lysates also were collected from explants treated with and
without TGF-b2 and VAS2870 and Western blotting demonstrated
similar reductions in Nox4 and a-SMA expression in the presence of
VAS2870 at 24 and 48 hours. GAPDH expression remained constant
regardless of treatment.
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the maintenance of the thiol redox status of lens proteins,
including the crystallins. Previous studies have shown the
indirect role of ROS in the development of TGF-b–dependent
cataract in rats.17 In these studies, addition of the antioxidant
GSH was shown to strongly suppress TGF-b–induced opacifi-
cation and subcapsular plaque formation in whole rat lens
cultures. Furthermore, microarray studies using TGF-b–treated
human lens cell lines highlighted that Nox4 was not only
induced in response to TGF-b, but was one of the highest
induced transcripts in these cultured human lens epithelial
cells compared to controls.14
While we demonstrate Nox4 to be involved in TGF-b–
dependent EMT in lens, it has previously been reported to be
involved in a number of other different models of EMT. For
example, in breast cancer cells, TGF-b has been shown to
induce Nox4 expression and activity (by measuring the
production of ROS in the presence of a NADPH oxidase
inhibitor19). Furthermore, in this earlier study, TGF-b–depen-
dent Nox4 expression and activity was dependent on the Smad
signaling pathway, given inhibition of this pathway (via siRNA
or pharmacological inhibition) inhibited Nox4 labeling/activity
and abolished the development of an EMT.19 Additionally,
blocking NADPH oxidase activity alone (either pharmacolog-
ically or by siRNA), also prevented EMT in breast cancer cells,19
highlighting that Nox4 expression and activity was responsible
for the development of EMT in breast cancer cells.
It is likely that TGF-b signals through the Smad pathway to
induce Nox4 expression and activity in lens. In future studies, it
would be of great interest to determine whether direct or
indirect TGF-b–Smad signaling contributes to the differential
nuclear (at 8 hours) and cytosolic (48 hours) Nox4 labeling we
observed here. Furthermore, Nox4 expressed at later time points
in the EMT process may directly influence the actin cytoskeleton
with which it is colocalized. Novel studies in the kidney have
highlighted the role of Nox4 in actin cytoskeleton rearrange-
ment,27 leading to regulation of focal adhesion turnover and
VSMC migration.28 It is feasible that this also could occur in lens
epithelial cells undergoing EMT. Members of the Rho GTPase
family are strongly associated with the formation of the actin
cytoskeleton. Manickam et al.29 ascertained that RhoA/ROCK
activation is upstream of Poldip2 and Nox4 in TGF-b signaling in
the kidney, and controls myofibroblast activation. Indeed, in the
rat lens explant system we observe cell blebbing and cell loss
through the activation of apoptotic pathways.28 Cellular blebbing
is an indirect indication of apoptosis, where cells are physically
dismantled from within by modulation of the actin cytoskeleton.
This process is mediated by members of the proapoptotic
caspase family, where the plasma membrane is weakened
allowing the cytosol to protrude from the cell.30 Caspases have
been shown to cleave and activate Rho kinase (ROCK I), a
downstream effector of RhoA signaling.31 Activation of ROCK I
leads to the formation of actin stress fibers, cell contraction and
dynamic membrane blebbing induced by active ROCK I.30
Therefore, it is feasible that the changes seen in the TGF-b–
driven EMT in the lens may signal at least in part through the
RhoA/ROCK pathway via Nox4.32
Reflective of its multiple roles in proinflammatory respons-
es, migration, differentiation and apoptosis, Nox4-derived ROS
appear enigmatic in their downstream targets. Using TGF-b–
stimulated human aortic muscle cells, Martin-Garrido et al.33
found that silencing of Nox4 abolished the formation of stress
fibers and a-SMA accumulation in a MAPK/p38-dependent
manner. This is in contrast to research using fibroblastic cells
that report the c-jun N-terminal kinase (Jnk pathway) as
capable of regulating a-SMA accumulation34 in a Nox4-
dependent fashion. Together, these findings from other fibrotic
models and the lens suggest that the progressive accumulation
of a-SMA is the result of a heterogeneous process that
converges on the a-SMA promoter, and that Nox4 may act as
a common mediator of these pathways. More broadly, this is
indirect evidence to the notion that redox signaling is capable
of serving as a nexus between parallel signaling pathways, such
as Smads and MAPKs.
The present study shows for the first time to our knowledge
that Nox4 has a role in TGF-b–driven lens EMT. In particular,
Nox4 appears to have a crucial role in the regulation of a-SMA,
potentially apoptosis, cell elongation and capsular wrinkling.
The findings of this study provide new avenues for the
potential treatment of cataract and the prevention of second-
ary cataract, given TGF-b–driven EMT is integral to the
development of some cataracts in humans.35 Future studies
will concentrate on expanding these findings in genetic models
of TGF-b–dependent cataract, ascertaining the upstream events
crucial to Nox4 expression and delineating the specific targets
of ROS during lens EMT.
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3.2 Concluding Remarks 
The findings of the present study serve as a great advancement to current body of existing 
lens literature, which has identified links between TGFβ and ROS. :KLOH the results of the 
present study are novel to the lens and constitute a seminal paper in the field, they add to a 
growing body of evidence that suggests a key role of ROS on the mediation of pathways 
leading to EMT. Thus, this work will act as a platform to better explore Nox4-derived ROS 
and EMT in the onset of cataract but also many other pathologies such as fibrosis and 
cancer. This work also provides a platform to better characterise the role of Nox4 in a 
physiological context, through the use of transgenic approaches.  
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4. Results
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CKDSWHU  5HVXOWV NR[ LV UHTXLUHG EXW QRW HVVHQWLDO IRU AQWHULRU 
SXEFDSVXODU CDWDUDFW IRUPDWLRQ
4.1 Introduction 
:H KDYH HVWDEOLVKHG HDUOLHU LQ &KDSWHU  WKDW SKDUPDFRORJLFDO LQKLELWLRQ RI 1R[ GHOD\HG WKH 
SURJUHVVLRQ RI (07 DQG DEURJDWHG WKH GHYHORSPHQW RI P\RILEUREODVWV 7KLV ZDV DFKLHYHG 
XVLQJ DQ LQ YLWUR FHOO FXOWXUH PRGHO ZKHUH OHQV HSLWKHOLDO FHOOV ZHUH WUHDWHG ZLWK H[RJHQRXV 
7*)ȕ WR VWLPXODWH DQ (07 UHVSRQVH, DQG 1R[GHULYHG 526 ZHUH VHOHFWLYHO\ EORFNHG 
XVLQJ 9DV 1R[ H[SUHVVLRQ ZDV IRXQG WR EH XSUHJXODWHG DQG GULYHQ E\ 7*)ȕ DW HDUO\ 
VWDJHV RI (07 E\  KRXUV¶ FXOWXUH ZLWK 7*)ȕ KRZHYHU, PRVW LPSRUWDQWO\, 1R[ ZDV 
DOVR H[SUHVVHG DW  KRXUV RI FXOWXUH ZLWK 7*)ȕ, DW D SRLQW ZKHUH WKH PRUSKRORJLFDO 
FKDQJHV RI (07 DUH PRUH QRWLFHDEOH LQ RXU OHQV (07 PRGHO 7KLV VXJJHVWHG DQ LPSRUWDQW 
UROH IRU 1R[ LQ OHQV (07 DQG SURYLGHG XV ZLWK D SODWIRUP WR EHWWHU HOXFLGDWH LWV UROH ,Q WKH 
SUHVHQW FKDSWHU, ZH XVH DQ LQ YLYR WUDQVJHQLF PRXVH PRGHO WR VHUYH DV DQ H[WHQVLRQ WR RXU 
HDUOLHU LQ YLWUR VWXGLHV IURP &KDSWHU 
The development of anterior subcapsular cataracts, in vivo, is underscored macroscopically 
by a progressive clouding of the lens after a given cellular stimulus. Unlike our in vitro model 
of EMT using rat lens epithelial explants, LECs in our TGF-β transgenic mouse lines are not 
only exposed to elevated levels of TGF-β, but also SRWHQWLDOO\ WR numerous other ocular 
growth factors found in the aqueous humour and lens capsule, such as FGF, BMP, PDGF and 
EGF (145). These growth factors have the potential to crosstalk with TGF-β signalling to 
drive LECs to a heterogeneous cell fate; whereby plaques of mice specifically overexpressing 
TGF-β in the lens have been found to comprise of OHQV epithelial-like cells, myofibroblasts 
and lens fibre-like cells (146). In contrast, in vitro rat lens explants treated with only TGF-β2 
are reported to give rise to only αSMA-positive myofibroblasts (146). Interestingly, it is also 
widely known and accepted that FGF, and potentially FRPELQDWLRQV RI other aqueous-derived 
growth factors, are able to induce β-crystallin-positive fibre cells (147). Taken together, these 
in situ findings raise the potential complication of understanding the role of WKH H[RJHQRXV 
ocular growth factors. It is, therefore, particularly important to characterise the role of Nox4 
in this setting, especially how Nox4 is impacting on the in vivo progression of EMT, and 
also ASC in general. This is also particularly important given the previous reports of 
JURZWK IDFWRUV, VXFK DV PDGF, being able to induce RI LVRIRUPV RI 1R[ HJ Nox2 activity 
(127). 
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Murine Nox4-deficient models have been used extensively to explore potential roles for Nox4 
in fibrosis, nephropathy and cancer. The major advantage of these studies is that germline 
deletion of Nox4 from the tissue/mouse ensures that the gene cannot exhibit compensatory 
upregulation in response to its inhibition. This was cited as a major drawback to the 
aforementioned in vitro studies in Chapter 3, as there are only Nox4 selective inhibitors 
commercially available, and these may quench ROS non-specifically, or even simultaneously 
block and/or upregulate other Nox homologous at different concentrations (148). 
Nox4deficient mice have been associated with significant rescuing effects in numerous 
models of disease (149, 150); however, germline Nox4 deletion has also been shown to have 
negligible impact on disease progression in other models (151). This reiterates the 
pleotropic nature of ROS targets and raises the question of exactly what role Nox4 plays in 
the lens.  
To that avail, the present chapter aims to further characterise the role of Nox4 in lens EMT 
by utilising a transgenic approach. /HQV WLVVXH IURP D transgenic mouse line that is 
overexpressing TGF-β specifically in the lens, on a Nox4-deficient background, will be 
characterised to observe whether this FRPELQDWLRQ has any effect on the expected TGF-β-
induced ASC that normally develops in these mice.  
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4.2 Materials and Methods 
4.2.1 Transgenic Mouse Lines 
Mice overexpressing TGF-β specifically in the lens were previously generated (4), and used 
here for matings and for comparative histology. In short, these lines of mice were generated 
by microinjection of the CPV2EDVHG vector containing a 2.8-kb bioactive fragment of 
mature human TGF-β1, driven by the aA-crystallin promoter and also containing 
polyadenylation sequences from simian virus 40 (Fig. 4.2 A), into the pronuclei of FVB/N 
embryos . 
Figure 4.1 Schematic representation of transgene insertion for both TGFβ overexpression  and Nox4 
deletion. Bioactive (Mature) TGFβ1 is cleaved from precursor TGFβ1 via a disulfide bond. This construct is 
directed to the alpha-a-crystallin promoter region (αAp). Included in the minigene is simian virus 40 (SV40), 
which was used to direct PCR primers to screen for transgenic mice (A). Nox4 was deleted by replacing the 
NADPH coding region of exons 14 and 15 with a transgene that contained flanking loxP sites, neomycin 
cassette and dta-cassette. The mutatated allele could then XQGHUJR Cre-induced recombination to induce either 
Type I or Type III recombination (B). Type III (constitutive Nox4 deletion) was used for the present study. 
Adapted from (4) and (5), respectively.
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Nox4 deficient mice were obtained from .OHLQVFKQLW] DQG FROOHDJXHV (5). In brief, these 
mice were generated using a Cre/lox recombinase approach to delete the NADPH oxidase 
binding pockets in exons 14 and 15. A neomycin resistance cassette with a flanking loxP site 
and a diphtheria toxin A (dta) were introduced into embryonic-day-14 mice. The neomycin 
cassette served as the targeting vector for exons 14 and 15, with the replacing 
transgene (see Fig. 4.2B). Termed type 1 recombination, the neomycin cassette was 
removed, leaving behind intact Nox4, enabling conditional knockout of exons 14 and 15. 
Type 3 recombination removed the neomycin cassette and both exons 14 and 15, thus, 
UHVXOWLQJ LQ a constitutive knockout of Nox4 (Fig. 4.2 B).
4.2.2 Genotyping Mouse Lines 
TGF-β overexpressing and Nox4-deficient mice were screened by collecting tail biopsies at 
postnatal day 14 (P14). Tails were digested overnight at 55˚C in tail lysis buffer (Viagen, 
USA) supplemented with Proteinase-K. The following morning, samples were heat 
inactivated at 80ºC for one hour. Samples were then either frozen for future use or allowed to 
cool to room temperature. PCR was performed on tail lysates using the MyTaq Red DNA 
Polymerase Kit (Bioline, UK), as per manufacturer’s instructions.  
Screening for TGF-β overexpression was performed with primers that detected a sequence on 
the SV40 insert of the inserted minigene (300bp PCR product, see Fig 4.2). Forward and 
reverse primers sequences were 5’ gtg aag gaa cct tac ttc tgt ggt g 3’ and 5’ gtc ctt ggg gtc ttc 
tac ctt tct c 3’, respectively. The PCR thermal cycling conditions were as follows: initial 
denaturation; 95˚C for 3 minutes; followed by 28 cycles of denaturation at 95˚C for 30 
seconds, annealing at 62˚C for 30 seconds, extension at 72˚C for 40 seconds and final 
extension at 72˚C for 2 minutes. 
Screening for Nox4 deletion was performed using primers that detect a 435 bp, wild-type 
PCR product and a 517 bp knockout PCR product. To achieve these, three primers were 
used: a forward (5’gtg gat caa gaa aca tgc tga c 3’) and reverse (5’aga cat cca atc att cca gtg 
g 3’) pair to detect the wildtype PCR product and an additional primer (5’ tgt ctg tcg gcg cac 
tca cta 3’) to detect the Nox4 KO product (Fig 4.2). For all experiments littermate wild-
type mice 
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were used as controls. The PCR thermal cycling conditions were as follows: initial 
denaturation; 95˚C for 3 minutes; followed by 37 cycles of denaturation at 95˚C for 30 seconds, 
annealing at 56˚C for 30 seconds, extension at 72˚C for 45 seconds and final extension at 
72˚C for 7 minutes. PCR productV for both SV40 and Nox4 KO were loaded onto a 3% 
agarose TAE gel and run for 40 minutes at 100V. PCR products were viewed under a UV 
fluorescent tray attached to a digital camera. See Fig. 4.2 for representative bands of all 
possible PCR products. 
4.2.3 Mouse Mating 
In order to generate mice that overexpressed TGF-  β specifically in the lens on a Nox4 
deficient background, homozygous TGF-β (  7*)ȕGOF) overexpressing mice were crossed 
with homozygous Nox4-deficient mice (NKO). This generated an all-agouti progeny that was 
heterozygous for both traits (Het). Het mice were then crossed to generate four possible 
genotypes: Wildtype (WT), 7*)ȕGOF, NKO and T*)ȕ overexpressing mice that were Nox4 
deficient (TGFβGOF/NKO). A schematic of this mating protocol is presented in Fig. 4.3. 
Figure 4.2 Representative gels of all possible PCR products from the Nox4 deletion screen and TGF-β 
overexpression screen. The Nox4 deletion screen yielded one of three possible genotypes: +/- (heterozygous for Nox4 
deletion), -/- (homozygous for Nox4 deletion) and +/+ (wildtype). The wildtype Nox4 PCR product was 435 EDVHSDLUV bp 
whereas the Nox4 KO PCR band was 517bp. 7KH SRVLWLYH 69 EDQG LQGLFDWLQJ 7*)ȕ RYHUH[SUHVVLRQ 7*)ȕ*2) ZDV 
 ES
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Figure 4.3 Schematic of transgenic mouse mating strategy to generate TGF-β overexpressing mice on a 
Nox4-deficient background. 
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4.2.4 Tissue Collection and Processing 
Postnatal mice at P30 and P90 mice were asphyxiated with CO2 and subject to cervical 
dislocation. Eyeballs were removed from mice and fixed overnight in 10% (v/v) neutral 
buffered formalin (POCD, Australia) at room temperature. Eyeballs were then stored in 70% 
ethanol XQWLO UHTXLUHG. The eyes were then dehydrated in an automated Excelsior tissue 
processor (Thermo Fisher Scientific, USA) and embedded in paraffin using TissueTek 
TECTM (Sakura Finetek, USA). The dehydration protocol was as follows: 70% ethanol, 
60 minutes; 80% ethanol, 60 minutes; 95% ethanol, 2 x 90 minutes; 100% ethanol, 2 x 90 
minutes; xylene, 2 x 90 minutes; molten paraffin, 2 x 60 minutes and 1 x 90 minutes. 
All ethanol and xylene exposures were performed at 40ºC, whereas paraffin exposures were 
performed at 60ºC.  
Eyeballs were embedded in moulds containing molten paraffin ZD[ using fine 
watchmaker’s forceps such that the cornea RI HDFK H\H faced each other. Moulds were then 
placed on a 4ºC cooling block to allow the paraffin ZD[ to solidify. Set paraffin blocks were 
then mid-sagittaly cut in 6µm serial sections that were then floated on a water bath at 45ºC. 
5LEERQHG sections were collected on an electrostatically charged glass microscope slide 
(Grale, USA), and placed in a 37ºC oven overnight for drying.  
4.2.5 Period acid Schiff Stain 
Slides were deparaffinised in xylene (3 x 5 minutes) and rehydrated in ethanol (100% ethanol, 
2 x 2 minutes; 90% ethanol, 2 minutes; 70% ethanol, 5 minutes; 50% ethanol, 2 minutes; and 
deionised water, 5 minutes. Slides were then incubated in 0.5% (w/v) periodic acid solution for 
10 minutes and washed with deionised water for 3 minutes. Slides were then stained with 
freshly made Schiff’s reagent for 20 minutes. Schiff’s reagent was prepared by mixing 10% 
(w/v) basic fuschin, 18% (w/v) sodium metabisulphite (dissolved in concentrated HCl) and 2% 
(v/v) concentrated HCl for 3 hours and allowed to develop overnight. The following day, 
activated charcoal was mixed into the solution and filtered through #2 Whatman filter paper 
until the solution ran clear and was colourless. 
After the stain, slides were placed in sodium meta-bisulphite for 3 minutes. Slides were 
rinsed under running tap water for 5 minutes and then in deionised water for 1 minute. Nuclei 
were counterstained using Harris’ concentrated +aematoxylin solution (Sigma-Aldrich, 
Australia). Slides ZHUH rinsed in deionLsed water for 2 x 1 minutes and dehydrated to 100% 
ethanol from using 
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Primary	
Antibody	
Species	
Reactivity	
Manufacturer	 Catalogue	
Number	
Dilution	 Secondary	
Antibody	
Nox4	 Rabbit,	
polyclonal	
Santa	Cruz,	USA	 sc-30141	 1:50	 Invitrogen	Alexa	fluor	IgG	594	
alpha-Smooth	
Muscle	Actin	
Mouse,	
monoclonal	
Sigma,	USA	 A2547	 1:100	 Invitrogen	Alexa	fluor	IgG	488	
E-cadherin Rabbit	
monoclonal	
Cell	 Signalling	
Technologies,	USA	
3195S	 1:100	 Invitrogen	Alexa	fluor	IgG	488	
Prox1	 Rabbit,	
monoclonal	
Merck,	USA	 AB5475	 1:50	 Invitrogen	Alexa	fluor	IgG	594	
beta-Crystallin	 Rabbit,	
polyclonal	
In	house	 n/a	 1:50	 Invitrogen	Alexa	fluor	IgG	594	
Total	Smad2/3	 Rabbit,	
monoclonal	
Cell	 Signalling	
Technologies,	USA	
8685S	 1:100	 Invitrogen	Alexa	fluor	IgG	594	
pP44/42	
(pERK1/2)	
Rabbit,	
monoclonal	
Cell	 Signalling	
Technologies,	USA	
4370S	 1:100	 Invitrogen	Alexa	fluor	IgG	594	
the aforementioned steps. Slides were cleared in xylene and mounted in DePex (Lomb 
Scientific, Australia).  
4.2.6 Immunofluorescent labelling of paraffin sections 
Sections were deparaffinised in xylene (3 x 5 minutes) and rehydrated in ethanol (100% 
ethanol, 2 x 2 minutes; 90% ethanol, 2 minutes; 70% ethanol, 5 minutes; 50% ethanol, 2 
minutes; and deionised water, 5 minutes. Slides were then rinsed in 3 x 5 minutes 0.1% (w/v) 
RI bovine serum albumin (BSA) in phosphate buffered saline (PBS) in a coplin jar. As 
needed, slides were transferred to a 10mM solution of sodium citrate buffer to undergo antigen 
retrieval for 10 minutes at 105ºC. Slides were then allowed to cool to room 
temperature and subsequently rinsed for 5 minutes in PBS-BSA. Using KimWipeV 
(Kimtech USA), the edge of the section was dried such that a 10% (v/v) solution of NGS 
diluted in PBS-BSA could be applied for one hour to facilitate blocking of nonspecific 
secondary antibody binding. After this, the appropriate diluted primary antibody 
solution(s) were applied to sections in an identical manner. Primary antibody solution 
constituted either a 1:100 or 1:50 dilution of the primary antibody with 0.015% (w/w) NGS, 
diluted in PBS-BSA. See table 4.1 for primary antibody dilutions. 1HJDWLYH SULPDU\ 
TDEOH  SXPPDU\ RI DOO SULPDU\ DQG WKH FRUUHVSRQGLQJ VHFRQGDU\ DQWLERGLHV XVHG IRU LPPXQRIOXRUHVFHQFH
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DQWLERG\ VDPSOHV ZHUH LQFOXGHG WKURXJKRXW WKH SUHVHQW VWXG\ WR DFFRXQW IRU IDOVHSRVLWLYH 
ODEHOV DQG DXWRIOXRUHVFHQFH 
The following day, sections were returned to room temperature for approximately 40 minutes 
and subject to 3 x 5 minute washes in PBS/BSA. An appropriate secondary antibody was 
diluted in PBS/BSA and applied to the tissue for 2 hours in dark conditions. A dilution of 
1:1000 was used for all secondary antibodies. Following a 2 hour incubation, excess antibody 
was removed with 3 x 5 minute washes in PBS/BSA. Sections were dried and a 1:2000 
solution of bisbenzimide (Hoechst dye) was applied for 5 minutes for the visualisation of cell 
nuclei. Slides were then rinsed in 3 x 5 minute washes in PBS/BSA DQG VHFWLRQV mounted 
in 40µl 10% glycerol/PBS EHIRUH YLHZLQJ using a confocal laser scanning microscope 
(Zeiss LSM 800, Germany). 7KH H[SRVXUH XVHG WR LGHQWLI\ WKH SURWHLQ RI LQWHUHVW 
IHDWXUH
4.2.7 SDS-PAGE and Western Blotting 
Western blotting was performed as described in Chapter 2. Primary antibodies were diluted in 
either 5% (w/v) skim milk or 2.5% (w/v) bovine serum albumin tri-buffered saline 
supplemented with 0.1% (v/v) Tween-20 (TBST) (see Table 4.2 for antibody information).  
Primary	
Antibody	
Species	
Reactivity	
Manufacturer	 Catalogue	
Number	
Dilution	 Secondary	
Antibody	
Nox4	 Rabbit,	
polyclonal	
Santa	Cruz,	USA	 sc-30141	 1:200	 CST	anti-Rabbit	IgG	HRP	
alpha-Smooth	 Muscle	
Actin	
Mouse,	
monoclonal	
Sigma,	USA	 A2547	 1:2000	 CST	anti-mouse	IgG	HRP	
pP44/42	
(pERK1/2)	
Rabbit,	
monoclonal	
Cell	 Signalling	
Technologies,	
USA	
9101S	 1:1000	 CST	anti-Rabbit	IgG	HRP	
P44/42	
(ERK1/2)	
Rabbit,	
monoclonal	
Cell	 Signalling	
Technologies,	
USA	
4695S	 1:1000	 CST	anti-Rabbit	IgG	HRP	
pSmad2/3	 Rabbit,	
monoclonal	
Cell	 Signalling	
Technologies,	
USA	
8828S	 1:1000	 CST	anti-Rabbit	IgG	HRP	
GAPDH	 Mouse,	
monoclonal	
Sigma,	USA	 G8795	 1:5000	 CST	anti-mouse	IgG	HRP	
Table 4.2 Summary of all primary DQG WKH VHFRQGDU\ DQWLERGLHV XVHG IRU LPPXQREORWWLQJ
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ZDV PHGLDWHG E\ FRQWUROOLQJ WKH H[SRVXUH WLPH DQG LQWHQVLW\ RI OLJKW SDVVLQJ WKURXJK WKH 
VHFWLRQ KRZHYHU, LQ RUGHU WR UHOLDEO\ PHDVXUH FKDQJHV LQ SURWHLQ H[SUHVVLRQ, WKHVH 
YDULDEOHV ZHUH NHSW FRQVWDQW LQ LQGHSHQGHQW H[SHULPHQWV ZKHQ DQDO\VLQJ WKH VDPH SURWHLQ
4.3 Results 
4.3.1 Nox4 deficiency abrogates TGF-β-induced cataractogenesis in whole lenses 
To gain an insight of the role of Nox4 in the in vivo development of TGF-β induced cataracts, 
whole lenses of transgenic mice were observed and compared to wild-type (WT) mice. This 
was achieved by removing intact lenses from whole eyes and viewing them under a dissecting 
microscope. Lenses were qualitatively examined for the presence/absence of any light 
scattering features and any chromatic aberrations of light passing through the lens.  
)RU WKLV H[DPLQDWLRQ, SRVWQDWDOGD\ 3 OHQVHV ZHUH SODFHG RQ D PP HOHFWURQ 
PLFURVFRS\ FRSSHU PHVK JULG WR REVHUYH IRU DQ\ UHIUDFWLOH DQRPDOLHV 7KH OHQVHV RI :7 PLFH 
SUHVHQWHG QR QRWLFHDEOH DEHUUDQW SKHQRW\SH /HQVHV ZHUH WUDQVSDUHQW DQG PDJQLILHG WKH 
XQGHUO\LQJ JULG VHH )LJ  $ ,Q FRQWUDVW, 7*)ȕ RYHUH[SUHVVLQJ OHQVHV 7*)*2) ZHUH 
ODUJHO\ RSDTXH DQG SUHVHQWHG D ODUJH FHQWUDOO\ SRVLWLRQHG SODTXH 7KH RSDFLW\ ZDV VHYHUH
HQRXJK WR QRW SHUPLW UHVROYLQJ WKH XQGHUO\LQJ JULG OLQHV )LJ  % 1R[GHILFLHQW OHQVHV
1.2 UHPDLQHG WUDQVSDUHQW, VLPLODU WR :7 OHQVHV KRZHYHU, WKH\ DSSHDUHG PRUH VSKHULFDO
XSRQ KDQGOLQJ 7KLV ZDV KLJKOLJKWHG E\ DQ µHQKDQFHG¶ PDJQLILFDWLRQ RI WKH XQGHUO\LQJ JULG
OLQHV )LJ  & FRPSDUHG WR :7 OHQVHV )LQDOO\, WKH OHQVHV RI PLFH RYHUH[SUHVVLQJ 7*)ȕ
LQ WKH OHQV, RQ D 1R[GHILFLHQW EDFNJURXQG 7*)ȕ*2)1.2 GLG QRW SUHVHQW DQ\ RSDFLWLHV,
QRU DQ\ DEQRUPDO UHIUDFWLYH SKHQRW\SHV FRPSDUHG WR WKDW RI :7 OHQVHV )LJ  ' 7KLV
PDFURVFRSLF VFUHHQLQJ ZDV LQLWLDOO\ FDUULHG RXW IRU DOO PLFH WKDW ZHUH XVHG LQ WKH SUHVHQW
VWXG\, IRU ERWK WKLV FKDSWHU, DQG WKH IROORZLQJ &KDSWHU 
To observe whether Nox4 deletion was delaying (and not necessarily completely blocking) 
the onset of TGF-β-induced cataract, older P90 lenses were also collected and 
macroscopically observed under a dissecting microscope. For this analysis, both lenses and 
eyeball were photographed in situ in freshly sacrificed mice, as excessive handling of older 
TGFGOF eyeballs often induced premature tissue damage and rupture. WT mice presented 
with no ocular abnormalities; with both lens and cornea remaining transparent (Fig 4.5 A). In 
contrast TGFβGOF lenses presented with a central opacity that appeared to span the entire 
anterior portion of the lens (Fig 4.5B). NKO lenses did not present any macroscopic ocular 
abnormalities (Fig 4.5 C). Interestingly, OHQVHV RI TGFβGOF/NKO PLFH VKRZHG evidence of 
lens 
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C: NKO D: TGFβGOF/NKO
1	mm
Figure 4.4 Macroscopic view of postnatal day 30 (p30) transgenic mouse lenses. Whole
eyeballs were collected p30 mice and lenses were enucleated under a dissecting microscope.
Lenses were positioned above an electron microscope grid to assess transparency and refractive
characteristics. Wt (A), NKO (C), and TGFβGOF/NKO (D) lenses were all found to be
transparent. However, TGFβGOF (B) lenses were exhibited opacity with a central plaque
(denoted in yellow).
500μM
B: TGFβGOFA: Wildtype
C: NKO D: TGFβGOF/NKO
Figure 4.5 Macroscopic view of postnatal day 90 (p90) whole eyes in situ. Eyes from p90
mice were photographed under a dissecting microscope to assess for opacities. Both Wt (A) and
NKO (C) mice displayed no opacities. Whereas, both TGFβGOF (B) and TGFβGOF/NKO lenses (D)
presented with a distinct opacity (denoted in yellow)
opacification, with a distinct plaque in the anterior portion of the lens similar to that observed 
in the 330 TGFβGOF (Fig 4.4 B) PLFH.  
7R DFFRXQW IRU WKH FHOOXODU DQG H[WUDFHOOXODU FKDQJHV WKDW ZHUH OLNHO\ FDXVLQJ WKH RSDFLWLHV, 
PLGVDJLWWDO VHFWLRQV RI H\HV ZHUH FROOHFWHG IRU ERWK 3 DQG 3 OHQV KLVWRORJ\ XVLQJ 3$6 
VWDLQLQJ $W ERWK 3 DQG 3, :7 OHQVHV H[KLELWHG D WKLFN DQG XQGLVWXUEHG OHQV FDSVXOH ZLWK 
VWDLQLQJ UHYHDOLQJ D VLQJOH HSLWKHOLDO PRQROD\HU %\ FRQWUDVW, ERWK 3 DQG 3 7*)ȕ*2) 
OHQVHV SUHVHQWHG VHYHUH KLVWRORJLFDO DEQRUPDOLWLHV 3 7*)ȕ*2) OHQVHV H[KLELWHG 
PXOWLOD\HULQJ RI WKH OHQV HSLWKHOLXP DQG DQ DSSDUHQW IRUPDWLRQ RI D KHWHURJHQHRXV FHOO 
SRSXODWLRQ WKDW ZDV KLJKOLJKWHG E\ GLIIHUHQW PRUSKRORJLHV RI FHOO QXFOHL $OVR SUHVHQW LQ 
WKHVH WLVVXHV ZHUH PDUNHG FKDQJHV WR WKH OHQV FDSVXOH, ZLWK WKLQQLQJ LQ WKH YLFLQLW\ RI WKH 
FHOOXODU PXOWLOD\HULQJ, ZLWK SURWUXVLRQV RI DEHUUDQW H[WUDFHOOXODU PDWUL[ (&0 $GGLWLRQDOO\, 
SDWFKHV RI DEHUUDQW (&0 GHSRVLWLRQ ZHUH QRWHG WKURXJKRXW WKH ILEURWLF SODTXH 3 7*)ȕ*2) 
OHQVHV SUHVHQWHG D VHYHUH DGYDQFHPHQW RI WKH DIRUHPHQWLRQHG IHDWXUHV 7KH VL]H RI WKH SODTXH 
KDG QRW RQO\ JURZQ ODUJHU, EXW DOVR VKRZHG HYLGHQFH RI ODUJH DQG H[SDQVLYH DEHUUDQW (&0 
GHSRVLWLRQ ,QWHUHVWLQJO\, WKHUH ZDV QR HYLGHQFH RI DQ LQWDFW OHQV HSLWKHOLXP QRU FHOO QXFOHL LQ 
WKH PLGGOH RI WKH SODTXH 3 DQG 3 1.2 OHQVHV ZHUH JURVVO\ KLVWRORJLFDOO\ VLPLODU WR :7 
OHQVHV, ZLWK WKH QXFOHL RI WKH OHQV HSLWKHOLXP DSSHDULQJ IODWWHU LQ PRUSKRORJ\ 
'HVSLWH WKH OHQVHV EHLQJ PDFURVFRSLFDOO\ WUDQVSDUHQW, LQWHUHVWLQJO\, WKH OHQVHV RI 3 
7*)ȕ*2)1.2 PLFH GLVSOD\HG DQWHULRU FHOOXODU PXOWLOD\HULQJ DQG D KLVWRORJLFDO SODTXH, 
VLPLODU WR WKH RQH IRXQG LQ 3 7*)ȕ*2) ,Q FRQWUDVW WR OHQVHV RI WKH 3 7*)ȕ*2) PLFH, 
WKHVH 7*)ȕ*2)1.2 OHQVHV GLG QRW H[KLELW DQ\ FKDQJHV WR WKH OHQV FDSVXOH RU DQ\ DEHUUDQW 
(&0 GHSRVLWLRQ WKURXJKRXW WKH SODTXH 7KLV ZDV LQ FRQWUDVW WR 3 7*)ȕ*2)1.2 OHQVHV, 
WKDW HYHQWXDOO\ GLG VKRZ PDUNHG UHDUUDQJHPHQW DQG WKLFNHQLQJ WR WKH OHQV FDSVXOH DQG 
DEHUUDQW (&0 GHSRVLWLRQ ,W ZDV DOVR LQWHUHVWLQJ WR WKH QRWH WKDW WKH 3 7*)ȕ*2)1.2 
KLVWRORJLFDO SODTXHV ZHUH QRWDEO\ VPDOOHU WKDQ WKH SODTXHV RI WKH 3 7*)ȕ*2) OHQVHV. 
4.3.2 Confirmation of Nox4 Deletion 
7R FRQILUP WKDW WKH JHQHWLF NQRFNRXW RI 1R[ OHG WR D VXEVHTXHQW DEURJDWLRQ RI LWV SURWHLQ 
SURGXFW, LPPXQRODEHOOLQJ IRU 1R[ ZDV SHUIRUPHG RQ :7, 7*)ȕ*2), 1.2 DQG 7*)ȕ*2)
1.2 H\H VHFWLRQV :7 OHQVHV H[KLELWHG ORZ EDVDO 1R[ ODEHOOLQJ WKDW DSSHDUHG WR EH 
GLVWULEXWHG WKURXJKRXW WKH F\WRVRO RI WKH HSLWKHOLDO FHOOV )LJ $& 7KLV ZDV LQ FRQWUDVW 
84
WR 7*)ȕ*2) OHQVHV WKDW H[KLELWHG D GLIIXVH 1R[ ODEHO WKURXJKRXW WKH SODTXH, VLPLODU WR WKH 
ODEHO WKDW ZDV GHVFULEHG LQ OHQV H[SODQWV LQ &KDSWHU , ZKHUH 1R[ DSSHDUHG DV D GLVWLQFW
SXQFWDWH ODEHO  +HUH WKHUH ZDV D SDUWLFXODU DEXQGDQFH RI WKLV ODEHOOLQJ WRZDUG WKH RXWHUPRVW
DVSHFW RI WKH SODTXH )LJ *, ,Q ERWK 1.2 )LJ ') DQG 7*)ȕ*2)1.2 OHQVHV )LJ
 -/ WKDW ZHUH KRPR]\JRXVGHILFLHQW IRU 1R[, QR 1R[ ODEHOOLQJ ZDV REVHUYHG
4.3.3 TGF-β overexpression leads to a heterogenous cell population in cataractous plaques 
+DYLQJ VKRZQ WKDW 1R[ H[SUHVVLRQ ZDV QRW SUHVHQW LQ 1R[GHILFLHQW PLFH, ZH QH[W VRXJKW 
WR FKDUDFWHULVH WKH FHOOXODU PDNHXS RI WKH SUHYLRXVO\ GHVFULEHG KLVWRORJLFDO SODTXHV RI WKH 
$6& ,PPXQRODEHOOLQJ RI PLGVDJLWWDO VHFWLRQV IRU WKH P\RILEUREODVW PDUNHU, ĮVPRRWK 
PXVFOH DFWLQ Į60$, UHYHDOHG HOHYDWHG Į60$ LQ 7*)ȕ*2) OHQVHV )LJ  *,, FRPSDUHG WR 
:7 OHQVHV )LJ  $& WKDW VKRZHG EDVDO Į60$ ODEHOOLQJ LQ VRPH FHOOV RI WKH 
HSLWKHOLXP 1.2 OHQVHV ZHUH QRW IRXQG WR H[SUHVV Į60$ LQ WKH HSLWKHOLXP )LJ  ') 
,QWHUHVWLQJO\, 7*)ȕ*2)1.2 OHQVHV DOVR GLG QRW H[SUHVV Į60$, GHVSLWH WKH SUHVHQFH RI D 
KLVWRORJLFDO SODTXH )LJ  -/  
The expression of αSMA in TGFβGOF lenses was accompanied by a dysregulation of the 
membranous epithelial marker, E-cadherin. In WT (Fig 4.10 A-C) and NKO lenses (Fig 4.10 
D-F), E-cadherin labelling was uniformly distributed, clearly defining the borders of the
epithelial cells. In TGFβGOF lenses, E-cadherin exhibited a sporadic membranous label
throughout the plaque (Fig 4.10 G-I). This suggested that some of the cells in the plaque were
of cuboidal morphology and were retaining their epithelial characteristics despite being
present in the histological plaque. A similar labelling pattern was observed in TGFβGOF/NKO
lenses, where E-cadherin appeared dysregulated and in membranous clusters. (Fig 4.10 J-L).
,PPXQRODEHOOLQJ IRU WKH OHQV ILEUH PDUNHU, ȕFU\VWDOOLQ, UHYHDOHG HOHYDWHG DFFXPXODWLRQ LQ 
SODTXHV RI 7*)ȕ*2) OHQVHV FRPSDUHG WR ERWK :7 )LJ  $& DQG 1.2 )LJ  ') 
OHQV HSLWKHOLXP ,Q 7*)ȕ*2) )LJ  *, OHQVHV, ȕFU\VWDOOLQ H[KLELWHG D GLIIXVH F\WRVROLF 
ODEHO, ZLWK VRPH FHOOV GLVSOD\LQJ D SDUWLFXODUO\ VWURQJ ODEHO \HOORZ DUURZKHDG $ VLPLODU
ODEHO ZDV DOVR REVHUYHG LQ WKH 7*)ȕ*2)1.2 OHQVHV )LJ  -/, ZKHUH D VXEVHW RI FHOOV
WRZDUGV WKH RXWHUPRVW DVSHFW RI WKH SODTXH H[KLELWHG SDUWLFXODUO\ HOHYDWHG ȕFU\VWDOOLQ
ODEHOOLQJ 7R VHUYH DV DQ LQWHUQDO SRVLWLYH FRQWURO IRU WKH LPPXQRODEHOOLQJ RI ȕFU\VWDOOLQ,
WUDQVLWLRQLQJ VHFRQGDU\ OHQV ILEUH FHOOV ZHUH DOVR YLVXDOLVHG LQ ZLOGW\SH WLVVXH )LJ  0
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A: Wildtype
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D: B: TGFβGOF/NKO
B: TGFβGOF
Figure 4.6 PAS stain of postnatal day 30 (p30) lenses. Mid-sagittal sections were collected
from p30 mice and stained with periodic acid-Schiff’s (PAS: purple) and nuclei were
counterstained for hematoxylin (hematoxylin: blue). Sections were viewed under a compound
microscope such that the anterior portion of the lens could be photographed. Wt lenses (A)
exhibited a single epithelial monolayer on the lens capsule TGFβGOF lenses (B) exhibited marked
multilayering of the lens epithelium and elongated nuclei. Marked disruption of the lens capsule
was also observed, with the formation of capsule extrusions (yellow arrowhead) and degradation
of the overall membrane towards the thicket part of the histological plaque. Throughout the
histological plaque, there was also evidence of aberrant extracellular matrix (ECM) formation
(yellow arrow). NKO lenses (C) were comparable to Wt lenses, although nuclei were less
cuboidal in morphology. Finally, TGFβGOF/NKO lenses (D) also displayed a multilayering of the
epithelium with evidence of elongated nuclei. However, there was no evidence of aberrant
accumulation of ECM, nor any changes to the lens capsule. a.h: aqueous humour; l.c: lens
capsule; l.e: lens epithelium; l.f: lens fibres
a.h
l.c
l.e
l.f
100µm
A: Wildtype
C: NKO
D: B: TGFβGOF/NKO
B: TGFβGOF
Figure 4.7 PAS stain of postnatal day 90 (3) lenses. Mid-sagittal sections were collected from 
P0 mice and stained with periodic acid-Schiff’s (PAS: purple) and nuclei were counterstained 
with hematoxylin (hematoxylin: blue). Sections were viewed under a compound microscope such 
that the anterior portion of the lens could be photographed. WT lenses (A) exhibited an epithelial 
monolayer on the lens capsule. TGFβGOF lenses (B) exhibited marked multilayering of the lens 
epithelium with no evidence of present nuclei. The most notable feature of these lenses was the 
large aberrant deposition of ECM throughout the histological plaque. NKO lenses (C) were 
comparable to WT lenses, although the nuclei were less cuboidal in morphology. Finally, 
TGFβGOF/NKO lenses (D) also displayed multilayering of the epithelium with evidence of 
elongated nuclei. ECM protrusions from the lens capsule were also noted (yellow arrow) with 
areas of aberrant ECM accumulation (yellow arrowhead).
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A: Wildtype
B: Wildtype
C: Wildtype
D: NKO
E: NKO
F: NKO
G: TGFβGOF
H: TGFβGOF
I: TGFβGOF
J: TGFβGOF/NKO
K: TGFβGOF/NKO
L: TGFβGOF/NKO
Figure 4.8 Immunofluorescence of Nox4 expression in postnatal day 30 (p30) lenses. Mid-
sagittal sections were collected from p30 mice and immunolabelled for Nox4. Micrographs are
displayed vertically as Hoechst, Nox4 and merged. In Wt lenses (A-C), Nox4 exhibited a basal
cytosolic label. In both NKO (D-F) and TGFβGOF/NKO lenses (J-L), Nox4 expression was not
observed. In contrast, TGFβGOF lenses (G-I) exhibited noticeable punctate Nox4 expression that
appeared strongest towards the outermost (laminal) aspect of the plaque (yellow arrowhead).
20µm
Figure 4.9 Immunofluorescence of αSMA expression in p30 lenses. Mid-sagittal sections
were collected from p30 mice and immunolabelled for the myofibroblast marker αsmooth muscle
actin (αSMA). Micrographs are displayed vertically as Hoechst, αSMA and merged. In Wt lenses
(A-C), αSMA expression was seen in some nuclei of the epithelial monolayer. In both NKO (D-
F) and TGFβGOF/NKO lenses (J-L), no αSMA expression was observed. In contrast, TGFβGOF
(G-I) lenses exhibited noticeable labelling for αSMA.
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B: Wildtype
C: Wildtype
D: NKO
E: NKO
F: NKO
G: TGFβGOF
H: TGFβGOF
I: TGFβGOF
J: TGFβGOF/NKO
K: TGFβGOF/NKO
L: TGFβGOF/NKO
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Figure 4.10 Immunofluorescence of E-cadherin expression in p30 lenses. Mid-sagittal
sections were collected from p30 mice and immunolabelled for the epithelial marker E-cadherin.
Micrographs are displayed vertically as Hoechst, E-cadherin and merged. In both Wt lenses (A-
C) and NKO (D-F) lenses, e-cadherin expression was observed throughout the lens epithelium,
largely exhibiting a membranous localisation. However, in both TGFβGOF (G-I) and
TGFβGOF/NKO lenses (J-L), E-cadherin expression was dysregulated and was less uniformly
expressed throughout the cells.
: Wildtype
: Wildtype
: Wildtype
: NKO
: NKO
: NKO
: TGFβGOF
: TGFβGOF
: TGFβGOF
: TGFβGOF/NKO
: TGFβGOF/NKO
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Figure 4.11 Immunofluorescence of β-crystallin expression in
p30 lenses. Mid-sagittal sections were collected from p30 mice and
immunolabelled for the lens fibre marker β-crystallin. Micrographs
are displayed vertically as Hoechst, β-crystallin and merged. In both
Wt lenses (A-C) and NKO (D-F) lenses, β-crystallin expression
was not detected. However, in both TGFβGOF (G-I) and
TGFβGOF/NKO lenses (J-L), β-crystallin expression was observed
diffusely throughout the histological plaque with some cells/ areas
exhibiting a stronger label (yellow arrowhead). A similar expression
pattern for β-crystallin was observed in the transitional zone lenses
of lenses, irrespective of the genotype (M). This was used as an
internal positive control for the β-crystallin label.
A: Wildtype
B: Wildtype
C: Wildtype
D: NKO
E: NKO
F: NKO
G: TGFβGOF
H: TGFβGOF
I: TGFβGOF
J: TGFβGOF/NKO
K: TGFβGOF/NKO
L: TGFβGOF/NKO
7R FRUURERUDWH WKH ȕFU\VWDOOLQ H[SUHVVLRQ UHVXOWV, D OHQV ILEUH VSHFLILF WUDQVFULSWLRQ IDFWRU, 
3UR[, ZDV DOVR LPPXQRODEHOOHG LQ VHFWLRQV $ VLPLODU WUHQG ZDV REVHUYHG LQ 7*)ȕ*2) 
OHQVHV, ZKHUH HOHYDWHG 3UR[ ODEHOOLQJ ZDV REVHUYHG LQ VRPH FHOOV RI SODTXHV ZKHQ FRPSDUHG 
WR OHQV HSLWKHOLD RI :7 )LJ  $& DQG 1.2 )LJ  ') OHQVHV ,PSRUWDQWO\, D GLVWLQFW 
QXFOHDU ORFDOLVDWLRQ SDWWHUQ RI 3UR[ ZDV REVHUYHG LQ WKH SODTXHV RI ERWK 7*)ȕ*2) )LJ  
*, +, , DQG 7*)ȕ*2)1.2 OHQVHV )LJ  -/ WKXV VXJJHVWLQJ WKH SUHVHQFH RI OHQV ILEUH 
OLNH FHOOV ZLWKLQ WKH KLVWRORJLFDO SODTXH 7R VHUYH DV DQ LQWHUQDO SRVLWLYH FRQWURO IRU WKH 
LPPXQRODEHOOLQJ RI 3UR[, WUDQVLWLRQLQJ VHFRQGDU\ OHQV ILEUH FHOOV ZHUH DOVR YLVXDOLVHG LQ 
ZLOGW\SH OHQVHV )LJ  0
4.3.4 Nox4 deficiency disrupts normal Smad and ERK1/2 activation 
7R GHPRQVWUDWH WKDW 7*)ȕ*2) ZDV DFWLYDWLQJ FDQRQLFDO 6PDG VLJQDOOLQJ, WRWDO 6PDG 
W6PDG ZDV LPPXQRODEHOOHG WR REVHUYH LWV LQWUDFHOOXODU QXFOHDU ORFDOLVDWLRQ ,Q :7 )LJ 
 $& DQG 1.2 OHQVHV )LJ  '), W6PDG H[KLELWHG D GLIIXVH F\WRVROLF ODEHO LQ 
HSLWKHOLDO FHOOV ,Q SODTXHV RI 7*)ȕ*2) PLFH KRZHYHU, W6PDG H[SUHVVLRQ ZDV HOHYDWHG 
UHODWLYH WR :7 OHQVHV, DQG VRPH FHOOV WRZDUG WR WKH RXWHUPRVW DVSHFW RI WKH SODTXH VKRZHG FR
ORFDOLVDWLRQ RI WKH W6PDG ODEHO ZLWK FHOO QXFOHL )LJ  *,, \HOORZ DUURZKHDG ,Q 7*)ȕ*2)
1.2 OHQVHV, D VLPLODU HOHYDWHG W6PDG H[SUHVVLRQ ZDV REVHUYHG, DOWKRXJK, WKHUH GLG QRW
DSSHDU WR EH DQ\ GLVWLQFW QXFOHDU ORFDOLVDWLRQ DV VKRZQ LQ 7*)ȕ*2) OHQVHV )LJ  -/
6LPLODU WR W6PDG, S(5. VKRZHG EDVDO OHYHOV ZKHQ LPPXQRODEHOOHG LQ :7 OHQVHV )LJ 
 $& ,Q 7*)ȕ*2) OHQVHV, HOHYDWHG OHYHOV RI S(5. ZHUH REVHUYHG DQG VRPH FHOOV 
H[KLELWHG D SDUWLFXODUO\ VWURQJ ODEHO IRU S(5. UHODWLYH WR RWKHUV )LJ  *, \HOORZ 
DUURZKHDG ,QWHUHVWLQJO\, WKLV VDPH ODEHOOLQJ SDWWHUQ ZDV REVHUYHG LQ 1.2 OHQVHV )LJ  
') GHVSLWH WKH DEVHQFH RI D KLVWRORJLFDO SODTXH WKXV VXJJHVWLQJ SRWHQWLDO HOHYDWHG S(5. 
VLJQDOOLQJ LQ 1R[GHILFLHQW OHQVHV ,QWHUHVWLQJO\, S(5. DOVR DSSHDUHG WR H[KLELW HOHYDWHG 
ODEHOOLQJ LQ 7*)ȕ*2)1.2 OHQVHV )LJ  -/ FRPSDUHG WR 7*)ȕ*2) OHQVHV )LJ  *,
7R JDLQ D EHWWHU DSSUHFLDWLRQ RI WKH REVHUYHG LQFUHDVH LQ LPPXQRIOXRUHVFHQW ODEHOOLQJ RI 
S6PDG DQG S(5. LQ OHQV HSLWKHOLD DQG SODTXHV, WKH OHQV FDSVXOH DQG LWV DWWDFKHG 
HSLWKHOLDSODTXHV ZHUH LVRODWHG IURP P21 :7, 7*)ȕ*2), 1.2 DQG 7*)ȕ*2)1.2 PLFH, DQG 
O\VHG IRU ZHVWHUQ EORWWLQJ DQDO\VLV ,Q DGGLWLRQ, O\VDWHV ZHUH FROOHFWHG IURP PLFH WKDW ZHUH
KHWHUR]\JRXV IRU ERWK 7*)ȕ RYHUH[SUHVVLRQ DQG 1R[ GHOHWLRQ 7*)ȕ*2)1.2
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Membranes were probed and immunolabelled for Nox4, pSmad2/3, pERK1/2, tERK1/2, 
αSMA, and the housekeeping protein GAPDH (Fig. 4.15 A). 
Densitometry was performed on these protein bands such that protein levels could be 
determined relative to the total protein content (represented by GAPDH) of the respective 
lysate. Nox4 was found to be significantly elevated (p=0.0364) in TGFβGOF lens cell lysates 
compared to WT lysates. WT levels of Nox4 were comparable to that of NKO and 
TGFβGOF/NKO. Interestingly, highest levels of Nox4 were found to be in TGFβGOF+/-/N4KO+/- 
lysates (heterozygous for a loss of Nox4), when compared to either WT (p=0.0001) or TGFβGOF
(p<0.0001) lenses. pSmad2/3 levels were found to be significantly elevated in all TGFβGOF 
lysates compared to WT lysates (TGFβGOF, p=0.0008; TGFβGOF/NKO, p=0.0051; and 
TGFβGOF+/-/N4KO+/-, p=0.0001) (Fig 4.15 B).  
'HOHWLRQ RI 1R[ GLG QRW LPSDFW RQ 7*)LQGXFHG 6PDG SKRVSKRU\ODWLRQ 7*)ȕ*2) YV 
7*)ȕ*2)1.2, QV )LJ  & KRZHYHU, LQ 1.2 O\VDWHV, S6PDG ZDV IRXQG WR EH WKH 
PRVW HOHYDWHG RI DOO WKH JHQRW\SHV 1.2 YV WT, S  S(5. ZDV IRXQG WR EH 
VLJQLILFDQWO\ HOHYDWHG LQ DOO 7*)ȕ*2) O\VDWHV FRPSDUHG WR :7 OHQV O\VDWHV 7*)ȕ*2), 
S  7*)ȕ*2)1.2, S  DQG 7*)ȕ*2)1.2, S  1R[ GHOHWLRQ ZDV 
IRXQG WR LQFUHDVH 7*)ȕLQGXFHG S(5. ODEHOOLQJ, FRPSDUHG WR 7*)ȕ*2) OHQVHV 7*)ȕ*2) 
YV 7*)ȕ*2)1.2, S  )LJ  ' ,QWHUHVWLQJO\, 1R[ GHOHWLRQ DORQH ZDV VXIILFLHQW 
WR LQGXFH D VLJQLILFDQW LQFUHDVH LQ S(5. OHYHOV FRPSDUHG WR :7 O\VDWHV S  
Į60$ SURWHLQ H[SUHVVLRQ ZDV IRXQG WR EH VLJQLILFDQWO\ HOHYDWHG LQ 7*)ȕ*2) OHQV O\VDWHV 
FRPSDUHG WR :7 OHQV S  7KH DEVHQFH RI 1R[ VLJQLILFDQWO\ DEURJDWHG 7*)ȕ
LQGXFHG Į60$ H[SUHVVLRQ WR WKDW RI :7 OHYHOV 7*)ȕ*2)1.2 YV :7, QV ,QWHUHVWLQJO\, 
SDUWLDO ORVV RI 1R[ GLG QRW \LHOG WKH VDPH UHGXFWLRQ LQ Į60$ DV REVHUYHG LQ 7*)ȕ*2)1.2 
7*)ȕ*2)1.2 YV 7*)ȕ*2)1.2, S  )LJ  ( 
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Figure 4.12 Immunofluorescence of Prox1 expression in p30
lenses. Mid-sagittal sections were collected from p30 mice and
immunolabelled for the lens fibre-specific transcription factor
Prox1. Micrographs are displayed vertically as Hoechst, Prox1 and
merged. In both Wt lenses (A-C) and NKO (D-F) lenses, Prox1
expression exhibited basal cytosolic labelling. In some cells, a
perinuclear localisation was observed (yellow arrowhead).
However, in both TGFβGOF (G-I) and TGFβGOF/NKO lenses (J-L),
elevated Prox1 expression was observed with somecells exhibiting
a strong nuclear localisation of Prox1 (yellow arrow). A similar
expression pattern for β-crystallin was observed in the transitional
zone lenses of lenses, irrespective of the genotype (M). This was
used as an internal positive control for the Prox1 label.
40µm
A: Wildtype
B: Wildtype
C: Wildtype
D: NKO
E: NKO
F: NKO
G: TGFβGOF
H: TGFβGOF
I: TGFβGOF
J: TGFβGOF/NKO
K: TGFβGOF/NKO
L: TGFβGOF/NKO
M: Wildtype
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Figure 4.13 Immunofluorescence of total Smad2/3 (tSmad2/3) expression in p30 lenses.
Mid-sagittal sections were collected from p30 mice and immunolabelled for tSmad2/3.
Micrographs are displayed vertically as Hoechst, tSmad2/3 and merged. In both Wt lenses (A-C)
and NKO (D-F) lenses, tSmad2/3 expression was observed at low basal expression, diffuse
throughout the cytosol. In both TGFβGOF (G-I) and TGFβGOF/NKO lenses (J-L), tSmad2/3
labelling was overall higher. In TGFβGOF lenses, however, a distinct nuclear localisation of
tSmad2/3 was found in some cells (yellow arrowhead).
A: Wildtype
B: Wildtype
C: Wildtype
D: NKO
E: NKO
F: NKO
G: TGFβGOF
H: TGFβGOF
I: TGFβGOF
J: TGFβGOF/NKO
K: TGFβGOF/NKO
L: TGFβGOF/NKO
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Figure 4.14 Immunofluorescence of total phosphoERK1/2 (pERK1/2) expression in p30
lenses. Mid-sagittal sections were collected from p30 mice and immunolabelled for pERK1/2.
Micrographs are displayed vertically as Hoechst, pERK1/2 and merged. In Wt lenses (A-C),
pERK1/2 expression was observed at low basal expression, diffuse throughout the cytosol. In
NKO (D-F) lenses, however, pERK1/2 labelling was elevated with some cells exhibiting a
particularlarly strong label (yellow arrowhead) In both TGFβGOF (G-I) and TGFβGOF/NKO lenses
(J-L), pERK1/2 expression was elevated compared to Wt lenses.
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Figure 4.15  Western blot analysis of 3 lenses. Lens epithelial explants were collected from 
P30 mice, lysed for the purpose of western blotting. Immunoblotting was performed on a 
PVDF membrane, immunolabelled for Nox4, phospho-Smad2/3 (pSmad2/3), phospho-ERK1/2 
(pERK1/2), ERK1/2, αSMA and GAPDH (A). Densitometry was performed and protein 
expression levels were normalised to GAPDH. pERK1/2 was first normalised to ERK1/2 and 
then GAPDH. (D). Total Smad was not assayed for for normalisation  to pSmad2/3, UDWKHU 
*$3'+ % 1R[ SURWHLQ H[SUHVVLRQ ZDV QRUPDOLVHG WR *$3'+ $. Į60$ SURWHLQ 
H[SUHVVLRQ ZDV QRUPDOLVHG WR *$3'+ ( Statistical analysis was performed using one-way 
ANOVA with Tukey’s post-hoc analysis (2-tailed). *P < 0.05,**P < 0.01, ***P < 0.001 and 
****P < 0.0001. Error bars: SEM. n=3 individual experiments.
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4.4 Discussion 
,Q WKH FXUUHQW FKDSWHU ZH KDYH VKRZQ WKDW D GHILFLHQF\ RI 1R[ LV QRW VXIILFLHQW WR 
FRPSOHWHO\ SUHYHQW 7*)ȕLQGXFHG FDWDUDFWRJHQHVLV $W 3, ERWK 7*)ȕ*2) DQG 7*)ȕ*2)
1.2 OHQVHV H[KLELWHG KLVWRORJLFDO SODTXHV WKDW ZHUH FKDUDFWHULVHG E\ PXOWLOD\HULQJ RI WKH 
OHQV HSLWKHOLXP ZLWK HYLGHQFH RI HORQJDWHG FHOO QXFOHL 8QOLNH OHQVHV IURP 7*)ȕ*2) PLFH, 
7*)ȕ*2)1.2 OHQVHV GLG QRW H[SUHVV WKH P\RILEUREODVW PDUNHU Į60$ DOWKRXJK, ERWK 
SODTXHV H[SUHVVHG WKH OHQV ILEUH PDUNHU ȕFU\VWDOOLQ DQG H[KLELWHG G\VUHJXODWHG (FDGKHULQ 
ODEHOOLQJ ,W ZDV LQWHUHVWLQJ WR QRWH WKDW LQ ROGHU 3 PLFH, WKH 7*)ȕ*2) OHQVHV H[KLELWHG DQ
DGYDQFHG FDWDUDFWRXV SKHQRW\SH, ZKHUHDV, 7*)ȕ*2)1.2 OHQVHV H[KLELWHG D OHVV VHYHUH
SKHQRW\SH, PRUH FRPSDUDEOH WR WKDW VHHQ LQ WKH \RXQJHU 3 7*)ȕ*2) OHQVHV +HUH, ZH DOVR
SURYLGH HYLGHQFH RI 6PDG DQG (5.VLJQDOOLQJ ZLWK UHVSHFW WR 1R[ DFWLYLW\ 7DNHQ
WRJHWKHU, WKHVH ILQGLQJV VXJJHVW WKDW 1R[ GHILFLHQF\ LV DEOH WR LPSDFW RQ WKH ILEURWLF DVSHFW
RI DQWHULRU VXEFDSVXODU SODTXH GHYHORSPHQW, DQG SRWHQWLDOO\ EH D NH\ FRPSRQHQW RI HDUO\
ILEURWLF FDWDUDFW GHYHORSPHQW
4.4.1 Nox4 deficiency still yield histological plaques in transparent lenses 
The most notable finding of the present chapter was the discrepancy between our observation 
of transparent macroscopic lenses, that still presented histological plaques in section. Gross 
opacities resulting from anterior subcapsular fibrotic cataract are largely driven by the 
development of a myofibroblastic cell population, as well as aberrant lens fibre 
differentiation. These cells synthesise and associate with aberrant deposits of extracellular 
matrix that facilitate changes to cell structure giving rise to the opacity (13, 18). In the 
present study, the histological plaques found in TGF βGOF/NKO lenses did not exhibit any 
aberrant deposits of ECM as seen in the TGF  βGOF lenses, as previously described (4). From 
this we can conclude that the transparency observed in 7*)ȕ*2)/NKO was due to the 
absence of significant cataractous changes within the plaque. Given that both 7*)ȕ*2) and 
TGFβGOF/NKO lenses expressed β-crystallin and only TGFβGOF expressed αSMA, Nox4 does 
not appear to be involved in aberrant lens fibre formation. It is possible that Nox4 deletion 
delays myofibroblast formation and aberrant ECM deposition and this leaves behind the 
fibre-like cells that do not yield opacity. Further evidence of this can be drawn from the 
observation that P90 7*)ȕ*2)/NKO lenses exhibited both opacity and evidence of aberrant 
ECM deposition. This also suggests that RWKHU IDFWRUV PD\ EH DEOH WR FRPSHQVDWH IRU WKH 
ORVV RI 1R[
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Indeed, a role for Nox4 in the deposition of ECM components has been previously reported 
in other models. Pharmacological inhibition of Nox4 has been shown previously to 
negatively regulate fibronectin and collagen I expression (57, 152, 153). Proteins such as 
fibronectin and collagens form networks that are critical to facilitate the necessary underlying 
cellular changes observed in many different pathologies. Reviewed in detail by Shu and 
Lovicu , myofibroblasts PD\ use this newly secreted aberrant ECM as a meshwork to 
contract through mechano-transduction (154). It has also been shown that siRNA-mediated 
knockdown of Nox4 could prevent TGF-β-induced collagen gel contractility (155). 
Therefore, it is possible to conclude that Nox4-derived ROS plays an important role in the 
deposition of ECM necessary for complete myofibroblast formation and functioning, as we 
did not observe αSMA protein labelling in TGFβGOF/NKO lenses.  
Further evidence of ECM remodelling was observed through the changes to the lens capsule 
due to TGF-β activity. In both P30 TGFβGOF and P90 TGFβGOF/NKO lenses, evidence of 
significant changes to the lens capsule were observed in regions where the plaque was most 
pronounced/thickest. Lens capsule remodelling is widely thought to be mediated by matrix 
metalloproteinases (MMPs), through proteolytic cleavage of essential matrix components. It 
is thought that matrix remodelling of the lens capsule is essential to facilitate cell 
proliferation and, more importantly, cell migration through contraction (156, 157). It has 
been well documented that ROS are able to stimulate collagen turnover through activation of 
MMPs (158). Specifically, H2O2 was shown to induce both MMP2 and MMP9 in porcine 
lens (159). This is an interesting finding given that the regulation of MMP2 and MMP9 
may in part be regulated via NF-κB through NADPH oxidase ROS (160). 
Taken together, the abrogating effect of Nox4 on the progression of ECM changes within the 
plaque, and also the lens capsule suggest that Nox4-derived ROS plays an important role in 
the early development of myofibroblastic cells in anterior subcapsular cataract. In the 
present 
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chapter, perhaps the most salient evidence of this was the absence of αSMA in P30 
TGFβGOF/NKO lenses. As previously discussed in Chapters 1 and 3, αSMA is D key marker 
for the maturation of the myofibroblastic phenotype. In the lens, constitutive basal expression 
of αSMA has been reported in LECs (161); however, the incorporation of αSMA into actin 
stress fibres is considered a positive marker for activated myofibroblasts. Reviewed by Hinz 
, complete myofibroblast maturation/activation is largely driven by increasing 
mechanical stress from the progressive accumulation of ECM proteins such as fibronectin 
(162). αSMA has been shown to only be incorporated into stress fibres once a certain level of 
extracellular stiffness is achieved (162). Nox4 has been suggested as being an important 
mediator of this phenomenon (130, 155). The findings of the present chapter add credence to 
this theory, in that, in the absence of aberrant ECM deposition in the plaque, αSMA was not 
detected in P30 TGFβGOF/NKO lenses. 
4.4.2 Nox4 GHOHWLRQ maintains a heterogeneous cell population within the histological plaque 
In the plaques of TGFβGOF lenses, as previously reported (146), there was evidence of a 
heterogeneous cell population, comprised of cells that labelled positively for αSMA, β-
crystallin and membranous E-cadherin. In the previous study, the authors hypothesize that the 
formation of fibre-like cells in the plaque may be caused by aqueous humour-derived FGF 
signaOling, and that FGF may play a role in ASC formation (146). In the present chapter, 
validation of the fibre-like cells in the plaque was achieved through positive labelling for 
both β-crystallin and nuclear localisation of Prox1. As described in Chapter 1, transparency 
of the lens is afforded by the tightly regulated protein-protein interactions. This high range 
spatial order is thought to be facilitated by members of the crystallin family of proteins, that 
promote uniform light-scatter (163, 164). Therefore, it is possible that another explanation for 
the transparency of P30 TGFβGOF/NKO lenses is that, in the absence of activated 
myofibrobalsts, β-crystallin expression promoted a transparent phenotype. Although, this 
hypothesis would require further analysis for validation.  
4.4.3 Nox4 deficiency promotes elevated pERK1/2 and pSmad2/3 expression 
To gain a better appreciation of how Nox4 deletion may be impacting on downstream 7*)
ȕsignaOling, the present chapter also looked at pERK1/2 and pSmad2/3labelling in mouse 
eye sections, and in ex vivo lens epithelial explants derived from these mice. The interplay of 
pERK1/2 and Nox4 has been extensively researched, through association with redox-sensitive 
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MAPK phosphatases (discussed in Chapter 1). An interesting finding of the present study 
was that Nox4 deletion alone led to increased pERK1/2 labelling using 
immunofluorescence or western blotting. A similar finding has been reported in another 
model using Nox4-defcient preadipocytes, where siRNA-mediated knockdown of Nox4 
induced elevated pERK1/2 expression (150). In contrast, Nox4 deletion has also been 
shown have no impact of pERK1/2 levels in some other models (165). Given that protein 
phosphatases such as PTP are inactivated by oxidation, it is possible to consider that 
another source of oxidation is driving PTP inactivation (166). Taken together, these 
findings suggest that in the absence of Nox4, LECs are able to upregulate other ROS sources 
such as other members of the Nox family of enzymes, although, a potential mechanism for 
this is yet to be determined.  
Analysis of pSmad2/3 labelling in Nox4-deficient lenses and explants revealed an increase of 
pSmad2/3 in explants, but no evidence of nuclear Smad2/3 translocation (indicative of active 
TGFβ-signalling in histological sections. In tissue sections, it was interesting to note that in 
P30 TGFβGOF lenses, there was evidence of nuclear Smad2/3 observed towards the outermost 
aspect of the plaque; however, no nuclear localisation was observed in P30 TGFβGOF/NKO 
lenses. Given that Nox4 deletion-alone was not sufficient to induce nuclear Smad2/3, this 
suggests that Nox4 is required for TGFβ-induced Smad2/3 nuclear translocation to promote 
downstream TGF-β activity. There is significant evidence pointing at an upstream role of 
Smad2/3 impacting on Nox4 activity (121, 167); however, little is known about whether 
Nox4 forms part of a positive feedback loop and is able to impact on Smad2/3. The interplay 
of Smads and ERK1/2 has been previously discussed in Chapter 1; however, a particular 
caveat of this crosstalk is the ability of ERK1/2 to drive phosphorylation of Smads and 
receptor-Smad complex nuclear translocation via the Smad linker region (168). Other 
MAPKs have also been shown to be able to regulate the expression of the inhibitory Smad, 
Smad7, suggesting that Smad activity can be controlled independent of TGFβ (169).  
4.4.4 Concluding remarks 
The present chapter provides evidence that Nox4 is playing a role in the formation of TGFβ-
induced anterior subcapsular cataract in situ. Similar to the findings in Chapter 3, the absence 
of Nox4 appeared to delay or potentially completely prevent the progression of both 
WKH macroscopic opacity and cataractous plaque formation. This suggests that Nox4 may in 
the least be an early mediator of EMT progression in LECs. It appears as though 
Nox4 is 
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orchestrating this phenomenon by abrogating the development of myofibroblasts by 
potentially impeding the deposition RI aberrant ECM, and/or compromising TGFβ-
signalling. As Nox4 deletion led to an upregulation of both pSmad2/3 and pERK1/2
phosphorylation, Nox4-derived ROS appears to be an important intermediate signalling 
element. The appearance of a cataractous plaque in older TGFβGOF/NKO lenses raises the 
possibility of other sources of ROS compensating for the loss of Nox4 to complete the 
EMT process. This is an interesting hypothesis and will require further analysis to 
substantiate.  
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5. Results
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Chapter 5 Results: Absence of Nox4 Promotes other ROS-
producing mechanisms 
5.1 Introduction 
In Chapter 4, we showed the Nox4 deletion could delay the onset and progression of TGF-β-
induced EMT and cataractogenesis; however, cataracts would still develop in older 
TGFβGOF/NKO lenses. A similar finding was raised in Chapter 3, where pharmacological 
inhibition of Nox4 delayed the progression of TGFβ-induced EMT in vitro. It was proposed 
that pharmacological inhibition of Nox4 could still yield compensatory upregulation of Nox4 
later in culture. The findings of Chapter 4 suggest; however, that there are potentially factors 
(other than Nox4) that are upregulated to compensate for the loss of Nox4, and to ensure that 
EMT FDQ still progress in situ. Above all, it is timely to reiterate the non-specific nature of 
ROS targets and that there are multiple sources of ROS within a cell.  
The principal candidates for alternative sources of ROS to Nox4 are other members of the 
NADPH oxidase family, given that the aqueous humour has an assortment of growth factors 
and NADPH oxidases are known to be regulated by growth factors in general (170). As 
described in Chapter 1, an important role for Nox2 has been previously shown in the lens 
(126, 127). In this earlier study, PDGF was shown to drive LEC proliferation via Nox2. Nox2 
has also been shown to be regulated by FGF2, FGF2 and FGF2 in other experimental 
models (171-173). Given that it has previously been proposed that in vivo TGF-
β-driven cataractogenesis involves FGFsignalling (146), it is possible that Nox2 may be 
upregulated by TGF-β-mediated FGFsignalling. It is interesting to note that Nox2 has also 
been reported to play a role in other models of EMT (174); thus raising the immediate 
question of whether Nox2 could also be involved in TGF-β-driven lens EMT.  
Another source of complication to the regulation of Nox4, and other sources of ROS, arises 
from cross-talk of TGF-β signalling pathways with other growth factors. Co-treatment of 
TGF-β and EGF has been shown to abrogate TGF-β-induced Nox4 expression in fRetal rat 
hepatocytes (175). Later work by these authors revealed; however, that when the EGF 
receptor (EGFR) was pharmacologically inhibited with addition of TGF-β, it shifted rat 
hepatoma cells to an oxidant state characterised by a decrease in GSH-synthesis 
pathways, downregulation of MnSOD, and upregulation of Nox4 compared to TGF-β 
alone treatment (176). The authors also provided preliminary evidence that suggested 
inhibiting EGFR-signalling induced 
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proteasome-mediated degradation of TGF-β-induced Nox1. This is in congruence to recent 
findings from our laboratory where it was revealed that TGF-β was able to induce 
phosphorylation of EGFR in LECs via aQ ERK1/2-dependent mechanism (177). Further, it 
was shown that pharmacological inhibition of EGFR was able to block TGF-β-induced 
EMT via Smad signalling (177). Taken together, these findings highlight the potential 
implications of crosstalk of EGFR-signalling with TGF-β signalling pathways.  
As a by-product of aerobic respiration, mitochondria-derived ROS are a major source of 
intracellular oxidative stress. If antioxidant mechanisms are overwhelmed or downregulated, 
mitochondrial ROS can damage mitochondria and in turn yield further production of aberrant 
ROS, giving rise to ‘The Free Radical Theory of Ageing’ (178). Interestingly, in additional to 
its ability to downregulate antioxidant mechanisms (discussed in Chapter 1), TGF-β has 
also been shown to promote mitochondrial-derived ROS in senescent cells. In this study the 
authors also show that TGF-β treatment of fibroblasts induced early NADPH-driven 
transient ROS production WKDW, when removed with WKH DQWLR[LGDQW NAC, was not 
sufficient to ameliorate prolonged disruption of the mitochondrial membrane potential. 
TGFȕ was instead found to decrease complex IV activity, which led to a direct increase in 
ROS (109). The results from this study, therefore, raise an important question as to the 
involvement of mitochondrial-derived ROS in the onset of lens EMT and warrants further 
investigation. 
The present chapter aims to explore the potential role of other growth factors in the onset of 
TGF-β-induced EMT in a Nox4 deficient context. We show the importance of Nox4 in 
maintenance of an epithelial phenotype and establish a potential role of Nox4 deficiency in 
the onset of spontaneous EMT. Additionally, other sources of ROS during TGF-β-induced 
EMT are explored in the absence of Nox4 to observe whether these can take the place of 
Nox4-derived ROS.  
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5.2 Materials and Methods 
5.2.1 Transgenic Mouse Lines 
Primary	
Antibody	
Species	
Reactivity	
Manufacturer	 Catalogue	
Number	
Dilution	 Secondary	
Antibody	
Nox4	 Rabbit,	
polyclonal	
Santa	Cruz,	USA	 sc-30141	 1:50	 Invitrogen	 Alexa	
fluor	IgG	594	
αSMA	 Mouse,	
monoclonal	
Sigma-Aldrich,	
USA	
A2547	 1:100	 Invitrogen	 Alexa	
fluor	IgG	488	
E-cadherin Mouse,	
monoclonal	
Cell	 Signalling	
Technolgies,	USA	
3195S	 1:100	 Invitrogen	 Alexa	
fluor	IgG	488	
Β-crystallin	 Rabbit,	
polyclonal	
Made	in-house	 n/a	 1:50	 Invitrogen	 Alexa	
fluor	IgG	594	
Total	Smad2/3	 Rabbit,	
monoclonal	
Cell	 Signalling	
Technolgies,	USA	
8685S	 1:100	 Invitrogen	 Alexa	
fluor	IgG	594	
The same TGF-β overexpressing and Nox4-deficent mouse lines were used as described in 
Chapter 4. These mice were genotyped using the same protocol and crossed to yield mice 
overexpressing TGF-β in the lens on Nox4-deficient background (TGFβGOF/NKO) (refer to 
4.2.3).  
5.2.2 Preparation of Media and Lens Epithelial Explants 
Please Refer to Chapter 2 (2.2.1-2.2.5) for detailed methodology as to how lens epithelial 
explants were prepared and grown in culture. As previously described (13), explants were also 
treated with both a high 100ng/ml and low 5ng/ml dose of human recombinant FGF2 
(Peprotech, USA). In the present Chapter, epithelial explants were prepared from wildtype and 
Nox4deficient lenses, such that any changes to the phenotype of Nox4-deficient explants 
could be directly compared to an identically prepared wildtype control. 
5.2.3 Immunofluorescent Analysis 
Please refer to Chapter 2 (2.3.1-2.3.3) for detailed methodology as to how lens explants were 
immunolabelled and viewed using confocal microscopy. The table below outlines primary 
antibodies used in the present chapter and their corresponding secondary antibodies (Table 
5.1). 
Table 5.1 Summary of all primary DQG FRUUHVSRQGLQJ VHFRQGDU\ antibodies used for immunofluorescence
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5.2.5 DHE ROS Detection 
At the conclusion of the treatment period, 1µL of 30mM DHE (Life Technologies, USA) 
(reconstituted in DMSO, according to manufacturer’s instructions) was added to each dish 
containing 1mL of Hank’s Balanced Salt Solution to yield a working concentration of 30µM. 
Dishes were returned to the incubator for 30 minutes. Explants were then rinsed in cold PBS 
(3 x 15 seconds), before being mounted in 40µl 10% glycerol/PBS. In its reduced form, DHE 
typically fluoresces blue; however, it undergoes oxidation in the presence of the superoxide 
anion, enabling it to intercalate with the cell’s DNA and emit red fluorescence; thus staining 
nuclei of cells. Similar to the protocol outlined in 2.3.3, DHE staining was viewed with an 
epifluorescence microscope (Leica-DMLB, Germany) and digital camera (Q-Imaging 
MicroPublisher 3.3 RTV, Canada).  
5.2.6 MitoSox Mitochondrial ROS Detection 
At the conclusion of the treatment period, 1µL of 5mM 0LWR6R[ (Life Technologies, 
USA) (reconstituted in DMSO, according to manufacturer’s instructions) was added to 
each dish containing 1mL of Hank’s Balanced Salt Solution to yield a working 
concentration of 5µM. Dishes were returned to the incubator for 30 minutes. Explants were 
then rinsed in cold PBS (3x 15 seconds) and counterstained with D 1:2000 dilution of 
Hoechst, before being mounted in 40µl 10% glycerol/PBS. Similar to the protocol outlined in 
2.3.3, MitoSox staining was viewed with an epifluorescence microscope (Leica-DMLB, 
Germany) and digital camera (Q-Imaging MicroPublisher 3.3 RTV, Canada).  
5.2.7 qRT-PCR Expression Analysis 
Lenses were explanted and immediately collected. Explants of the same mouse genotype were 
pooled and collected into an Eppendorf tube. The Isolate II Micro RNA Extraction Kit (Bioline, 
UK) was used to extract RNA as per manufacturer’s instructions. 
RNA integrity and concentration ZHUH measured using a NanoDrop spectrophotometer 
and Agilent Bioanalyser. A RIN of  > 9 was considered acceptable. An input cDNA amount of 
200ng had previously been optimised and this was used to perform cDNA synthesis. For 
cDNA synthesis, the SensiFast cDNA synthesis kit (Bioline, UK) was used as per 
manufacturer’s instructions.  
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For qPCR expressional analysis, the SYBR No-ROX kit (Bioline, UK) was used as per 
manufacturer’s instructions to create a mastermix for each gene of interest. cDNA was added 
to each sample such that each gene was tested for each treatment group, ZLWK 2 technical 
replicates and 2 reverse transcriptase controls. These samples were loaded onto a single 384 
well plate and run on a Roche Lightcyler 480 qPCR thermal cycler. The PCR thermal cycling 
conditions were as follows: initial denaturation; 95˚C for 2 minutes; followed by 40 cycles of 
denaturation at 95˚C for 5 seconds, annealing at 63˚C for 10 seconds, extension at 72˚C for 
15 seconds and standard melt-curve analysis after the completion of the thermal qPCR 
cycling. The following primer pairs were used for qPCR in Chapter 5 (Table 5.2) 7KHVH 
For data analysis, the 2^-ΔΔCt method was used to estimate the relative fold change in gene 
expression. Using the 2^-ΔΔCt method, the gene of interest was quantified relative to the 
housekeeping gene, GAPDH.  
Gene	 Accession	 Forward	Primer	 Reverse	Primer	 Amplicon	
GAPDH	 NM_001289726.1	 CAGGAGAGTGTTTCCTCGTCC	 TTCCCATTCTCGGCCTTGAC	 222	
Nox1	 NM_172203.2	 AGGTGTGCATATGGGTGTCA	 GCCAAGGCAGTCCCAAGAAT	 274	
Nox2	 NM_007807.5	 GGGAACTGGGCTGTGAATGA	 CAGTGCTGACCCAAGGAGTT	 147	
Nox3	 NM_198958.2	 AACCTTCGGCCTGGAAATGG	 GAGCGGAGGTGAGAGTGAAG	 240	
Nox4	 NM_001285833.1	 CACCAAATGTTGGGCGATTGT	 GGCTACATGCACACCTGAGA	 221	
p22phox	 NM_007806.3	 TGGAGCGATGTGGACAGAAGT	 TCAATGGGAGTCCACTGCTC	 211	
p40phox	 NM_008677.2	 CTTCAAGGAGGGTCCAGAGAAG	 GCTCAAAGTCGCTCTCTGATCG	 220	
p47phox	 NM_001286037.1	 TGGAGGGCAGAGACAATCCA	 AGGGATAGGAGCCGTCTAGG	 162	
p67phox	 NM_010877.5	 TAAACTGAGCTACCGGCGTC	 ACATTCACGTAGCCAGCACA	 651	
PolDip2	 NM_026389.3	 CAAGTGCTGATTGATGCCCG	 AGTCCAACCCTGGGATAGCA	 121	
Rac1	 NM_001347530.1	 AAAGACAAGCCGATTGCCGA	 AGGATACCACTTTGCACGGA	 90	
Rac2	 NM_009008.3	 GAATGTCCGTGCCAAGTGGTTC	 TTCTCCTTCAGCTTCTCGATGG	 123	
Table 5.2 Summary of all genes of interest for qPCR analysis in Chapter 5 
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JHQHV HQFRGH IRU RWKHU PHPEHUV RI WKH 1$'3+ R[LGDVH IDPLO\ DQG WKHLU UHVSHFWLYH FRUH 
VXEXQLWV
5.3 Results 
5.3.1 Nox4 Deletion Induces DQ EMT Phenotype in LECs 
7R GHWHUPLQH ZKHWKHU 7*)ȕDORQH ZDV DEOH WR LQGXFH WKH DFWLYDWLRQ RI RWKHU 526 VRXUFHV, 
OHQV HSLWKHOLDO H[SODQWV ZHUH SUHSDUHG IURP ERWK :7 DQG 1R[GHILFLHQW OHQVHV ,Q XQWUHDWHG 
:7 OHQVHV, /(&V UHPDLQHG FXERLGDO LQ PRUSKRORJ\ RYHU  GD\V RI FXOWXUH ZKHUH 
HSiWKHOiDO FHOOs ZRXOG SURJUHssiYHO\ DJJUHJDWH FORsHU RYHU WKH FXOWXUH SHUiRG )LJ  
$(, ZKHUHDV, LQ 7*)ȕWUHDWHG H[SODQWV, /(&V H[KLELWHG FHOOXODU HORQJDWLRQ, WKDW 
SURJUHVVLYHO\ LQFUHDVHG RYHU  GD\V RI FXOWXUH )LJ  )- ,W ZDV LQWHUHVWLQJ WR QRWH WKDW 
WKHUH ZDV QR HYLGHQFH RI FHOO GHDWK E\ GD\V  RI FXOWXUH ZLWK 7*)ȕ )LJ  -, FRPSDUHG WR 
XQWUHDWHG :7 H[SODQWV )LJ  $ ,Q DGGLWLRQ, RQO\ 7*)ȕWUHDWHG :7 PRXVH OHQV 
HSLWKHOLDO H[SODQWV H[KLELWHG PDUNHG XSUHJXODWLRQ RI Į60$ H[SUHVVLRQ E\  GD\V RI FXOWXUH 
)LJ  % 
:KHQ WKH DERYH VWXGLHV ZHUH UHSOLFDWHG XVLQJ /(& H[SODQWV SUHSDUHG IURP 1R[GHILFLHQW 
1.2 PLFH, XQWUHDWHG 1.2 H[SODQWV ZHUH QRW LQLWLDOO\ VWDEOH LQ FXOWXUH 2YHU  GD\V RI 
FXOWXUH, XQWUHDWHG 1.2 /(&V H[KLELWHG PDUNHG HORQJDWLRQ DQG WKH IRUPDWLRQ RI UHIUDFWLOH 
ERGLHV, DOWKRXJK QR FHOO ORVV ZDV HYLGHQW )LJ  $( 7R JDLQ DQ DSSUHFLDWLRQ RI ZKHWKHU 
WKLV SKHQRPHQRQ ZDV EHLQJ LQWULQVLF WR WKH FHOOV RU SRWHQWLDOO\ GULYHQ E\ RWKHU IDFWRUV, WKH 
FRQGLWLRQHG PHGLD ZDV UHPRYHG DQG UHSODFHG ZLWK IUHVK PHGLD HDFK GD\ RI FXOWXUH ,W ZDV 
LQWHUHVWLQJ WR QRWH WKDW ZKLOH /(&V LQ WKH XQFKDQJHG PHGLD XQGHUZHQW WKH DIRUHPHQWLRQHG 
PRUSKRORJLFDO FKDQJHV E\ GD\  RI FXOWXUH )LJ  $, %, /(&V PDLQWDLQHG LQ IUHVK PHGLD 
ZHUH PRUH VWDEOH LQ FXOWXUH DQG UHWDLQHG WKHLU HSLWKHOLDO PRUSKRORJ\ )LJ  &, ' 7KLV 
µVSRQWDQHRXV¶ (07 SKHQRPHQRQ GLG QRW DOZD\V RFFXU DQG VRPH RI WKH H[SODQWV ZHUH DEOH WR 
UHWDLQ WKHLU HSLWKHOLDO PRUSKRORJ\ LUUHVSHFWLYH RI DQ\ FKDQJHV WR WKH JURZWK PHGLXP :H 
VXEVHTXHQWO\ SURSRVHG WKDW WKLV µVSRQWDQHRXV¶ (07 SKHQRPHQRQ PD\ KDYH EHHQ GXH WR WKH 
YDU\LQJ GHJUHHV RI /(& FRQIOXHQF\ LPPHGLDWHO\ DIWHU H[SODQWLQJ HVVHQWLDOO\, WKH OHVV 
FRQIOXHQW WKDW FHOOV ZHUH RQ DQ H[SODQW, WKH JUHDWHU WKH SURSHQVLW\ IRU WKHP WR XQGHUJR WKLV 
VSRQWDQHRXV (07 ,W ZDV IRXQG WKDW ZKHQ 1.2 H[SODQWV ZHUH PRUH FDUHIXOO\ KDQGOHG iQ 
sXFK D ZD\ WKDW WKHiU FRQIOXHQF\ ZRXOG EH PD[iPisHG, WKH\ UHWDLQHG WKHLU FXERLGDO HSLWKHOLDO 
PRUSKRORJ\ RYHU WKH  GD\V RI FXOWXUH )LJ  $( 2YHU  GD\V RI FXOWXUH, QRQFRQIOXHQW 
H[SODQWV ZHUH IRXQG WR ODEHO SRVLWLYHO\ IRU Į60$ )LJ  $, &, ', ZKHUHDV FRQIOXHQW 
H[SODQWV H[KLELWHG EDVDO Į60$ H[SUHVVLRQ )LJ  (, *, + ,PSRUWDQWO\, ZKHQ WKHVH 
FRQIOXHQW H[SODQWV ZHUH WUHDWHG ZLWK 7*)ȕ, WKH\ XQGHUZHQW WKH W\SLFDO (07 UHVSRQVH 
H[KLELWLQJ HYLGHQFH RI HORQJDWLRQ, FHOO ORVV DQG FDSVXODU ZULQNOLQJ )LJ  )- 
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Figure 5.1 TGF-β induces EMT in postnatal day 21 (3) wildtype (:T) mouse explants. 
Lens epithelial explants from WT lenses were prepared and left untreated (A-E) or treated with 
TGF-β2 (F-J). Untreated explants remained cuboidal over 5 days of culture. Whereas, TGF-β 
treated explants started to exhibit cellular changes by two days of culture (G) such as blebbing 
(yellow arrow) and elongation. Representative photos are shown vertically Day 1-5.
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Figure 5.2 TGF-β induces αSMA expression in wildtype (:T) mouse explants. Lens 
epithelial explants from P21 lenses were prepared and left untreated $ or treated with TGF-
β2 (B). After 5 days of culture, explants were fixed and immunolabelled for αSMA. 
Untreated explants remained cuboidal over 5 days of culture and did not label positively 
for αSMA. Whereas, TGF-β treated explants exhibited elongated nuclei and noticeable αSMA 
labelling that localised to stress fibres.
115
A: NKO Day 1 B: NKO Day 2
C: NKO Day 3 D: NKO Day 4
E: NKO Day 5 100µm
Figure 5.3 p21 Nox4-deficient (NKO)
explants are not stable in culture. Lens
epithelial explants from p21 NKO lenses were
prepared and cultured in M199 media for 5
days. Representative photos are shown from
Day 1-5 (A-E, respectively). Lens epithelial
cells (LECs) were found to undergo
elongation by 2 days of culture and exhibit
evidence of blebbing (yellow arrow).
Evidence of capsular wrinkling was also
observed (yellow arrowhead)
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100µm
A: NKO Day 1 B: NKO Day 3 without media change
C: NKO Day 1 D: NKO Day 3 with media change
Figure 5.4 Spontaneous LEC elongation in p21 NKO explants driven by endogenous
signalling. NKO explants were prepared and left untreated in culture for 3 days. Explants were
either cultured in the same media (A, B) or fresh media that was replaced at the end of each day
(C, D). Representative phase-contrast photos are shown at Day 1 (A, C) and Day 3 (B, D) of
culture. By 3 days of culture, explants in unchanged media exhibited cell blebbing (yellow
arrowhead) and patches of denuded lens capsule (yellow arrow). Whereas, explants in freshly
renewed media retained an epithelial morphology.
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Figure 5.5 Spontaneous LEC elongation in 3 NKO explants is abrogated by 
they were carefully handled and cultured for 5 days WR HQsXUH PD[iPXP FRQIOXHQF\. Explants 
were either left untreated (A-E) or treated with TGF-β2 (F-J). Representative phase-contrast 
photos are vertically shown of each day throughout the culture period. Untreated explants 
were largely stable throughout the culture period and remained epithelial until day 5 (E), 
where some evidence of blebbing and/or mitosis was observable (yellow arrowhead). 
Whereas, TGF-β treated explants exhibited marked elongation and evidence of cell loss and 
capsular wrinkling (yellow arrow).
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confluent explant preparation. NKO explants were prepared slowly and in a manner in which 
5.3.2 Endogenous TGF-β Signalling Mediates Spontaneous EMT in NKO LECs  
7R GHWHUPLQH ZKHWKHU 7*)ȕ VLJQDOOLQJ ZDV EHLQJ HQGRJHQRXVO\ DFWLYDWHG LQ QRQFRQIOXHQW 
1.2 /(&V, QXFOHDU W6PDG WUDQVORFDWLRQ ZDV XVHG DV D PDUNHU IRU µDFWLYH¶ 7*)ȕ 
VLJQDOOLQJ &HOOV IURP :7 OHQVHV H[KLELWHG EDVDO F\WRVROLF ODEHOOLQJ IRU W6PDG LQ XQWUHDWHG 
H[SODQWV )LJ  $& 8SRQ WUHDWPHQW ZLWK 7*)ȕ, W6PDG WUDQVORFDWHG WR WKH QXFOHXV RI 
/(&V, HYLGHQW E\ WKH FRORFDOLVDWLRQ RI WKH ODEHO ZLWK WKH QXFOHDU FRXQWHUVWDLQ )LJ  ') 
7KH QRQFRQIOXHQW 1.2 H[SODQWV ZHUH IRXQG WR H[KLELW QXFOHDU W6PDG WUDQVORFDWLRQ 
LUUHVSHFWLYH RI 7*)ȕ WUHDWPHQW )LJ  $& DQG )LJ  '), UHVSHFWLYHO\ 7KH GRZQVWUHDP 
HIIHFWV RI 6PDGVLJQDOOLQJ ZHUH WKHQ REVHUYHG XVLQJ WKH 6PDG VHOHFWLYH LQKLELWRU 6,6 1RQ
FRQIOXHQW 1.2 H[SODQWV WUHDWHG ZLWK 6,6 UHWDLQHG D FXERLGDO HSLWKHOLXP RYHU  GD\V RI 
FXOWXUH VXJJHVWLQJ WKDW WKH VSRQWDQHRXV (07 SKHQRW\SH ZDV 7*)ȕ PHGLDWHG YLD 6PDG 
VLJQDOOLQJ  
1RQFRQIOXHQW 1.2 H[SODQWV WKDW ZHUH IL[HG DW D VWDJH ZKHUH WKH\ ZHUH DOUHDG\ FRPPLWWHG WR 
DQ (07 IDWH  KRXUV RI FXOWXUH ZHUH FRPSDUHG WR H[SODQWV QRQFRQIOXHQW H[SODQWV WUHDWHG 
ZLWK 6,6 DW WKH VDPH WLPHSRLQW ,W ZDV IRXQG WKDW 6,6 WUHDWPHQW LPPHGLDWHO\ DIWHU 
H[SODQWLQJ ZDV DEOH SUHYHQW ORQJ WHUP W6PDG QXFOHDU WUDQVORFDWLRQ DQG Į60$ 
DFFXPXODWLRQ )LJ  (+ LQ QRQFRQIOXHQW H[SODQWV 7KLV ZDV LQ FRQWUDVW WR XQWUHDWHG 
1.2 H[SODQWV WKDW H[KLELWHG HQKDQFHG Į60$ODEHOOLQJ DQG SHUVLVWHQW QXFOHDU W6PDG 
ORFDOLVDWLRQ )LJ  $' ,QWHUHVWLQJO\, ZH VKRZHG WKDW ZKHQ (5. ZDV 
SKDUPDFRORJLFDOO\ EORFNHG ZLWK 82, WKLV ZDV DOVR DEOH WR LPSHGH QXFOHDU W6PDG 
WUDQVORFDWLRQ )LJ  $& 7DNHQ WRJHWKHU, WKHVH ILQGLQJV VXJJHVW DQ LPSRUWDQW UROH IRU 
1R[ LQ WKH PDLQWHQDQFH RI WKH HSLWKHOLDO SKHQRW\SH DQG WKLV PD\ EH PHGLDWHG YLD LQWHUSOD\ RI 
6PDG DQG (5.VLJQDOOLQJ ,W LV DOVR HYLGHQW WKDW 1R[ GHILFLHQF\ LV DEOH WR GLUHFWO\ 
5.3.3 FGF2 protects against spontaneous EMT in NKO explants 
In non-confluent XQWUHDWHG NKO explants, a basal level of β-crystallin expression was not 
observed compared to confluent NKO explants (compare Fig 5.6 B vs. 5.6 F, respectively) as 
the myofibroblastic phenotype predominated. Knowing the importance of FGF2 on the 
regulation and accumulation of β-crystallin in lens ILEUH development, we next decided to treat 
non-confluent explants with varying dosages of FGF2. It was found that FGF2 treatment was 
sufficient to abrogate the previously described spontaneous EMT in NKO LECs. Explants that 
were cultured for 5 days in the presence of a low non-differentiating dose (5ng/ml) of FGF2 
did not undergo spontaneous EMT and exhibited basal levels of both β-crystallin and αSMA 
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Figure 5.6 Confluent 3 NKO LECs do not undergo spontaneous EMT. NKO explants 
were prepared in a manner in which they were either carefully handled (E-H) or normally 
explanted (A-D) and cultured for 5 days. Explants were then fixed and immunolabelled for 
αSMA (green), β-crystallin (red) and counterstained with Hoechst (blue). Gently handled 
explants exhibited low basal expression labels for both αSMA and β-crystallin. Whereas, 
explants that were handled normally exhibited a strongly stress fibre label for αSMA and no 
labelling for β-crystallin
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Figure 5.7 TGF-β2 induces nuclear tSmad2/3 translocation in 3 wildtype (:T) explants. 
WT explants were prepared normally and cultured with (D-F) and without TGF-β (A-C) for 1 
day. Explants were then fixed and immunolabelled for, tSmad2/3 (red) and counterstained with 
Hoechst (blue). In untreated explants, tSmad2/3 exhibited cytoslic labelling. Whereas, TGF-β-
treated explants exhibited a label for tSmad2/3 that colocalised with the nuclei.
124
AB
C
D
E
F
20µm
WT: Untreated WT: +TGFβ
H
o
e
c
h
st
tS
m
a
d
2
/3
M
e
rg
e
d
125
Figure 5.8 Non-confluent 3 NKO LECs promote nuclear tSmad2/3 translocation. NKO 
explants were prepared normally and cultured for 1 day with (D-F) and without TGF-β (A-C). 
Explants were fixed and immunolabelled for, tSmad2/3 (red) and counterstained with Hoechst 
(blue). In both untreated and TGF-β-treated explants, tSmad2/3 exhibited a label for tSmad2/3 
that colocalised with the nuclei.
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100µm
Figure 5.9 Abrogation of spontaneous lens
epithelial cell (LEC) elongation by SIS3 in
p21 NKO explants. p21 NKO lens epithelial
explants were prepared normally and cultured
in media for 5 days with the Smad3 inhibitor,
SIS3. Representative photos are shown from
Day 1-5 (A-E, respectively). LECs remained
epithelial throughout the culture period and
exhibited evidence of cytoplasmic projections
(yellow arrow) and mitosis (yellow
arrowhead) in areas of denuded lens capsule.
A: NKO +SIS3 Day 1 B: NKO +SIS3 Day 2
C: NKO +SIS3 Day 3 D: NKO +SIS3 Day 4
E: NKO +SIS3 Day 5
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Figure 5.10 Abrogation of spontaneous EMT by SIS3 in p21 NKO explants. NKO explants
were prepared normally and cultured for 5 days with (E-H) or without SIS3 (A-D). Explants
were fixed and immunolabelled for αSMA (green), tSmad2/3 (red) and counterstained with
Hoechst (blue). Untreated explants exhibited noticeable labelling for αSMA and nuclear
tSmad2/3. Whereas, SIS3-treated explants exhibited a low basal αSMA and cytosolic tSmad2/3
label.
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)LJ 5.12 A-D). 7KLV low-dose treatment ZLWK FGF2 in WT explants did not yield any 
noticeable evidence of LQFUHDVHG β-crystallin, nor αSMA expression, DW  GD\V and ZDV 
comparable to that of untreated WT LECs (Fig. 5.13 E-H vs. Fig. 5.13 A-D).  
When the above experiment was repeated using a high ILEUH differentiating-dose of 
FGF2 (100ng/ml), the spontaneous EMT phenotype LQ QRQFRQIOXHQW H[SODQWV was also 
suppressed. Interestingly,  this higher dose of FGF2 that is known to normally induce lens 
fibre cell differentiation, only induced ORZ β-crystallin ODEHOOLQJ and localisation in NKO 
LECs (5.12, F). In these explants, αSMA expression also appeared to be partially 
augmented, as cells exhibited incomplete stress fibre formation (5.12, G). This was in 
contrast to WT LECs WKDW exhibited elongated LECs that labelled positively for β-crystallin 
(Fig 5.14 B, F) upon high-dose FGF2 treatment.  It was noted that in peripheral regions of the 
FGF2 treated WT explantV, there was a strong stress-fibre label for αSMA (Fig 5.14 E-H); 
however, in central regions of the same explant, FGF2 treatment yielded more of a 
heterogenous cell population, with cells labelling positively for either β-crystallin or αSMA 
(Fig 5.14 A-D).  
5.3.4 Alternative ROS Sources to Nox4 in TGF-β-induced EMT 
The pleiotropic nature of TGF-β signalling suggests that there are many downstream 
effectors that could potentially activate other sources of ROS, other than Nox4 to influence 
EMT. In order to elucidate this potential mechanism further, we decided to use ROS 
fluorogenic probes in NKO LECs. To establish that Nox4 is upregulated at early timepoints 
during TGF-β-induced EMT, we initially H[DPLQHG Nox4 expression at 8 hours in WT 
explants. It was found that TGF-β was able to upregulate Nox4 expression compared to 
untreated WT explants (Fig. 5.15 D-F vs. Fig. 5.15. A-C).  
As Nox4 is constitutively active upon expression, we next decided to use this 8hour 
timepoint to probe for ROS using the superoxide probe DHE. In WT LECs, TGF-β treatment 
induced elevated ROS labelling at 8 hours and also at 48 hours, when compared to FHOOV RI 
untreated WT explants (Fig. 5.16 A-C). In contrast, there was no notable ROS labelling at 8 
hours in NKO OHQV explants (Fig 5.16 E), comparable to untreated explants (Fig 5.16 D); 
however, ROS labelling increased at 48 hours DIWHU treatment with TGF-β in NKO explants 
(Fig 5.16 F), thus suggesting that TGF-β FDQ upregulate ROS production independent of 
Nox4 expression. 
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A: Hoechst B: tSmad2/3
C: Merged
Figure 5.11 ERK1/2 inhibition abrogates
tSmad2/3 nuclear translocation in p21 NKO
explants. NKO explants were prepared
normally and cultured for 1 day with the
ERK1/2 inhibitor UO126. Explants were fixed
and immunolabelled for tSmad2/3 (red) (B)
and counterstained for Hoechst (blue) (A).
SIS3 was found to inhibit nuclear
translocation of tSmad2/3.
20µm
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Figure 5.12 FGF2 abrogates generation of spontaneous EMT phenotype in 3 NKO 
LECs. NKO explants were prepared normally and cultured for 5 days with a high (E-H) or low 
dose (A-D) of FGF2. Explants were then fixed and immunolabelled for αSMA (green), β-
crystallin (red) and counterstained for Hoechst (blue). Explants treated with a low dose of FGF2 
exhibited low basal expression levels for both αSMA and β-crystallin. Whereas, explants treated 
with a high dose of FGF2 exhibited low basal expression levels for β-crystallin and a mixed 
expression label for αSMA. This mixed label showed evidence of cells expressing αSMA in a 
basal manner (white arrow) however, also in stress fibre formation (white arrowhead). 6FDOHEDU 
IRU $' is HTXDO WR  PiFURQs DQG sFDOHEDU IRU (+ is HTXDO WR  PiFURQs
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Figure 5.13 Low-dose FGF2 does not affect αSMA, not β-crystallin protein expression in 
3 wildtype (:T) explants. WT explants were prepared normally and cultured for 5 days with 
(E-H) or without (A-D) a low dose of FGF2 . Explants were then fixed and immunolabelled for 
αSMA (green), β-crystallin (red) and counterstained for Hoechst (blue). Untreated explants 
exhibited no labelliing for either β-crystallin or αSMA. Low dose FGF treated explants 
exhibited no labelling for either β-crystallin or αSMA.
135
AB
C
D
E
F
G
H
20µm
WT: +Hd FGF (Central) WT: +Hd FGF (Perif.)
H
o
e
c
h
st
β-
C
ry
st
a
lli
n
αS
M
A
M
e
rg
e
d
136
Figure 5.14 High-dose FGF2 induces β-crystallin expression in 3 wildtype (:T) 
explants. WT explants were prepared normally and cultured for 5 days with a high dose of 
FGF2. Explants were then fixed and immunolabelled for αSMA (green), β-crystallin (red) and 
counterstained for Hoechst (blue). Representative photos are shown of central (A-D) and 
peripheral (E-H) regions of the explant. In both central and peripheral regions of explants, a high 
dose of FGF induced strong β-crystallin labelling. However, peripheral regions exhibited marked 
stress fibre formation that labelled positively for αSMA. αSMA expression was also noted in 
central regions, albeit not in a stress fibre formation.
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Figure 5.15 TGF-β2 induces Nox4 expression in 3 :T LECs. WT explants were prepared 
normally and cultured for 8 hours with (D-F) and without (A-C) TGF-β. Explants were then 
fixed and immunolabelled for Nox4 (red) and counterstained for Hoechst (blue). Untreated 
explants exhibited a low basal label for Nox4. Whereas, TGF-β-treated explants exhibited 
eleavted and punctate cytosolic labelling for Nox4.
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Figure 5.16 TGF-β2 induces ROS at 48 hours in both 321 NKO and :T explants. WT (A-
C) and NKO (D-F) explants were prepared normally and cultured for 8 hours (B, E) and 48 
hours (C, F) with TGF-β. Explants were then labelled using the superoxide probe DHE (red). In 
untreated explants at 48 hours (A, D), no notable DHE labelling was observed. Upon treatment 
with TGF-β at 8 hours, WT explants exhibited notable labelling for DHE (B), whereas NKO 
explants exhibited no labelling for DHE (E). Interestingly, both WT (C) and NKO (F) explants 
displayed strong labelling for DHE at 48 hours of treatment with TGF-β.
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This above experiment was repeated using the mitochondrial ROS probe, MitoSox. It was 
found that upon TGF-β treatment, OHQV FHOOV LQ WT explants exhibited a fluorescent label 
compared to that of untreated explants at 8 hours (Fig. 5.17 B & A, respectively). At 48 
hours of TGF-β treatment, certain LECs exhibited a slight elevation of MitoSox labelling 
(Fig. 5.17 C). A similar trend was observed in NKO OHQV explants, where TGF-β treatment 
did not induce noticeable MitoSox labelling at 8 hours compared to untreated explants (Fig. 
5.17 E & D, respectively); however, explants that were treated with TGF-β for 48 hours 
exhibited marked elevation for MitoSox labelling (Fig. 5.17 F) compared to both untreated 
NKO explants (Fig. 5.17 D) and also WT TGF-β treated explants at 48 hours (Fig. 5.17 C). 
To serve as a positive control for the observed MitoSox label, explants from 321 TGF-βGOF 
mice were also imaged. The LECs and pyknotic cells of the plaque from these explants 
displayed enhanced cytosolic labelling for MitoSox (Fig. 5.17 G). These findings suggest that 
in the absence of Nox4, TGF-β could induce elevated mitochondrial-derived ROS as a 
putative compensatory ROS source.  
In addition to mitochondrial ROS, another potential source of ROS that could drive the 
observed increase in DHE fluorescence in NKO explants, ZRXOG EH other members of the 
Nox family. To explore this further, we collected explants from 321 mice from the same 
genotypes used HDUOLHU in Chapter 4 (Wildtype, WT; TGFβGOF; NKO; and TGF-β 
overexpressing mice that were Nox4 deficient, TGFβGOF/NKO). Nox1-4 are known to be 
expressed in mouse. Therefore, we initially explored the expression of these genes in the 
genotypes of the present study. Relative to WT OHQV H[SODQWV, Nox1 (Fig 5.18 A) and Nox3 
(Fig 5.18 C) expression did not appear to be affected LQ H[SODQWV RI either TGF-β*2) 
overexpression and/or Nox4 deficiency. Nox4 was found to be significantly upregulated in 
TGFβGOF explants, with a ~5-fold increase in expression relative to WT explants (Fig 5.18 
D). Interestingly, Nox2 was found to be upregulated ~9-fold in TGFβGOF/NKO explants 
relative to WT explants (Fig 5.18 B). FurtherPRUH, Nox2 expression was significantly 
elevated relative to TGFβGOF lenses (Fig 5.18 B; TGFβGOF vs. TGFβGOF/NKO, p= 0.0004), 
thus suggesting that D loss of Nox4 UHVXOWHG in the FRPSHQVDWRU\ upregulation of Nox2.  
Having established that deletion of Nox4 could promote compensatory upregulation of Nox2, 
we next decided to explore whether this correlated DOVR ZLWKc hanges to WKH H[SUHVVLRQ RI 
some of the key Nox UHJXODWRU\ subunits. Rac1, Rac2, p22phox, p67phox and PolDip2 (Fig. 
5.19 A, B, C, F, G) did not exhibit significant changes in expression between the 4 
genotypes. 
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Figure 5.17 TGF-β2 induces ROS at 48 hours in both 3 NKO and :T explants. WT (A-
C) and NKO (D-F) explants were prepared normally and cultured for 8 hours (B, E) and 48 
hours (C, F) with TGF-β. Explants were then labelled using the mitochondrial reactive oxygen 
species probe MitoSox (red), counterstained with Hoechst (blue). Representative photos are 
shown of merged micrographs. In untreated explants (A, D), no notable MitoSox labelling was 
observed. Upon treatment with TGF-β, neither WT (B) nor NKO (E) explants exhibited labelling 
for MitoSox, Interestingly, both WT (C) and NKO (F) explants displayed strong labelling for 
MitoSox at 2 days of treatment with TGF-β. MitoSox was also found to label strongly in the 
FHOOs of TGFβGOF explants (G).
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Figure 5.18 nox4 deletion induces upregulation of nox2 in TGFβGOF explants. Lens
epithelial explants were collected from p21 mice, lysed for the purpose of RNA extraction and
quantitative reverse transcriptase PCR (qPCR). qPCR was performed to detect mRNA transcript
levels from nox1 (A), nox2 (B), nox3 (C) and nox4 (D). mRNA expression levels are shown as
the fold-change relative, firstly, to GAPDH and, secondly, to wildtype (WT). Statistical analysis
was performed using one-way ANOVA with Tukey’s post-hoc analysis (2-tailed). *P <
0.05,**P < 0.01, ***P < 0.001 and ****P < 0.0001. Error bars: SEM. n=3 individual
experiments.
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Figure 5.19 Nox4 deletion induces compensatory upregulation of p47phox in TGFβGOF
explants. Lens epithelial explants were collected from P21 mice, lysed for the purpose of RNA 
extraction and qPCR. qPCR was performed to detect mRNA transcript levels from rac1 (A), 
rac2 (B), p22phox (C), p40phox (D), p47phox (E), p67phox (F), and poldip2 (G). mRNA 
expression levels are shown as the fold-change relative, firstly, to GAPDH mRNA and, 
secondly, to WT. Statistical analysis was performed using one-way ANOVA with Tukey’s 
post-hoc analysis (2-tailed). *P < 0.05,**P < 0.01, ***P < 0.001 and ****P < 0.0001. Error 
bars: SEM. n=3 individual experiments.
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SSKR[ H[SUHVVLRQ ZDV VLJQLILFDQWO\ XSUHJXODWHG LQ OHQVHV RI ERWK 7*)ȕ*2) )LJ  ', 
aIROG DQG 7*)ȕ*2)1.2 )LJ  ', aIROG UHODWLYH WR :7 OHQVHV, DOWKRXJK, WKH 
DEVHQFH RI 1R[ DSSHDUHG WR SDUWLDOO\ VXSUHVV WKLV XSUHJXODWLRQ )LJ  ' 7*)ȕ*2) YV 
7*)ȕ*2)1.2, S SSKR[ H[SUHVVLRQ ZDV DOVR aIROG XSUHJXODWHG LQ 7*)ȕ*2)
1.2 OHQV WLVVXH, UHODWLYH WR :7 OHQV 0RUH LPSRUWDQWO\, WKLV XSUHJXODWLRQ RI SSKR[ ZDV 
DOVR VLJQLILFDQW FRPSDUHG WR 7*)ȕ*2) OHQV )LJ  ( 7*)ȕ*2) YV 7*)ȕ*2)1.2, 
S , VXJJHVWLQJ WKDW WKH ORVV RI 1R[ PD\ DOVR OHDG WR WKH FRPSHQVDWRU\ XSUHJXODWLRQ 
RI WKH HVVHQWLDO 1R[ VXEXQLW, SSKR[
5.4 Discussion 
In the present chapter, we have described an important role for Nox4 in the maintenance of 
the epithelial phenotype; in that its deletion promoted a spontaneous EMT event in QRQ
FRQIOXHQW explanted cells. This process was found to be likely regulated by endogenous TGF-
β signalling SUHVHQFH RI QXFOHDU W6PDG, VXSSRUWHG E\ WKH IDFW WKDW as SIS3 treatment was 
sufficient to pharmacologically block this process, thus suggesting that Nox4 may serve as an 
important protective factor to prevent against aberrant activation of signalling pathways. 
Additionally, in light of Nox4 deletion not yielding complete abrogation of TGF-β-induced 
EMT (described in both Chapters 3 and 4), the present chapter also explored and implicated 
the potential for alternative sources of ROS, such as mitochondria and other Nox’s in lens 
EMT. It was found that in the absence of Nox4, exogenous treatment of TGF-β was able to 
induce mitochondrial ROS and compensatory upregulation of Nox2/p47phox. These findings 
speak to the heterogeneous nature of redox signalling and raise the important question of 
whether Nox4 specifically is required for lens EMT, or whether ROS in general, irrespective 
of the source, are sufficient to facilitate EMT.  
 NR[ GHOHWLRQ LQGXFHG VSRQWDQHRXV E0T SKHQRW\SH 
An initial novel finding of the present chapter was that mouse lens epithelial explants 
deficient for Nox4 yielded a spontaneous EMT phenotype. This is also a somewhat 
paradoxical finding, given that in previous chapters Nox4 deletion/inhibition partially 
abrogated TGF-β-induced EMT. This discrepancy amongst the chapters has likely arisen 
from both the different experimental models and WKH GLIIHUHQW VWUDWHJLHV WR LPSDLU 1R[ used 
throughout the study. Indeed, this lends itself to previous concerns that have been raised 
about the consistency of both Nox4 deletion and overexpression studies and whether these 
are physiologically relevant (179). With WKLV said, it is evident What Nox4 appears to be 
playing a role in DW OHDVW some aspect(s) of the lens EMT process. 
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Spontaneous EMT has been previously described in various models of cancer as a potential 
means of cell dissemination and metastasis (180-182). It has been cited that in vitro changes 
to cell-cell adhesion, cell-ECM adhesion, and to the cytoskeleton are able to epigenetically 
drive epithelial cells to an EMT fate, independent of changes to the genome (183), such as 
those transcriptionally induced by growth-factor-ligand binding events. Increasing matrix 
stiffness and mechanoactivation of integrin signalling pathways have also been shown to 
be key promoters of spontaneous EMT, whereby shear stress to the underlying matrix can 
trigger EMT pathways (184). 
5.4.2 Nox4’s role in spontaneous EMT 
To our knowledge, a role for Nox4 in spontaneous EMT has not been previously explored; 
however, it was noted in the present study that the propensity of spontaneous EMT to occur 
was largely governed by the confluency of the cells in the explant, in that the less confluent 
the cells of an explant, the more likely spontaneous EMT would occur. This finding FRXOG 
suggest an important role for Nox4 in LEC migration across the denuded anterior lens 
capsule . Indeed, Nox4 deletion has been associated with decreased cellular migratory 
capacity in numerous experimental models (179). Due to its association with cell migration, 
RhoA signalling has been centrally implicated in this process, as Nox4 has been shown to 
interact with RhoA via TGF-β signalling (130). It is also possible that Nox4 deletion impacts 
cell adhesion  WR the lens capsule, as Nox4 has been shown to generate hotspots of ROS-
signalling in monoctyes to spatially direct cell adhesion (179). While it is tempting to 
speculate that Nox4 is centrally involved in aspects of both LEC migration and adhesion, and 
that loss of these may potentially drive LECs to a stress-derived EMT fate, the mechanisms 
through which this occurs are yet to be determined. It is also not clear why TGF-β or other 
factors cannot upregulate alternative sources of ROS to compensate for Nox4 loss and allow 
explants to regain confluence; thus, raising the question of whether there are other 
mechanisms at play that may account for this phenomenon.  
5.4.3 Spontaneous EMT in the lens 
In the lens, spontaneous EMT has also been reported in Spry 1- & Spry 2-deficient murine 
lenses; where whole in vivo lenses exhibited ASC plaque formation, and     in vitro explants 
exhibited enhanced sensitivity to exogenous TGF-β treatment compared to wildtype lens  
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WLVVXH (185). The authors of this study propose that these Spry homologs negatively regulate 
EMT in LECs by blocking the effects of TGF-β (185). The importance of TGF-β signalling 
on driving this phenomenon has also been shown in wildtype porcine primary lens epithelial 
cells where a spontaneous EMT phenotype was suppressed upon addition of a TGF-β 
neutralising antibody (44). The fact that this occurred in wildtype cells which were 
trypsinised from an intact capsule reiterates the importance of LECs EHLQJ PDLQWDLQHG DV an 
intact epithelium, cell-ECM contact and that loss of cellular contact increases theLU 
susceptibility to TGF-β.
The two-hit hypothesis of TGF-β has widely been reported as a key event that is necessary 
for TGF-β signal propagation. Thought to be a mechanism against aberrant activation of 
TGF-β signalling, it has previously been reported that an intact epithelium is largely resistant 
to TGF-β and additional events such as contact-disruption are required to initiate EMT 
(186). It is therefore possible to conclude that deletion of Nox4 may impact on some aspect 
of cell-cell adhesion or cell-ECM adhesion and this accounts for NKO LECs being 
susceptible to aberrant TGF-β signalling. It was interesting to note that exogenous FGF2 
treatment abrogated the spontaneous EMT phenotype in NKO LECs, suggesting FGF 
signalling could somehow compensate for WKH loss of Nox4. A potential explanation is that 
the low dose of FGF which is known to induce proliferation in LECs (13) increases the 
cell number via ERK1/2 signalling to rapidly facilitate confluency across the explant; 
thus, negating the need for the stress-induced EMT response. This could also explain why 
elevated pERK1/2 was observed in NKO lenses in vivo, as these cells could have been 
subjected to endogenously upregulated FGF signalling. To that avail, it would have 
been of value to observe whether NKO LECs in vivo were actively proliferating. This 
hypothesis would fit well into the aforementioned proposal of Nox4 deletion impacting on 
cell migration, as RhoA signalling would not be required if this were to occur. ,I 
indeed Nox4 is also critical to cell-ECM adhesion, an increase in cellular 
proliferation would not abrogate the spontaneous EMT phenomenon in NKO LECs. The 
uncoupling of Nox4’s role in both LEC adhesion and migration thus warrants investigation 
and future studies should be directed with this in mind.  
5.4.4 Alternate sources of ROS during TGF-β-induced EMT 
The final and most compelling result of the present chapter was that in the absence of Nox4, 
TGF-β-stimulated LECs still produced ROS. We first found that mitochondrial-derived ROS 
were upregulated in vivo irrespective of Nox4 deletion. It would be of value to characterise 
the 
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specific role of mitochondrial dysfunction and mitochondrial-derived ROS in future studies of 
lens EMT. This is a particularly pertinent research direction given that Nox4 deletion only 
partially abrogated 7*)ȕLQGXFHG (07 both in vivo and in vitro, suggesting that 
prolonged oxidative stress throughout EMT is important for its progression. Indeed, a role for 
chronic oxidative stress has been reported in other experimental models of EMT (187, 188). 
Aside from mitochondrial dysfunction, another unexplored caveat of the present chapter was 
TGF-β’s ability to downregulate antioxidant pathways.  It is possible that chronic oxidative 
stress from mitochondria are able to create a feed-forward loop of TGF-β signalling that 
persistently downregulates antioxidant mechanisms, such as catalase or GSH synthesis 
pathways (110, 112). 
Compensatory upregulation of Nox2 in TGF-β stimulated Nox4-deficient lenses is the most 
notable finding of the present chapter. It was particularly interesting to note that Nox2’s 
functional subunit, p47phox, was also upregulated in these lenses. p47phox has been shown to 
be the central organiser of Nox2, with SH3 binding domains to the other essential subunits 
p67phox and p40phox which are activated when p47phox is phosphorylated (189). 
Phosphorylation of p47phox has been shown to be controlled by many upstream factors such 
as ERK1/2-signalling (190). This raises the possibility that non-canonical TGF-β signalling 
could potentially activate Nox2 in a Nox4-deficient context to facilitate the progression of lens 
EMT.  
To the best of our knowledge, this is the first time the compensatory upregulation of both Nox2 
and p46phox (in place of Nox4) has been observed in any experimental model. Numerous 
studies that have failed to show complete abrogation of pathology with Nox4 deletion have 
suggested that other Nox family member genes could undergo compensatory upregulation 
(151, 191, 192). In one of these studies, qRT-PCR was also used in a similar manner to the 
present chapter in Nox4-deficient cells. Compensatory upregulation other Nox homologs was 
not observed in this SUHYLRXV study (191). 
The discrepancy between the findings of the present chapter and of those previously reported 
is likely attributable to the unique genotype of the mice used in the present study. This is the 
first time the TGF-β overexpressing lines of mice have been crossed to a Nox4-deficient line. 
Given the numerous signalling pathways that TGF-β can simultaneously upregulate, there is 
great potential for it to upregulate Nox2-promoting pathways, Dlthough the mechanism 
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through which Nox4 deletion could yield TGF-β-induced Nox2 is not yet clear. Alternatively, 
given the unique proximal positioning of LECs to the aqueous humour, it is IHDVLEOH that 
TGF-β is directly recruiting other growth factors to upregulate Nox2. Indeed, it has 
previously been shown that TGF-β is capable of inducing autocrine PDGF signalling in a 
hepatocyte model of EMT (193). Therefore, it is possible that Nox2 could be upregulated by 
via TGF-β-mediated PDGF signalling, given that Nox2 is known to be upregulated by PDGF 
in lens (127).  This warrants further investigation, as to the best of our knowledge, TGF-β 
has not been previously shown to upregulate Nox2 in other models. Taken together, these 
findings suggest that there is inherent redundancy in the way that TGF-β-induced lens EMT 
progresses. 
5.4.5 Concluding remarks 
In this chapter, we have shown that in addition to its role in lens pathology, Nox4 also 
appears WR play a vital role in preservation of the epithelial phenotype of LECs in vitro. The 
importance of this association is not yet understood; however, it appears WKDW Nox4 may be a 
critical factor in LEC migration and/or adhesion to the lens capsule and this would require 
further investigation. We have also shown that TGF-β is capable of upregulating other 
sources of ROS in addition to Nox4, and that these are likely playing a role in lens EMT. It is 
evident that these alternate sources of ROS are upregulated at later stages of EMT and that 
Nox4 may not be essential for complete EMT to occur. Alternatively, Nox4 may only play an 
early role in the EMT process. To this avail, it would be of value to use a general ROS 
inhibitor such as GSH or NAC at later stages of EMT to observe whether this can effectively 
block EMT completely. 
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6. General Discussion
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Chapter 6: General Discussion 
6.1 TGF-β upregulates Nox4 in LECs 
The present study, foremost, shows for the first time that Nox4 is present in LECs and is able 
to be upregulated by TGF-β in this tissue. This builds on numerous studies that have reported 
a similar phenomenon in different models of TGF-β-induced pathology (110, 121, 194). 
Smad-signalling, in particular, appears to be pivotal in this regulatory process (121). :KLOH 
the present study did not explore the GLUHFW downstream relationship of Smads on Nox4 
activity, it was found in vitro that just the absence of Nox4 in the mouse lens was sufficient 
for the nuclear translocation of tSmad2/3 (endogenous TGF-β-signaling activity) in LECs, 
leading to a spontaneous EMT phenotype. Together, these findings suggest that Nox4-
derived ROS may be able to feed into Smad-signaling to form a negative feedback loop, with 
TGF-β driving the upregulation of Nox4, as Nox4-derived ROS negatively acts back on the 
Smad2/3-signalling pathway. It is feasible that deletion of Nox4 dysregulated this process 
leading to elevated pSmad2/3 and its nuclear translocation (see Fig. 6.1).  
:KLOH the significance of the Smad - Nox4 interplay is yet to be fully elucidated, the ability 
of ERK1/2 MAPKs to modulate and impact on the TGF-β-induced EMT process lends itself 
to the notion of crosstalk between the downstream canonical and non-canonical pathways of 
TGF-β (34, 40). It was shown in Chapter 5.3.2 that the spontaneous nuclear translocation of 
tSmad2/3 and subsequent EMT could be abrogated upon pre-treatment with the MAPKK/MEK 
inhibitor (UO126) in LECs of Nox 4-deficient explants, suggesting that Smad2/3-activity is at 
least, in part, governed by ERK1/2-signalling, and this may be modulated by Nox4-derived 
ROS. Discussed in Chapter 1.3.4, ERK1/2 is negatively regulated by protein phosphatases that 
are controllable by oxidative changes to cysteines in the enzyme’s active site (195); thus raising 
the possibility that Nox4 is controlling ERK1/2 phosphorylation required for Smad2/3 
phosphorylation. It was also interesting to note that, in Chapter 4, that LECs deficient for Nox4 
had increased levels of pERK1/2. There exists a large body of research that alludes to the 
importance of ERK1/2 on Smad2/3 phosphorylation (41), consistent with the results of the 
present study that suggest that Smad2/3 phosphorylation is dependent on ERK1/2 activity 
(summarised in Fig. 6.1). It must be noted that in Chapter 4 (Fig. 4.13), the absence of Nox4 
in LECs did not result in nuclear tSmad2/3 translocation in vivo, suggesting that ERK1/2 
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activity may only be partly responsible for the phosphorylation and activity of Smad2/3 in situ, 
with other regulatory factors/molecules involved.  
The ability of TGF-β to modulate many downstream signalling pathways simultaneously raises 
important questions as to where the upstream effectors of Nox4 lie, and whether Smad 
signalling is sufficient to induce Nox4. This is complicated by reports in hepatocytes of Nox4 
being negatively regulated by EGF-activation of PI3-K signalling (196). In this model, the 
authors cite that EGF-signalling has a protective effect against TGF-β-induced apoptosis by 
impairing TGF-β-induced oxidative stress caused by Nox4 (196). This is in contrast to LECs 
treated with both TGF-β and EGF, where EGF can augment the TGF-β induced EMT response 
Figure 6.1 Proposed mechanism of Nox4 modulated crosstalk between Smad2/3 and ERK1/2. TGF-β recruits 
and phosphorylates Smad2, Smad3 and Smad4 (not depicted) WKDW upregulates Nox4 protein expression (1). 
Simultaneously, TGF-β activates the upstream signalling pathway WKDW leads to ERK1/2 activation (2) ERK1/2 
is likely also required for Smad2/3 phosphorylation. In the present study, deletion of Nox4 was able to induce 
prolonged Smad2/3 and ERK1/2 phosphorylation, VXJJHVWLQJ that Nox4 is a negative regulator of ERK1/2 signalling 
(3).  
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and that this EMT is dependent on EGFR-signalling (197). In light of these results it would be 
interesting to see if and how concurrent EGF and TGF-β treatment would affect Nox4 activity. 
In the aforementioned study, TGF-β was found to transactivate EGFR-signalling in LECs at 
18 hours of culture (197). Given that in Chapter 3 we showed that Nox4 protein expression is 
detectable in LECs as early as 6 hours of treatment with TGF-β, it would seem unlikely then 
that EGF signalling is impacting on Nox4 expression during lens EMT. Thus, it would appear 
that Smad-signalling is more likely vital for the upregulation of Nox4. The importance of 
Smad3 on Nox4 upregulation has been previously reported in metastatic breast cells (121) and 
future experiments should be directed towards uncoupling this process during lens EMT, 
perhaps through the use of in vitro pharmacological in inhibition of Smad3 by using SIS3, 
or using an in vivo approach RI crossing the TGF-βGOF mice LQ the present study with Smad3-
deficeint mice reported by Yang and colleagues (198) RU WKURXJK DGHQRYLUDO WUDQVIHFWLRQ RI 
7*)ȕ RQ 6PDGGHILFLHQW PLFH UHSRUWHG E\ 5REHUWVRQ DQG FROOHDJXHV .
The specific downstream targets of Nox4 were largely unexplored in the present study; 
however, recent reports indicate that these changes to both ERK1/2 and Smad2/3 
phosphorylation may largely be controlled by oxidative conformational changes to protein 
phosphatases (199). The ability of protein phosphatases to regulate MAPKs, such as ERK1/2 
were discussed in detail in Chapter 1 (66, 195). Given that ERK1/2 activity appeared to 
impact on Smad2/3 phosphorylation, it is possible that Nox4-derived ROS are mediating this 
interplay through changes to the allosteric conformation of phosphatases that would 
regulate the enzyme’s activity. As discussed in Chapter 1, radical molecules such as 
hydrogen peroxide and superoxide are able to reversibly oxidase cysteine residues in the 
active site of phosphatases that change the overall conformation of the enzymes active site, 
thus regulating its activity (64). Future studies should be directed at identifying which 
phosphatases are involved in this process, if any, and assaying for their temporal activity 
levels.  
Protein tyrosine phosphatase-1b (PTP1B) has been reported as a target of Nox4-derived ROS 
and may have an important role in how Nox4 can simultaneously modulate multiple 
signalling pathways. PTP1B, like other phosphatases (195), has been shown to be sensitive to 
oxidative modification which has been directly linked to resultant ERK activity, whereby, 
deletion of PTP1B reduced ERK-activity in numerous experimental models that propose 
PTP1B as an important activator of Erk (200). PTP1B is particularly interesting among 
oxidant-sensitive phosphatases on the basis of its ability to orchestrate EGFR activity through 
Nox4 (132). In a seminal study, it was found in human amniotic epithelial cells that Nox4 
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FRORFDOLVHG ZLWK PTP1B in the endoplasmic reticulum to coordinate the dephosphorylation of 
EGFR (132). In this study, it was proposed that phosphorylated EGFR is internally 
trafficked to the endoplasmic reticulum where Nox4-derived ROS inactivates PTP1B 
and prevents the dephosphorylation of EGFR (132). Such a mechanism could also 
explain why exogenous addition of EGF augments TGF-β-induced EMT in lens (197), as 
persistent EGFR activation by Nox4-derived ROS inactivation of PTP1B may be a major 
contributor to driving LECs to a mesenchymal fate. To that avail, it would also be 
interesting to observe whether the TGF-β-induced transactivation of EGFR at 18 hours in rat 
lens epithelial explants (197) is mediated in part by Nox4-derived ROS. Taken together, the 
results from these prospective studies would provide a detailed understanding of the targets 
of Nox4-derived ROS.  
6.2 Are Nox4-derived ROS important in early stages of lens EMT? 
Given that in Chapter 5 we showed that alternate ROS production mechanisms are able to be 
upregulated in the absence of Nox4, it is somewhat surprising that Smad2/3 and ERK1/2 
activity could be modulated by Nox4 deletion alone. This concern is raised due to Nox4’s 
ability to produce either superoxide (1) and/or hydrogen peroxide (134). These two radical 
molecules/compounds are also able to be produced by many other sources, such as other Nox 
isoforms, including Nox2 (1) or even mitochondrial ROS (58). In Chapter 3, we did not 
observe any changes to Nox2 by TGF-β, either with or without Nox4 inhibition, at a 
relatively early timepoint of 8 hours of culture. Blocking with a pharmacological inhibitor 
may not be sufficient to switch on the transcriptional machinery required to upregulate Nox2; 
however, genetically deleting Nox4 may be the required trigger as we observed. Additionally, 
in Chapter 5.3.4, mitochondrial-derived ROS were only apparent at later stages of in vitro 
culture with TGF-β. It is interesting to note that Nox4 has been shown to cause mitochondrial 
dysfunction and H2O2 production in mitochondria, suggesting that mitochondria are targets of 
Nox4-derived ROS, thus leading to prolonged mitochondrial dysfunction and further ROS 
production through disruption of the mitochondrial membrane potential (201). Taken 
together, given the early upregulation of Nox4 in response to TGF-β, these findings suggest 
that Nox4 may play a more important role in the early stages of lens EMT, such as the initial 
coordination of parallel signalling pathways that are necessary to commit the LECs to an 
EMT fate. The notion of ROS serving a nexus between signalling pathways is largely 
accepted; however, the mechanisms through which ROS are able to coordinate this are poorly 
understood (199).  Moreover, it is likely that alternative sources of ROS are able to drive 
EMT progression either with/without 
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the assistance of Nox4. Given that both in vitro and in vivo Nox4 deletion strategies in the 
present study only yielded partial abrogation of an EMT response, it is likely that other sources 
of ROS are playing a role in the shift to a mesenchymal phenotype in LECs.  
Further uncoupling of the role of Nox4-derived ROS against other sources of ROS would 
provide a better explanation as to why Nox4 inhibition/deletion only delayed the progression 
of TGF-β-induced lens EMT as observed in our studies.  It is apparent that for EMT to progress, 
prolonged or ongoing exposure of LECs to ROS is necessary. Future studies should be directed 
toward understanding the contribution of ROS, as a whole, to the progression of lens EMT, 
and whether lens EMT is dependent on prolonged oxidative stress, irrespective of the source. 
Indeed, it has previously been shown that TGF-β-induced lens EMT could be completely 
blocked upon treatment of LECs with both GSH and catalase (113). To assess the role of ROS 
generally in the onset of lens EMT, TGF-β stimulated LEC explants could be post-treated with 
either GSH or catalase at a stage where LECs are beginning to transdifferentiate. A previous 
study from our lab used this approach to block ERK1/2 signalling (41). It was found that 
ERK1/2 was required for lens EMT initiation; however, that post-treatment to block ERK1/2-
signalling in TGF-β stimulated LECs at later stages of culture, could not abrogate this process 
(41). Given the non-specific nature of GSH, its post-treatment on TGF-β stimulated LECs may 
abrogate EMT and, potentially drive LECs to an apoptotic fate directly (202). If that were to 
be the case, it would be interesting to also see the in vivo effect of GSH on the TGFGOF mice 
used in the present study, given that many cells in anterior subcapsular plaques of TGFGOF mice 
do not undergo apoptosis. This could be achieved by crossing the TGFGOF mice to the GSH-
impaired mouse reported by Fan and colleagues (203). Exacerbation of the 
cataractous phenotype presented by the TGFGOF PLFH would suggest an important role for 
ROS, more generally, in the progression of lens EMT and cataract. 
6.3 Nox4 regulates myofibroblast development in lens EMT 
Our studies in vitro showed that pharmacological inhibition of Nox4 activity could block TGF-
β-induced lens capsular wrinkling in rat epithelial explants. This capsular wrinkling is observed 
and thought to be a by-product of myofibroblast-orchestrated cell contractility that directly 
impacts on the underlying capsule, immediately beneath the myofibroblasts (18, 33). In this in 
vitro model of lens EMT, LECs undergo EMT and apoptosis (202) to reveal capsular wrinkling. 
It was interesting to note that selective Nox4 inhibition entirely abrogated the formation of 
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myofibroblasts, and hence any subsequent capsular wrinkling. If the same putative 
compensatory sources of ROS that were observed in our more recent in situ work, were to also 
be upregulated in vitro, one would assume that myofibroblast formation and the subsequent 
capsular wrinkling, would still take place in the absence of Nox4. Given that TGF-β stimulates 
EMT and also apoptosis in rat lens epithelial explants, it is possible to conceive that LECs are 
already committed to a cell death fate before compensatory upregulation of other ROS sources 
is possible. It is also possible that mitochondrial ROS may be upregulated in these cells; 
however, only for the purpose of driving apoptosis (204). To that avail, the findings of the 
present study suggest an important role of Nox4-derived ROS in the maturation and 
development of myofibroblasts during EMT. 
Although the importance of myofibroblasts in wound healing and pathology is widely known 
(154), the contribution of Nox4-dervied ROS to this process is not fully understood. The results 
of the present study found that in the absence of Nox4, αSMA is not expressed, suggesting that 
Nox4 is required for myofibroblast formation. This raises a question as to whether Nox4-
derived ROS directly impacts on αSMA protein accumulation, or whether Nox4-derived ROS 
indirectly plays a role in the processes leading to myofibroblast development by impeding 
myofibroblast maturation, that is marked by expression of αSMA (139). This vital question has 
been previously raised, as to whether Nox4 could regulate the actual αSMA gene or focal 
adhesion maturation to facility stress fibre assembly (144). The present study observed that 
Nox4 localises at early timepoints to perinuclear regions of the cell, whereas at later stages of 
culture (where LECs are elongated and starting to form myofibroblasts) Nox4 localises along 
αSMA-labelled stress fibres. These findings, therefore suggest a putative dual role for Nox4, 
in that its localisation may determine and/or control its ultimate function. Coupled to findings 
that Nox4 can regulate focal adhesion maturation by specifically oxidising Cys272 and Cys374 
on F-actin (205), it is most likely that Nox4 is impacting on the formation of myofibroblasts 
during lens EMT by mediating stress fibre assembly. Based on our observation that anterior 
subcapsular plaques of younger TGFGOF/NKO lenses did not demonstrate any aberrant ECM 
accumulation, nor notable changes to the lens capsule, it is highly likely that Nox4-derived 
ROS is also playing some role in aberrant ECM turnover that has been reported to precede, and 
be required for myofibroblast maturation  (139).  
It was interesting to note that either by using an in vitro (Chapter 3; selectively inhibiting Nox4) 
or in vivo approach to delete Nox4 (Chapter 4; genetic deletion of Nox4), the effects on TGF-
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β-induced EMT were largely comparable, in that Nox4 deletion delayed changes to the 
underlying lens capsule and also abrogated αSMA protein accumulation. This was a 
particularly interesting finding, as it was initially hypothesised that the wide assortment of other 
growth factors found in the aqueous humour would provide a more physiologically accurate 
representation to further elucidate a role for Nox4, as the exposure of LECs to their native 
aqueous humour would highlight the effects of both Nox4 and TGF-β in the context of other 
homeostatic signalling pathways. However, the Chapter 3 in vitro studies revealed that 
pharmacological inhibition of Nox4 activity delayed the progression of EMT in our explant 
model by slowing TGF-β-induced cell death and also the accumulation of the myofibroblast 
marker, αSMA. These findings were corroborated later in Chapter 4 with our observation that 
the anterior subcapsular plaques in P30 TGFGOF/NKO lenses were phenotypically less severe 
than those observed in P30 TGFGOF lenses, highlighted also by the fact that cells of the 
former plaques did not express αSMA. By P0, in lenses of TGFGOF/NKO mice, we did see 
notably larger plaques with age that were now more comparable to P30 TGFGOF lenses, with 
evidence of extensive capsular remodelling that was not present in TGFGOF/NKO mice 
at P30. A drawback of the present study is that αSMA was not assayed for in P0 lenses and 
this should be addressed in future studies to better this claim. These findings; however, raise 
an important question as to the interplay of myofibroblast formation (as evidenced by αSMA-
labelling) and capsular ECM remodelling, and how these combine to drive EMT. 
Understanding how these processes work and whether they (alone) are able to regulate the 
progression of EMT may open up novel therapeutic targets.  
6.4 Concluding remarks 
The present study is the first of its kind to examine the role for Nox4-derived ROS in TGF-β 
induced EMT in the lens, using both in vitro and in vivo approaches. The results of this study 
add to a growing body of evidence that centrally implicates TGF-β in the upregulation of Nox4. 
It was also evident that there is some interplay between the essential TGF-β signaling 
intermediates, Smad2/3 and ERK1/2, with Nox4; however further research is needed to identify 
the direct upstream promoters of Nox4 expression. Our generation of a mouse line that 
specifically overexpresses TGF-β in lens, on a Nox4-deficint background, is a novel model to 
elucidate a specific role for Nox4 in TGF-β induced EMT in a more physiologically relevant 
context that has not been previously reported. This approach has led to the observation that 
heterogeneous ROS production mechanisms exist in the lens, providing redundancy for the 
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main ROS producers involved in this pathology. To that avail, future studies should be directed 
to understanding the role of ROS in lens EMT as a whole, with a particular emphasis on 
discovering the targets of ROS during EMT. Given the nonspecific nature of ROS targets that 
can simultaneously regulate multiple signaling pathways, understanding the precise role of 
ROS in lens EMT may open the potential of developing novel therapeutic strategies to abrogate 
the development, and or progression of both ASC and PCO. More generally, given that 
oxidative stress arguably plays a role in most diseases, understanding the role of Nox4 and 
other sources of ROS will serve to better our understanding on how these molecules function 
in normal biology and pathology.   
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